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ABSTRACT:
This thesis examines the phagocytic function of blood
monocytes in patients with rheumatoid arthritis (RA) and systemic
lupus erythematosus (SLE). In vitro methods for studying the
kinetics of phagocytosis by blood monocytes have been developed and
validated. In preliminary studies Candida albicans opsonised with
fresh serum was used as the phagocytic test particle, however since
this becomes coated with a number of opsonins including IgG, IgM,
IgA and ccrrplement (C3) two different particles were used in later
studies to distinguish Fc and "complement" receptor mediated
phagocytosis. Fc receptor mediated phagocytosis was studied using
IgG coated Candida albicans while "ccrrplement" receptor mediated
phagocytosis was studied using serum opsonised Saccharcmyces
cerevisiae. Using Ffelfo fragments directed against Clq, C4, C3/C3c,
/5lH and the Fc component of IgG, uptake of the latter particle was
shown to be "complement" dependent and involved mainly C3 (85%) and
to a lesser extent Clq (15%). It was not established whether C3b or
C3bi or both were present on the yeast and hence whether or not the
CR1, CR3 or both receptors were involved.
Initial studies of monocytes frem RA patients using serum
opsonised Candida albicans showed a significant reduction in
phagocytosis by cells from patients with cutaneous vasculitis but
no change in monocytes from patients with active arthritis alone.
Further studies of Fc and "complement" receptor mediated
phagocytosis showed that Fc receptor mediated phagocytosis was
normal but "complement" receptor phagocytosis was depressed in
monocytes from patients with active cutaneous vasculitis and
certain other extra-articular ccnplications of RA. Correlations
were noted between these alterations and tests for circulating
irrmune complexes as well as reduced serum complement levels.
However immunofluorescence studies did not support the possibility
that these changes in phagocytic function were due to receptor
blockade by immune complexes, and serum from patients with
defective monocyte phagocytosis did not inhibit phagocytosis by
normal monocytes. Further studies showed that changes in phagocytic
function are due to the appearance of increased numbers of
mononuclear phagocytes in the circulation with normal Fc but
functionally absent "complement" receptors. These may represent a






Fc and "complement" receptor mediated phagocytosis were also
studied in patients with SLE. A significant proportion of patients
(9/18) had depressed rates of "complement" receptor mediated
phagocytosis and only a snail number (3/18) had depressed Fc
receptor mediated phagocytosis. Although reduced "complement"
mediated phagocytosis was correlated with increased frequency of
disease manifestations there was no correlation with serum DNA or
Clq binding activity, C3 or C4 levels. Serum from SLE patients with
depressed monocyte phagocytosis did not inhibit phagocytosis by
normal monocytes. Preliminary studies suggest that, as in RA
patients, the functional changes in "complement" receptor
phagocytosis may reflect an increase in numbers of mononuclear
phagocytes in the blood with functionally inactive "complement"
receptors. However, study of monocytes frcm the relatives of one of
these patients showed that monocytes from the father had reduced
rates of "ccnplement" receptor mediated phagocytosis thus
suggesting that there may be an inherited predisposition to this
functional abnormality.
Further studies are required to elucidate which "complement"
receptor is involved in these functional abnormalities in monocytes
from RA and SLE patients, and whether the abnormalities reflect
alterations in the number or the function of "complement"
receptors. Alterations in the phagocytic function of peripheral
blood monocytes may reflect receptor blockade by immune ccrrplexes
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HISTORICAL BACKGROUND TO RHEUMATOID ARTHRITIS (RA), SYSTEMIC LUPUS
ERYIHEMATOSUS (SLE), AND THE ROLE OF MACROPHAGES IN IMMUNITY
The use of the term "rheuma" is attributed to Hippocrates ("On
the locations of the human body"; 4th Cent. BC) and means literally
"flowing". The term was used in the humoral theory of disease,
which was based on the belief that ailments were due to
"defluxation of the humours", and referred to the flowing of
"humours" frem the brain to various parts of the body. A later,
13th century Latin derivation of the word is "gutta", meaning a
"drop", which was later corrupted to "gout" and used widely as a
general term to describe any form of rheumatic complaint. The
specific association of "rheumatism" with joint complaints was
first proposed by the French physician Guillaume Baillou
(1558-1616) in a posthumously published work "The Book on
Rheumatism and Back Pain". He wrote - "...one may designate the
condition we are considering inexactly as rheumatism, better as a
sort of precipitation like a seasickness of the vessels (which
vcmit), until better terms offer themselves"! Perhaps a few grains
of truth can be seen hiding in his florid description.
The first clinical description of RA is usually attributed to
Augustin-Jacob Landre-Beauvais (1772-1840) who in 1800 described
nine wemen with a disease which he considered to be a variant of
gout (Short 1959). He believed it was due to a "primary weakness"
and that in contrast to true gout it was associated with poverty.
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Several other descriptions of the clinical features of RA were made
by Jean-Martin Charcot (1881), Robert Adams (1873) and Benjamin
Brodie (1818) but it was Garrod (1892) who coined the term
"rheumatoid arthritis" to enable a distinction to be made frati true
gout and other undifferentiated forms of rheumatism. Later
developments include the histological description of RA nodules by
Douglas Collins in 1937 (Benedek & Rodnan 1982) and the association
of splenomegaly with leucopenia in RA patients described by Felty
(1924).
The discovery of rheumatoid factor (RF), which forms the
cornerstone of our current understanding of the pathophysiology of
the disease, springs frcm Frank Billings hypothesis that RA is a
response to chronic focal infections (Benedek & Rodnan 1982).
Subsequent bacteriological research stimulated by this idea
demonstrated that serum from RA patients caused agglutination of
streptococci. Martin Dawson (1932) later demonstrated that this was
a nonspecific phenomenon and noted that RA serum agglutinated many
other organisms. A few years later Erik Waaler observed that sheep
erythrocytes sensitised with anti-sera were agglutinated by 94% of
RA sera (Benedek & Rodnan 1982). Waaler did not pursue his finding
and Harry Rose independently made the same observation during
serological studies of a Q-fever epidemic. A technician (Elizabeth
Pearce) who had RA, used her own serum as a control and found that
it caused agglutination of sensitised sheep erythrocytes even in
high dilutions. Rose et al (1948) later developed the sheep
erythrocyte feaction as a diagnostic procedure for RA.
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Early descriptions of SLE focussed exclusively on the
cutaneous manifestations of the disease. The first is attributed to
Laurent Biett (1781-1840) who described cutaneous lupus as
"erytheme centrifuge" (Jarcho 1957). Moritz Kaposi (1872) was the
first to recognise the potentially life threatening and systemic
nature of the disease and he described fever, adenopathy and
arthritis as associated features. William Osier (1904) described
the presence of renal failure in two patients with facial erythema
who almost certainly had SLE, and Emanuel Litman and Benjamin Sachs
(1924) later added sterile endocarditis to the list of
manifestations.
The recognition of the auto-immune features of the disease
stem from the demonstration of the LE-cell phenomenon in bone
marrow aspirates by Malcdm Hargr aves et al (1948) an observation
which gave great impetus to clinical and laboratory research. John
Haserick et al (1950) showed that the phenomenon was due to a
gammaglobulin while Miescher and Fauconnet (1954) found that it
could be absorbed from serum by isolated nuclei and suggested that
LE cell factor is an anti-nuclear antibody.
In parallel with these historical developments in the field of
rheumatic disease, the scientific understanding of the nature of
immunity and the bodys defence to infection had also been
developing from the late 19th century onwards. Edward Jenner and
Louis Pasteur had both developed empirical methods for immunisation
and in 1890 von Behring and Kitasato showed that immunity to
tetanus was due to a neutralising substance in the blood which
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could be used to transfer immunity passively to another animal.
Buchner in 1893 and Bordet in 1896 later demonstrated that there
were at least two anti-microbial components in immune serum - one
heat labile and the other heat stable - and it was believed that
these factors entirely accounted for the anti-microbial properties
of serum. In 1901 however Metchnikoff proposed that the blood
phagocytic cells were the more important anti-microbial system and
that serum factors merely "stimulated the phagocytes". Other
studies by Almroth Wright (1903) demonstrated the complementary
nature of serum and cellular factors and that the heat labile
components and specific factors in immune serum were important in
preparing bacteria for phagocytosis. Against this background
Aschoff (1924) described the "reticulo-endothelial system" of cells
which were defined functionally by their ability to take up vital
dyes in vivo, and were believed to play an important role in the
removal of bacteria and effete tissue. However Aschoffs
"reticuloendothelial system" included a rather heterogeneous
collection of cells, such as vascular endothelial cells, many of
which take up material by pinocytotic nonspecific mechanisms, as
well as phagocytic tissue macrophages which are capable of
ingesting large particulate material. The definition of tissue
macrophages and their precursors as a single system - "the
mononuclear phagocyte system" - by more precise functional criteria
has helped to clarify the role of these cells not only in
phagocytosis of microorganisms but also their role in the clearance
of immune complexes, the development of immunity and the regulation
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of the immune response.
The realisation that many "auto-immune" diseases including RA
and SLE are accompanied by the production of immune complexes has
led to a variety of studies on the mononuclear phagocyte system and
its role in the clearance of immune ccrrplexes as well as the
inflammatory consequences of the interaction of irrmune complexes
with phagocytic cells. It was with the purpose of examining the
phagocytic function of blood monocytes from patients with RA and




THE MONONUCLEAR PHAGOCYTE SYSTEM
The concept of the mononuclear phagocyte system (MPS) was first
proposed fcy Langevoort et al (1970) and the cells now included in
the MPS are shown in Table 1 (pl2).
Characterisation of mononuclear phagocytes
A variety of morphological, cytochemical and functional
characteristics may be used to define the cells of the MPS and to
distinguish than frcm lymphocytes, reticulum cells, dendritic
cells, fibroblasts, mesothelial and endothelial cells.
The characteristics used to classify mononuclear phagocytes
are shown in Table 2 (pl2). At the present time it is often
difficult to categorise a cell with only one marker and ideally
classification should be based on more than one property. The
peripheral blood monocyte is a large cell about 10pm or larger in
diameter with a kidney-shaped nucleus and abundant pale-staining
cytoplasm. The electron microscopic appearance of the mononuclear
phagocyte is characteristic - the cytoplasm contains numerous
granules, prominent secretory apparatus, mitochondria and
occasional phagosomes. The lysosomal granules are heterogeneous in
content - seme staining for peroxidase, others for enzymes such as
acid phosphatase and aryl sulphatase. With maturation into the
larger tissue macrophage the peroxidase content diminishes but
phagocytic vacuoles become more evident (van Furth 1976). The most
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used and reliable marker is non-specific esterase (tain et al 1971)
which, using a-napthyl butyrate or acetate as the substrate, gives
a diffuse cytoplasmic stain which is present in most macrophages
and monocytes. However the intensity of staining may vary with the
species, functional and developmental state of the cell (van Furth
et al 1980). Lysozyire is another good marker and can be
demonstrated with immunofluorescence or immunoperoxidase labelled
anti-lysozyrre antibody (van Furth 1980). Cells are usually positive
although sometimes staining is weak. Peroxidase activity varies
with the maturity of the cell. Peroxidase positive granules are
only positive in monoblasts, promonocytes, monocytes and exudate
macrophages while resident macrophages are usually negative. In the
latter peroxidase activity can be demonstrated in the rough
endoplasmic reticulum and Golgi region by electron microscopy
(Daems and van der Rhee 1980).
Functional definition of the cell by demonstrating ingestion
of latex or IgG coated particles is also used but may give rise to
difficulty with less mature cells which are less phagocytic and
have fewer Fc and C3 receptors, (van Furth et al 1980). A variety
of monoclonal antibodies to macrophage membrane antigens are
currently being investigated and may prove useful in the
identification of the various stages of development and
differentiation in the mononuclear phagocyte.
Kinetics of mononuclear phagocytes
Mononuclear phagocytes are present in all tissues and under
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normal conditions proliferate only in the marrow. The earliest
member of the series to be characterised is the monoblast (Goud et
al 1975) which is probably the immediate descendent of the
comnitted stem cell. Division of this cell results in two
promonocytes which are the immediate precursors of the monocyte.
The human monocyte is quickly released from the marrow into the
circulation where it survives for three to four days before leaving
randomly to enter the tissues and beccme a tissue macrophage.
Various eponyms are given to tissue macrophages (Table 1)
according to the site in which they are found. Isotope-labelling
experiments, however, have confirmed that blood monocytes are the
cocrmon source of these anatomically scattered but functionally
homogenous tissue macrophages (van Furth 1980).
The kinetics of turnover of promonocytes, monocytes and tissue
macrophages have been studied with isotope-labelling techniques in
animals with inflarrmatory lesions and in normal controls (van Furth
1980, Meuret and Hoffman 1973, Whitelaw 1972, Blusse van Oud Alblas
et al 1979). These studies show that while normally monocyte
production in the bone marrow and tissue emigration are relatively
slow, during inflanmation there is a doubling in marrow monocyte
output and a large efflux of these cells into the inflammatory
lesion. This results from premature release of monocytes frcm the
bone marrow and a halving of the promonocyte cell cycle time; an
effect which can be blocked by inhibitors of nucleic acid synthesis
such as azathioprine. It has been suggested that the tissue
macrophage is capable of dividing locally at the site of
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inflammation (Dannenberg 1975). However, the contribution of local
cell division to the tissue infiltrate is small and is probably due
to the arrival of immature monocyte precursors released prematurely
frcm the marrow which subsequently divide once, or at most twice,
at the inflamnatory focus (Blusse van Oud Alblas et al 1979, van
Waarde et al 1975).
Studies of human monocyte kinetics suggest that monocyte
traffic is qualitatively similar in man. Using autotransfused
blood cells labelled with tritiated di-isopropyl fluorophosphate
Meuret and Hoffman (1973) found evidence of both a circulating and
a larger marginated pool of monocytes. However, these two pools
formed essentially a single kinetic unit and the ratio of the
circulating and marginated pools was about 1:3.5 in both normal and
diseased subjects. There is doubt as to the significance of these
findings however, since the half-life of 8.4 hours for their
disappearance from the circulation approximates to the half-life of
6 hours for neutrophil polymorphs and is very much shorter that the
half-life of 71 hours found by Whitelaw (1972) using in vivo pulse
labelling with tritiated thymidine. Whitelaw (1979) calculated a
daily output of 9.4xlC^:ells/24hours and demonstrated a 13-26 hour
delay before labelled cells srerged from the bone marrow, giving
seme indication of the cell cycle time. In monocyte distribution
studies in the rat Whitelaw and Batho (1972) found that there were
25 tines more mononuclear phagocytes in the tissues than in the
peripheral blood and that the majority of tissue macrophages were
located in the spleen and lungs. By contrast the vast majority of
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neutrophil polymorphonuclear phagocytes remain in the circulation
during health.
The factors regulating monocyte production in health, and the
signals which stimulate the increase in monocyte production during
inflarrmation, are not fully understood. There is good evidence for
the existence of a humoral "factor inducing monocytopoiesis" (FIM),
which is released both in early acute inflammation and during
prolonged inflairmation (van Waarde at al 1975, van Waarde 1978).
This acts by reducing the promonocyte cell cycle time and, by
monoblast stimulation, increases the number of promonocytes. FIM
appears to be a thermolabile protein of molecular weight
18,000-24,000 which is produced by monocytes at the inflaitmatory
site. Macrophages are also a potent source of colony stimulating
factor (CSF); the generation of CSF by macrophages in an
inflammatory focus may provide an important feed back amplification
circuit stimulating proliferation of monocyte precursors in the
marrow (Eaves and Bruce 1974). With the subsidence of inflammation
a monocyte-inhibiting factor may slow monocytopoiesis by inhibiting
proliferation of monoblasts (van Waarde 1978).
Two morphological varieties of the mononuclear phagocyte found
in inflammatory exudate are the epithelioid cell and the
multinucleate giant cell, both of which have been shewn to be
monocyte derived (van Furth 1980). Epithelioid cells which are
found in granulomata have Fc and C3 receptors but are less
phagocytic than macrophages. In the presence of strong delayed
hypersensitivity reactions the epithelioid cell resembles an
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activated macrophage while in the presence of low immunity it takes
on a secretory constitutive appearance resembling the resident
macrophage. Multinucleate giant cells are formed by fusion of
exudate macrophages and two forms are recognised: the Langhans cell
with a few peripheral nucleii and the foreign body type which has
multiple diffusely distributed nucleii.
The ultimate fate of the macrophage is not known although
there is seme evidence that they migrate to lymph nodes and die
there (McPherson and Steer 1980).
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fixed & free macrophages (lyitph node)
splenic macrophages
bone marrow fixed macrophage
pleural & peritoneal macrophages
osteoclasts (bone)
microglial cell (nervous tissue)
? Langerhans cell (skin)
type A synoviocyte (joint)
exudate, exudate-resident, epithelioid,
multinucleate giant cell.
TABLE 2 Identification of mononuclear phagocytes
Structure - morphology on light, phase-contrast, and
electron microscopy
Cytochemistry - non-specific esterase, lysozyme, peroxidase
Ectoenzymes - 5'-nucleotidase, leucine aminopeptidase,
alkaline phosphodiesterase
Membrane - Fc, C3b, C3bi receptors and
macrophage antigens
Function - immune phagocytosis, pinocytosis
Size - cell volume
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MONONUCLEAR PHAGOCYTE ACTIVATION AND MEMBRANE EVENTS
Introduction
The macrophage has a remarkable ability to respond and adapt
functionally in response to inflammatory and immunological events.
The basis of this physiological plasticity which is termed
"activation" is not yet fully understood but a review of current
understanding of this area provides a basis for discussion of
macrophage phagocytic and receptor functions and their alterations
in health and disease.
Activation and membrane events
The term "activation" was coined by Mackeness (1962, 1969) to
describe macrophages that have enhanced ability to phagocytose and
kill micro-organisms and was a characteristic particularly
associated with infections such as tuberculosis and other
facultative intracellular parasites. It was subsequently shown that
activation can be induced either with the participation of
lymphocytes or with a number of chemical agents including bacterial
endotoxin, polyanions and pyran copolymer which interact with the
macrophage cell membrane. Activation can thus be induced in vivo or
in vitro (Table 3) (p29) (Ogmundsdottir and Weir 1980).
The term "elicited" refers to macrophages attracted to a given
site by non-specific irritants and inflammatory agents such as
thioglycollate and gives no specific indication of their functional
14
state.
A wide variety of biochemical and biological changes occur in
activated macrophages but it is likely that there is a common
initiating pathway for all these events. Some examples are listed
in Table 4 (p2?).
Clearly for each of the known "activating" agents (Table 3) a
stimulus-membrane interaction is likely to be a critical event and
a consideration of the current state of knowledge of
ligand-receptor interactions and their consequences is pertinent to
an understanding of receptor function and "activation" in
macrophages.
The lipid bilayer of cells is composed mainly of phospholipids
which provide a fluid matrix for protein organisation and movement
(Singer and Nicolson 1972). The lipids are asymmetrically
distributed with phosphatidyl ethanolamine largely facing the
cytoplasm and phosphatidyl choline facing the exterior (Rothman and
Lenard 1977). Following a wide variety of receptor-ligand
interactions the earliest event is rapid transmethylation of
phospholipids (reviewed by Hirata and Axelrod 1980). Studies of red
cell ghosts (inside out and right side out!) has revealed that
following receptor stimulation a phosphomethyltransferase (PMT-1)
in the cytoplasmic layer of the lipid bilayer methylates
phosphatidyl ethanolamine to phosphatidyl N-monomethyl
ethanolamine, and the structural change in the latter causes it to
"flip" to the outer layer where it is further methylated by PMT-2
to phosphatidyl choline (the immediate precursor of arachidonic
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acid). The substrate for these methylation reactions is S-adenosyl
methionine (SAM) (Figure 1) (pl$).
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(1) = phosphatidyl ethanolamine
(2) = phosphatidyl monomethylethanolamine
(3) = phosphatidyl choline
SAM = S-adenosyl methionine
PMT = phosphomethyl transferase
The first methylation step causes local reduction of membrane
viscosity, perhaps as a result of the lipid translocation, which
has two important consequences:
a) a transient change in permeability occurs with influx of calcium
(Ca-H-) which"may trigger a number of events including synthesis of
cGMP, activation of phospholipase-A2 (PLA2), and triggering of
contractile elements.
b) the increase in membrane fluidity permits increased
translational movements of proteins in the lipid bilayer and
therefore enhances coupling of receptors with effector enzymes such
as adenyl cyclase.
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These events and their metabolic sequelae have been studied in
several different cell types and a brief description of these model
systems will serve as a reference for subsequent consideration of
receptor function and "activation" in macrophages. The key role
which transmethylation plays in these systems has been demonstrated
using selective inhibitors of transmethylation which include
3-deazaadenosine + L-hcmocysteine-thiolactone or adenosine +
adenosine deaminase inhibitor + L-homocysteine-thiolactone. The
effect of these compounds is to cause accumulation of adenosyl
homocysteine and 3-deazaadenosyl homocysteine which compete with
S-adenosyl-methionine for the transmethylation enzymes (Kredich and
Martin 1977). The use of inhibitors and enhancers of adenyl
cyclase, PLA2, cyclooxygenase and lipoxygenase has helped to
elucidate other key steps.
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Beta-adrenergic receptors
The irnrediate events following beta receptor stimulation with
isoprenaline in model cell systems are an increase in
transmethylation followed by increased membrane fluidity. The
increase in fluidity results in exposure of cryptic beta receptors,
permits increased beta receptor coupling with adenyl cyclase and
triggers a rise in cAMP. A Ca-H- influx also occurs which activates
(PLA2) which in turn catalyses the degradation of phosphatidyl
choline to arachidonic acid and lysophosphatidyl choline. This step
is important since one of the subsequent products, perhaps PGE2, is
responsible for "down regulation" of the beta receptor and provides
a "braking system". Agents such as PMA which bypass the receptor
and directly stimulate PLA2 cause desensitisation of the beta
receptor. A variety of inhibitors and enhancing agents which
operate at different levels in the pathway are illustrated in
Figure 2.
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Figure 2. Beta receptors and transmethylation:
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Receptors and mast cells
In mast cells, triggered by crosslinked IgE or Con A a similar
sequence occurs. In this example, PLA2 activation is again
important because the lysophospbatidyl choline which is generated
has detergent, "fusogenic" properties which probably enhance fusion
of histaminogenic granules with the cell membrane during exocytosis
(Figure 3). Some typical inhibitors and enhancers of histamine
release are again illustrated. Phosphatidyl serine, in which mast
cells are deficient, will provide additional substrate for
transmethylation and enhance histamine release.
21
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Con A induced proliferation of lymphocytes
Following con A induced proliferation of lymphocytes,
transmethylation and influx of calcium are once again initial
events. In this model the onward conversion of arachidonic acid to
HETE appears to be essential for the proliferative response.
Inhibition of prostaglandin synthesis via the cyclooxygenase
pathway has no effect suggesting that products of the lipoxygenase
pathway may be important (Figure 4). Evidence in support of this is
that BW755c, which inhibits lipoxygenase, inhibits the enhancing
effect of interleukin 1 (ILl or LAF) on PHA induced thymocyte
proliferation (Dinarello et al 1983).
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Chemotaxis and superoxide generation
A number of workers (Pike and Snyderman 1982; Hirata et al
1979) have emphasised the importance of transmethylation in the
stimulation of phagocytes by chemotactic agents such as C5a and
F-met-leu-phe (TMLP). It is clear that transmethylation is a
necessary step which precedes both the chanotactic response, and
the associated burst of superoxide anion release and arachidonic
acid (AA) production which occurs in both polymorphs and
macrophages. Inhibition of transmethylation abrogates all three
events. Furthermore while it appears that production of
lysophosphatidyl choline and HETE play important roles in
chemotaxis, the molecular mechanism which triggers superoxide
release is not known. After stimulation by chemotactic agents such
as C5a or FMLP there is accelerated degradation of methylated
phospholipids which results in the production of large amounts of
arachidonic acid (AA) and lysophosphatidyl choline. The latter with
its detergent like properties may contribute to lowering the
membrane viscosity, allowing it to spread. The AA is almost
exclusively metabolised to HETE rather than PG which suggests an
important role for endogenous chemotactic lipids in charotaxis
(Hirata and Axelrod 1980). Inhibition of PLA2 by
21-phosphohydrocortisone inhibits chemotaxis thus emphasising the
importance of lysophosphatidyl choline and HETE. In addition to
these events it is likely that the Ca-H- influx triggers contraction
of contractile elements necessary for locomotion (Figure 5).
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Another consequence of stimulation of macrophages by FMLP and
C5a is enhancement of C3 receptor expression (Glass & Kay 1980). It
is likely that the exposure of cryptic C3 receptors is a direct
consequence of the increase in membrane fluidity which these agents
induce and occurs in an analogous fashion to the mechanism
described for ^-adrenergic receptors (Hirata and Axelrod 1980).
This hypothesis has not been formally tested.
Other recent studies (Pick and Mizel 1982) have examined the
role of transmethylation in the macrophage oxidative burst in
response to a number of agents including Con A, wheat germ
agglutinin (W3H), EMLP, NaF, digitonin, A23187 (calcium ionophore),
and phorbol myristate acetate (PMA). Their studies also demonstrate
that inhibitors of transmethylation inhibit superoxide production.
However it is clear that more than one mechanism may elicit a
respiratory burst since different degrees of inhibition were found
with different stimuli; PMA in particular was inhibited with
greater difficulty than the other stimuli, suggesting that it may
bypass transmethylation and activate a mechanism more closely
linked to the membrane oxidase. Similarly Smolen and Weissman
(1980) found that an inhibitor of PLA2, p-brcmophenacylbrcmide,
blocked the respiratory burst to sane stimuli more readily than
others.
Transglutaminase activity and macrophage activation
Another direct consequence of the calcium influx which follows
membrane perturbation is enhanced transglutaminase activity. The
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importance of this membrane enzyme is that it catalyses
cross-linking and polymerisation of proteins by forming
£(jf-glutamyl)-lysine crosslinks and it has been suggested that this
may play a role in the linking of receptors prior to endocytosis
(Leu et al 1982). Furthermore, primary amines which are inhibitors
of transglutaminase, have been shown to inhibit Fc mediated
phagocytosis (Leu et al 1982) and recycling of mannose receptors
during endocytosis of glycoprotein (Stahl and Schlesinger 1980). As
will be discussed later, there is evidence for the existence of at
least two Fc receptors with different physicochanical properties.
Gergely et al (1982) have proposed that these two receptors
represent polymerised and monomeric forms of the same protein and
that interconversion may occur by enhancement of transglutaminase
during macrophage activation.
Macrophage "activation" and membrane perturbation
Earlier studies of macrophages revealed that "activation" was
accompanied by increased turnover of membrane phospholipid and
calcium influx which was thought to trigger a rise in oGMP
(Ogmundsdottir"and Weir 1979). These observations are entirely in
keeping with current views of ligand-receptor interactions. A
possible mechanism for the "activation" of macrophages in the light
of this model is that activating agents trigger transmethylation,
enhance membrane fluidity and trigger calcium influx. These events
provide a molecular basis for a number of the features of
"activated" macrophages including enhanced spreading, expression of
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cryptic complement receptors, coupling of complement receptors to
contractile cytoplasmic elements, increased chemotaxis and
secretory activity. The demonstration that MIF or LPS-activated,
and oil-elicited macrophages all exhibit greatly increased
transglutaminase activity is also consistent with this hypothesis
(Leu et al 1982).
Hie role of prostaglandin secretion and rises in cAMP which
often follow these events seam primarily to provide a control
mechanism; if unchecked, cellular activation will proceed further
to proliferation and is illustrated by systems in which inhibition
of PG synthesis exposes proliferative potential (Krane 1981). The
suppressive effect of prostaglandins in cytokine and lymphokine
induced cellular stimulation and proliferation will be discussed
later in more detail in relation to lymphocytes and connective
tissue cells. Studies by Sorg (1982) on marrow macrophages in
liquid culture support the view that macrophage "activation" can be
linked to the cell cycle of the macrophage and that agents such as
lymphokines which activate resident macrophages push them frcm the
"constitutive" G-0 phase of their cell cycle to late G1 phase where
they show enhanced secretion and cellular activity such as
chemotaxis and responsiveness to MIF. Agents such as PMA have
similar effects stimulating the cells into late G1 phase and
subsequently into S phase, causing mitosis.
The description of mononuclear phagocytes which follows will
consider receptor expression and function in the light of these
concepts.
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TABLE 3 Agents which cause macrophage activation









immune lymphocytes + antigen
endotoxin, pyran copolymer
BOG, group A strep cell wall
zymosan
TABLE 4 Properties of activated macrophages
(Ogmundsdottir & Weir 1980; Cohn 1978)
Increased - size, spreading, membrane ruffling
- glucose uptake, protein synthesis
- synthesis & secretion of
neutral proteinases,
- secretion of LAF, superoxide anion
- content of lysosomal hydrolases
- number of Fc receptors
- phagocytic function of C3 receptors
- pinocytosis, chemotaxis
- microbial killing, cytoxicity
Unchanged - lysozyms secretion
- H202 generation
Reduced - 5' nucleotidase (ectoenzyme)
30
MONONUCLEAR PHAGOCYTE RECEPTORS AND PHAGOCYTOSIS
Introduction
The innate capacity of the macrophage to recognise self frctn
non-self and its ability to bind and phagocytose via lectin-like
receptors and receptors for complement and immunoglobulin are
illustrated by a consideration of the function of its invertebrate
counterpart the amoebocyte.
The invertebrate equivalent of serum is haemolymph which
contains no complement or inmunoglobulin but instead contains
lectins which mediate agglutination and opsonisation of foreign
material. The invertebrate blood phagocyte, the amoebocyte, closely
resembles the vertebrate macrophage in its morphology, its enzyme
content and its ability to phagocytose foreign material.
Studies of the relationship between the invertebrate lectins
and the amoebocyte show that the lectin acts not only as an opsonin
but also binds to the amoebocyte membrane and provides it with
specific receptors. Indeed, the slow phagocytic capacity of
amoebocytes from one strain of the water snail Lymnea stagnalis can
be corrected by simply incubating them for a short period in lymph
from a strain with "fast eating" amoebocytes. After washing, the
"slow eaters" are found to have became "fast eaters" (van der Knaap
et al 1983). The presence of the lectin on the membrane of these
cells has been confirmed irrmunocyrochemically. Other studies, of
starfish immunised with protein, also show a close correlation
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between the appearance of specific binding lectins in the lyitph and
the appearance of binding sites for the protein on the phagocytic
cells (Leclerc et al 1980).
In vertebrates these features have been preserved and
elaborated. The macrophage still has "lectin-like" receptors in its
membrane; it also synthesises the complement component C3, whose
activation products C3b and C3bi show remarkably lectin-like
properties and for which the macrophage has membrane binding sites.
The immunoglobulins, which are of great variety, and provide a
sophisticated degree of specificity, also perform cytophilic and
agglutinating functions comparable to the lectins of invertebrate
haemolymph, and cooperate with macrophages in a wide variety of
ways to defend the integrity of the host.
In the following sections, the mechanism of endocytosis, and
the structure and function of macrophage receptors for complement,




Bndocytotic mechanisms can be categorised functionally on the
basis of size: phagocytosis referring to the uptake of larger
particles Olmicron) and pinocytosis to uptake of snaller soluble
material. Perhaps a more useful categorisation is into
"non-receptor mediated" endocytosis and receptor mediated or
"adsorptive" endocytosis. "Non-receptor mediated" endocytosis is
largely a passive process of transfer of fluid phase materials and
the rate of transfer is dependent on the concentration gradient
(Steinman et al 1976). Uptake occurs via so called smooth or
uncoated vesicles formed by invagination of the plasma membrane.
"Receptor mediated adsorptive endocytosis" includes phagocytosis of
large particles as well as receptor mediated pinocytosis.
Uptake by this mechanism involves receptors located in
"coated" pits, so called because of the presence of bristle like
structures (Pearse 1975). On receptor-ligand binding, the pit
invaginates and internalises the ligand and receptor. A wide
variety of substances are taken up in this fashion and include
lysosomal enzymes and glyconjugates (Stahl et al 1978) and small
C3b-bearing immune complexes (Abrahamson and Fearon 1983). Larger
particulate material is taken up by phagocytosis, a process which
can be divided functionally into four parts:
1)The local membrane response to the particle;
2)the mechanism by which the membrane enfolds the particle;
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3) the contractile mechanism;
4)the energy supply which fuels the process.
1) The local segmental response to the particle:
The segmental nature of the membrane response to a phagocytic
stimulus was demonstrated by allowing erythrocytes to adhere to
macrophages via a "non-phagocytic" ligand and then feeding the
macrophages with a phagocytic stimulus such as latex or bacteria.
The latter were pronptly ingested while the erythrocytes remained
attached to the exterior (Griffin and Silverstein 1974; Griffin et
al 1975a). These observations suggested that the transmembrane
coupling mechanisms were interacting locally with contractile
mechanisms in a stoichiometric fashion rather than catalysing a
diffuse membrane response.
2) The mechanism by which the membrane enfolds the particle:
The mechanism of engulfirent of a particle proceeds by
sequential, circumferential interaction of membrane receptors with
ligands on the phagocytic particle - a process termed the "zipper
mechanism" (Griffin et al 1975b; 1976). Further studies using
B-lymphocytes" as the test particle have confirmed that the ligands
must be distributed uniformly over the surface of the particle for
phagocytosis to proceed (Griffin et al 1976). Mouse B-lymphocytes
o
were treated with anti-mouse IgG at 4C, washed and then incubated
O
at 25C to allow "capping" of the IgG ligands. The capped cells were
O
then incubated with macrophages at 4C to allow adherence to occur.
On warming to 3~fc no phagocytosis occurred because the ligands were
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asynmetrically distributed in the region of attachment. Hov^fer on
adding fresh anti-lymphocyte IgG to the macrophage-lynphocyte
complexes, phagocytosis was then completed. In a second experiment,
O
B-cells treated with anti-IgG at 4C were washed and incubated
O
directly with macrophages at 4C. Since the ligand had not been
allowed to cap and remained diffusely distributed on the lynphocyte
surface, on warming the system to 3~fc phagocytosis occurred
promptly. The restriction of the ligand to the
lymphocyte-macrophage attachment site when capped lynphocytes were
employed, was confirmed on electron microscopy by immunoperoxidase
localisation. Similar results have been obtained using other
systems.
3) Contractile proteins:
The submembrane region adjacent to the particle being ingested
has a thick (0.5-1.5um) meshwork of filaments from which
cytoplasmic organelles are excluded (Griffin et al 1976) and
contains actin (Berlin and Oliver 1978), myosin and actin binding
protein (ABP) (Stendahl et al 1980).
In vitro studies have shown that actin and ABP, purified from
macrophages, form gel lattices while macrophage myosin in the
presence of Mg-H- and ATP causes isometric contraction of the actin
filaments (Stossel and Hartwig 1976). A Ca-H- dependent regulator
protein (gelsolin) of actin has also been identified which controls
the formation of the actin-ABP lattice and probably has a
physiological role (Yin and Stossel 1980). It has been proposed
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that the initial membrane signal, following binding of the
phagocytic particle, causes aggregation of adjacent contractile
proteins (Griffin et al 1976) and results in a purely local
segmental response. In support of this model, Hartwig et al (1977)
demonstrated that ABP is released from the plasma membrane during
phagocytosis. This, in the presence of low Ca++ concentrations (nM)^
causes crosslinking of actin filaments in a stoichiometric fashion
and creates an ordered array of contractile proteins. Myosin in the
lattice, in the presence of Mg-H- and ATP, contracts the filaments,
increases the shearing force and pulls in filaments frcm adjacent
regions of lower rigidity by isotonic contraction. Since actin
filaments are attached to adjacent membrane, the membrane becomes
pinched upwards and outwards, forming a pseudopod which then
propagates the process of attachment. A secondary response to
particle attachment is a rise in cytoplasmic Ca++ which may come
frcm the plasma membrane or the cytoplasm (Hoffstein 1979). The
rise in Ca++ in the presence of gelsolin causes dissolution of the
ABP-actin lattice. Thus as the region of rigid advancing membrane
moves around the particle, it is followed by a secondary wave of
relaxation which maintains a gradient with rigidity maximal in the
tip of the advancing pseudopodium. Throughout this process, fresh
insertion of membrane occurs which keeps pace with the process of
internalisation (Ryter and DeChastellier 1977).
4) Energy supply for phagocytosis
Early evidence that ATP provided the fuel for phagocytosis was
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based on a) the association of phagocytosis with increased oxygen
consumption, glycolysis and hexose monophosphate shunt (HMP)
activity and b) the inhibitory effect of fluoride and iodoacetate
on phagocytosis (Karnovsky et al 1970, 1975). However it is now
clear that the increased oxygen consumption, glycolysis and HMP
activity are secondary consequences and that phagocytosis proceeds
normally in an atmosphere of nitrogen. Furthermore, fluoride and
iodoacetate are not selective and have effects on a variety of
enzyme systems.
Certain observations also suggested that the simple view that
ATP was the sole fuel source for phagocytosis was not correct.
Stossel et al (1970) demonstrated that during phagocytosis by
polymorphs there was no fall in ATP levels, and Michl et al (1976)
found that reduction of ATP to less than 25% by 2-deoxyglucose did
not completely prevent phagocytosis. However, since during skeletal
muscle contraction there is also no fall in ATP levels, attention
turned to ATP turnover during phagocytosis by measuring
32P-phosphate incorporation into ATP. These experiments
surprisingly showed reduction of ATP turnover in phagocytosing
cells compared with resting cells but again, by analogy with
skeletal muscle, the possibility was considered that creatine
phosphate was providing high energy phosphate to rephosphorylate
ADP to ATP. In support of this it has been shown that macrophages
have both creatine kinase (DeChatelet et al 1973) and three to five
times more creatine phosphate than ATP (Silverstein and Loike
1980); during phagocytosis 90% of labelled phosphate becomes
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incorporated into this large pool of creatine phosphate which
therefore explains the decrease in incorporation of labelled
phosphate into ATP. On the other hand since creatine is
phosphorylated by ATP and is present in 3 to 5x molar excess, the
specific activity of creatine on incubation of resting cells with
labelled phosphate should increase more slowly than ATP. This was
confirmed in experiments with resting cells which showed that the
ratio of ATP:creatine-P specific activity was 10:1. During
phagocytosis by resident macrophages, creatine phosphate falls by
50% but not in thioglycollate macrophages which have a much higher
creatine content.
Although creatine phosphate clearly provides high energy
phosphate for rephosphorylation of ATP during phagocytosis, it does
not fuel ingestion in any direct manner. Thus macrophages incubated
without glucose for 6 hours lose up to 90% of their creatine
phosphate but retain 80% of normal ATP levels. Under these
conditions phagocytosis proceeds quite normally but is accompanied
by a 25% fall in ATP levels - confirming that ATP is the primary
source of energy for the contractile mechanism.
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Complement and complement receptors
Introduction
The complement system of proteins is functionally linked in a
variety of ways with the complement receptors of phagocytes and
lyitphocytes. Products of the carpiement system activate and enhance
a variety of cellular functions and conversely complement receptors
have modulating effects on the complement system. As understanding
of complement advances it is becoming increasingly clear that no
distinct interface exists between the cellular and humoral
components of complement. On the one hand complement components
such as Clq (Loos 1982) and C5 (Gotze and Sundsmo 1981) are found
on the membrane of macrophages where they perform important
functions and conversely complement receptors modulate complement
function both on cell membranes and in the fluid phase. As a
preliminary to a discussion of complement receptors on macrophages,
the carpiement system will be briefly reviewed.
The complement system
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The complement system consists of a group of at least eighteen
serum proteins which are involved in the host response to a variety
of inflammatory and noxious stimuli. Activation of the complement
pathway occurs in a manner analogous to the clotting system and
results in the generation of products which are important in
various inflammatory processes including phagocytosis, chemotaxis,
anaphylaxis, cytotoxicity and immune regulation. Complement
activation can occur via either the "classical" or "alternative"
complement pathways. The classical pathway was first described in
the 1960's (Lepow et al 1963) and includes the components
designated CI, C2 and C4; the alternative pathway was first
described in 1954 by Pillemer et al and includes properdin (P),
factor B (B), and factor D (D). These two pathways converge on a
final ccmmon pathway containing C3, C5, C6, C7, C8 and C9. A number
of control proteins also regulate complement activation;
Cl-esterase inhibitor and C4 binding protein (C4bp) control the
classical pathway and C3INA and @1H control the alternative
pathway. There is also a poorly characterised inhibitor of the
terminal sequence ("S" protein or C567INH) which may serve to
inhibit formation of the terminal membrane attack sequence (MAC).
The total concentration of complement lies between 2 and 3gm/l with
C3 being the most abundant at about lgm/1. The C3 molecule is a
polypeptide of 180,000 daltons and consists of two peptide chains e<
& $ (Bokisch et al 1975). Most of the early components circulate in
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Activation of the classical pathway (Fig 6):
Activation of the first component of complement CI is usually
initiated by immune carpiexes (Porter & Reid 1979; Muller-Eberhard
1975, 1980) containing IgM or IgG. A minimum of two molecules of
IgG are required to activate CI while only one molecule of IgM is
sufficient; the efficiency of IgM probably reflects the presence of
its five Fc components. Not all IgG subclasses activate CI and in
humans IgGl and IgG3 are most efficient, IgG2 is poor and G4 does
not activate the classical pathway at all. CI binds to the CH2
domain of IgG-Fc (Colcmb and Porter 1975) and probably to the CH4
domain of IgM-Fc (Brown and Koshland 1977). A number of other
activators of the classical pathway have been identified and
include bacterial glycolipids (Morrison & Kline 1977), C-reactive
protein (Claus et al 1977), and various polyanions (Raepple et al
1976).
Fig 6 The classical complement pathway:
C4bp
Serum CI consists of a Ca++ dependent complex containing one Clq,
two Clr and two Cls subunits. The Clq subunit has been shown on
electron microscopy to resemble a bunch of tulips with six arms and
a "collagen" like stem bound to the protein core (Loos 1982). Each
arm has a binding structure which resembles a tulips head. Binding
of Clq by at least two of its arms causes a conformational change
which results in cleavage of Clr and Cls and generates Cls which
is enzymatically active (Medicus et al 1980). Cls converts C4 to
two fragments; C4a which is lost to the fluid phase and C4b which
remains bound to CI forming the C14 enzyme. The C4 cctrponent of
this complex binds to C2 allowing the CI component to cleave C2
into C2a and C2b. C2b is lost to the fluid phase and may have
anaphylatoxic activity (Nagasawa & Stroud 1977). C2a remains bound
to C14 which loses Cls to became the C3 convertase C42 . The
liberated Cls is free to generate many more C42 complexes and this
therefore represents an important amplification step in the
classical pathway. C42 next cleaves C3 to C3b and C3a the latter
having anaphylotoxic properties (Dias da Silva et al 1967). On
cleavage of C3 an evanescent binding site is exposed on C3b which
can bind firmly to biological surfaces via a covalent ester linkage
(Tack et al 1980). The binding site probably resides in the C3d
portion of the molecule which is part of the tf-chain since on
further cleavage of surface bound C3b (vide infra) the C3d portion
is left on the surface while C3c is liberated into the fluid phase
(Ruddy & Austen 1971). Binding of C3b however is inefficient and
much is lost to the fluid phase. Furthermore only 10% of the bound
C3b forms the C423 complex which has C5 convertase activity and
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initiates the final sequence to the MAC. Within the C3 convertase
(C42 ) the C4b carponent serves to bind the C3 molecule while C2
performs the enzymatic function of cleaving C3 to C3b.
Control of the classical pathway
CI esterase inhibitor (C1EI) and C4 binding protein (C4bp) are
the principle inhibitors of the classical pathway. C1EI binds to
Clr and Cls forming a ccnplex and inhibits the cleavage of either
C4 or C2 to form the classical C3 convertase. Genetic absence of
C1EI results in episodes of uncontrolled activation, which may be
triggered by infection, and are characteristically accompanied by
angioneurotic oedema.
Further control of the classical pathway is exerted both by
spontaneous decay of C142 and its enzymatic cleavage by C4bp. The
half life of C142 at 3cfc is only ten minutes and it decays by
dissociation of C2a which leaves C14 free to bind another C2.
However true inactivation of C142 occurs with the help of C4bp
which binds C4b, displacing C2 and allowing C4b to be cleaved by
C3INA (Fujita et al 1978).
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Activation of the alternative pathway (Fig 7).
The alternative pathway is in a continuous state of low grade
"turnover" which is closely regulated by C3bINA and j$lH. Activation
of this pathway reflects deregulation of the control proteins
which allows the pathway to generate more C3b which in turn forms
more C3 convertase,thereby creating a self anplifying system




Normal low grade turnover of the pathway is due to the activities
of factor D, factor B and C3b. Factor D circulates in an active
state and in the presence of C3b will cleave factor B generating a
C3bBb complex which has C3 convertase activity (Lesavre et al
1978). Clearly, a priori, a supply of C3b is required for this
process and this is probably provided by the breakdown of C3 to C3b
by slow spontaneous hydrolysis of an internal thioester bond (Vogt
et al 1978). The C3 convertase (C3bBb ) is exactly analogous to the
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classical pathway convertase. The C4b component of the classical
pathway convertase binds to C3 and allows C2a to cleave it
enzymatically while in the alternative pathway convertase, C3b
binds C3, and Bb causes enzymatic cleavage (Fearon et al 1973). The
alternative pathway convertase C3bBb which is intrinsically
unstable is stabilised by binding to properdin (Fearon and Austen
1976). Properdin also protects the convertase from degradation by
the action of jBlH and C3bINA.
Earlier work suggested that alternative pathway activation
occurred as a consequence of classical pathway activation which, by
increasing the supply of C3b, increased the generation of the C3bBb
convertase. However it is now clear that alternative pathway
activation can occur in the absence of classical components and is
triggered by a number of agents including certain xenogeneic
erythrocytes, yeasts, bacteria and viruses (Fearon and Austen
1980), as well as irrmunoglobulins including aggregated IgE and IgA.
Many alternative pathway activators "deregulate" the control
of normal low grade "turnover" of C3 by providing a protected
environment for C3b and the properdin stabilised convertase
PC3bBb , which prevents the control proteins blH and C3INA from
working. The consequence of this is rapid acceleration of C3bBb
convertase generation which in turn is fuelled by the increasing
amounts of surface bound C3b (Muller-Eberhard & Gotze 1972); in
addition, C5 convertase activity is generated which activates the
terminal sequence.
The capacity of alternative pathway activators to perform this
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function is directly related to the lack: of sialic acid on their
surface (Czop et al 1978a). For exanple sheep erythrocytes which
are not natural activators, beccrne so after treatment with
neuraminidase. Similarly yeast which have little or no sialic acid
are excellent alternative pathway activators. Conversely, the
presence of sialic acid appears to inhibit the alternative pathway
by aiding the binding of ^1H to C3b bound to a cell surface (Fearon
1978) of the alternate pathway
Control of the alternative pathway is exerted by inactivation
of the C3bBb C3-convertase. The complex is naturally unstable and
requires properdin (P) to stabilise it. plH binds to C3Bb
displacing Bb, and the et-chain of C3b in the resulting ^>1H-C3b
complex is cleaved by C3INA, leaving the jS-chain intact, to form
C3bi. The resulting three peptide chains which comprise C3bi are
held together by disulphide bridges and remain attached to the
activating surface via the C3d part of the et-chain. Further
degradation of C3bi occurs through the action of proteolytic
enzymes to C3c and C3d, and C3c may be further degraded to C3e. It
is likely that neutrophil elastase is one of the proteinases
responsible for this activity in vivo (Carlo et al 1979). Cell
membrane receptors for C3b may also play a role in the degradation
of immune ccmplex-bound C3b to C3c and C3d and this process will be
discussed later.
Msmbrane attack complex
The binding of C3b to C5 makes the latter susceptible to
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cleavage either by the classical pathway convertase C4b2a or the
alternative convertase C3bBb. Cleavage of C5 generates fluid phase
C5a which is chemotactic and stimulates respiratory burst activity
in phagocytes, and a C3bC5b ccnplex which binds C6 forming C5bC6.
The membrane attack ccnplex then assembles onto C5bC6 with the
preformed components C7, C8 ard C9 without the need for further
enzymatic cleavage. The final MAC is dimeric and contains six C9
molecules (Biesecker et al 1979).
Control of the final sequence
Control over the final membrane attack sequence is exerted by
the action of a poorly characterised serum protein ("S" protein or
C567INH) which inhibits complement dependent lysis after C567
assembly by competing with C8 for the labile binding site on C567.
Its function may be to prevent reactive lysis of adjacent cells by
fluid phase complement.
Biological activities
Corpleirent has a variety of functions both in the fluid phase
and when bound to surfaces. Activation of complement on membranes
and formation of the MAC results in lysis of erythrocytes, tumour
cells and seme gram negative bacteria. The role of terminal
complement components in antibacterial defence is not entirely
clear and genetic absence of late components which abolishes serum
bactericidal activity has been shown only to predispose to
Neisseria infection (Agnello 1978). However the generation of
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surface bound C3b is of much greater importance and allows
recognition and binding by receptors on both phagocytes and
lymphocytes. Bound C3b on bacteria is probably sufficient to
trigger phagocytosis in the absence of IgG (Horwitz and Silverstein
1980) although this is not the case for C3b on IgM coated
erythrocytes. There is also possibly opsonic role for C5b which
may become relatively important when levels of C3b are low
(Segerling and Opferkuch 1977). Alternative pathway generation of
C3b also plays a role in immune complex solubilisation and may
therefore help to protect against the inflammatory effects of ICs
(Miller & Nussenzweig 1975). C3b binding to lymphocyte receptors
may play a role in the primary immune response to T-independent
antigens by triggering the switch from IgM to IgG (Agnello 1978)
while binding of immune complexes to C3b receptors on dendritic
cells may be important in generating immunological memory (Klaus
and Humphrey 1977). There are also receptors for C3bi, blR and C3d
which will be discussed subsequently.
Hie three biologically active fluid phase complement molecules
generated during activation are C3a, C5a and C3e. C3a and C5a are
biochemically similar and it is therefore difficult to separate
their biological effects. C3a is an anaphylotoxin and binds to mast
cells causing degranulation with histamine, SRSA and heparin
release. C5a binds to receptors on mast cells, neutrophil and
eosinophil polymorphs, and macrophages stimulating chemotaxis and
superoxide anion generation as well as increased membrane
"stickiness" which may be involved in sequestration of neutrophils
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in the lung during haemodialysis and adult pulmonary distress
syndrome (Jacob et al 1980). The only function ascribed to C3e is
that of mobilising marrow leucocytes and it may be important in the





Receptors for complement proteins are found on a wide variety
of tissues (reviewed in Ross G.D. 1980) including primate
erythrocytes and nonprimate platelets (Nelson 1963), neutrophil
polymorphs (Anwar & Kay 1977a), macrophages (Mantovani et al 1972),
monocytes (Ehlenberger and Nussenzweig 1977), B lynphocytes (Ross &
Polly 1975), mast cells (Vrainen et al 1980) eosinophils (Anwar &
Kay 1977a), renal glomerular cells (Schreiber & Penny 1979),
synovial cells (Theophilopoulous et al 1980) and alveolar cells.
Specificity of complement receptors
Human monocytes have recently been shown, using fluorescein
labelled anti-Clq, to bind purified soluble Clq (Tenner and
Cooper 1980, 1981). However earlier workers (Wellek et al 1976 and
Gigli and Nelson 1968) were unable to demonstrate either CI or C2
receptor activity on macrophages.
It has been known for seme time that mononuclear phagocytes
and lynphocytes have receptors for C3 (Ehlenberger and Nussenzweig
1977, Reynolds et al 1975, Wellek et al 1976, Huber et al 1968,
Mantovani et al 1972, Lay and Nussenzweig 1968, Gigli and Nelson
1968) but more recently the specificity of these receptors has been
clarified. Receptors for C3b, C3bi and C3d which are designated
CRl, CR3 and CR2 respectively are now recognised on leucocytes and
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their presence has been d&nonstrated by rosetting techniques using
EACl,4b,2a,3b (i.e. sheep erythrocytes coated with antibody, CI,
C4, C2 and C3); EACl,4b,2a,3b,f3lH (i.e. EAC3b which have bound
piH); EACl,4b,2a,3bi (i.e. EAC3bi reacted with C3bINA); and
EACl,4b,2a,3d (i.e. EAC3bi treated with protease) (Dierich et al
1982).
Using these various complement intermediates receptors for
C3b, C3bi and ^1H but not C3d were shown on neutrophil polymorphs,
monocytes and eosinophils (Schmitt et al 1981a, 1981b).
B-lymphocytes bind all these intermediates as well as C3d while
erythrocytes bind only C3b (Ross et al 1973, Lambris and Ross 1981,
Schmitt 1981a, 1981b). Ross and Lambris (1982) obtained similar
results using either erythrocytes or fluoresceinated microspheres
coated with the complement intermediates C3b, C3bi and C3d.
Monocytes bound both C3b and C3bi but not C3d, and binding of C3b
but not C3bi was partially inhibited by soluble C3c. Treatment of
the rosetting particle with Fab anti C3c caused 100% inhibition of
either C3b or C3bi binding to monocytes and neutrophils while anti
C3d inhibited C3bi but not C3b binding. The binding site of C3bi to
CR3 may therefore be close to but not actually on the C3c and C3d
moieties while binding of C3b may be mediated through the C3c
portion of the molecule. Ross and Rabellino (1979) have also shown
that neutrophils and monocytes have CR3 and CR1 receptors but not
the CR2 receptor for C3d, and that the binding of C3bi to
phagocytes does not appear to involve the C3c or C3d regions
directly. Although both anti C3d or anti C3c caused inhibition of





binding, fluid phase C3c or C3d had no effect and they therefore
suggested that the binding site on C3bi may be C3e. The CR2
receptor for C3d which is found on lynphocytes on the other hand
will bind not only C3d but also C3bi via its C3d portion (Ross and
Lambris 1982).
It is now clear that previous work showing that phagocytic
cells, including monocytes, carried receptors for C3d (Ross et al
1978, Ehlenberger and Nussenzweig 1977, Reynolds et al 1975) were
in fact demonstrating C3bi receptor activity. In these studies,
putative C3d intermediates were prepared by treating EAC1-C3b with
purified C3bINA. However cleavage of C3b by C3bINA generates C3bi
(Law et al 1979, Pangburn 1977) and further cleavage into C3c and
C3d requires proteolytic action for exairple by plasmin (Nagasawa
and Stroud 1977). A further problem arose in early work on
neutrophil polymorphs. It had been suggested that immature
polymorphs had receptors for C3d which were lost during maturation
iRoss et al 1978). As before the intermediates in these experiments
were prepared losing C3bINA and thus demonstrated C3bi rather than
C3d receptors. However the interpretation was further complicated
by the fact that mature polymorphs secrete elastase which cleaves
C3bi to C3d (Taylor et al 1977); the apparent loss of receptor
activity was due to cleavage of C3bi to C3d on the rosetting
particle. When protease inhibitors are included in the test system,
C3bi receptors (CR3) can be demonstrated on both mature and
immature polymorphs (Ross and Lambris 1982).
A further problem may arise when attempting to demonstrate C3b
(CRl) receptors on leucocytes as a result of endogenous secretion
of plH and C3bINA. Both monocytes (Whaley 1980) and B lynphoycytes
(Ross 1980) secrete j&lH and C3bINA which will cleave C3b on
indicator cells to C3bi and thus interfere with the rosetting
assay. This can be prevented by inhibition of synthesis of C3bINA
and plH with EDTA and sodium azide or by inhibiting these proteins
with antisera (Ross 1980). Another approach is to use an alternate
pathway activator such as yeast or zymosan. Zymosan generates large
amounts of C3b on its' surface by providing a protected
"microenvironment" for both the C3b molecule and the properdin
stabilised convertase (P,C3b,Bb) (Fearon and Austen 1977). C3b is
activated by deregulation of the normal low grade turnover of the
alternate pathway and this is achieved by inhibiting the
inactivation of C3b by C3bINA and ^1R and by inhibiting the JBlH
catalysed dissociation of the stabilised C3 convertase (P,C3b,Bb).
Using rosetting techniques, receptors for £>1H have been
demonstrated on lymphocytes, neutrophils, eosinophils and monocytes
(Schmitt et al 1981a, 1981b, Dierich and Schmitt 1980). Dierich &
Schmitt (1980) have shown that binding of EAC3b to Raji cells is
considerably enhanced by JBlH and that seme pxitative C3b receptor
binding can be attributed to contamination by |3lH. Engagement of B
lymphocytes by aggregated or ccmplexed blH causes release of C3bINA
frcm B cells which may result in cleavage of bound C3b to C3bi as
described above (Ross 1980).
Receptors for C5b have been demonstrated on human neutrophils
which may play a role in phagocytosis (Segerling and Opferkuch
54
1977) but no comparable receptor has been demonstrated on
macrophages.
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Molecular characteristics of complement receptors
Perhaps the earliest isolation of an erythrocyte membrane
component which bound to complement was that performed by Hoffman
(1968). He isolated a substance from erythrocyte membrane on
agarose gel which inhibited complement dependent lysis of
erythrocytes. Subsequently, F'earon (1979) isolated a glycoprotein
of 205,000 daltons (gp205) from human erythrocyte membranes using a
non-ionic detergent Nonidet-P40 (NP40) which was found to inhibit
alternate pathway convertase activity by disassembling the C3b,Bb
complex and augmenting the cleavage of C3b to C3bi by C3bINA.
Antibody to gp205 was found to inhibit C3b dependent rosette
formation on human B lymphocytes, granulocytes and monocytes
suggesting that gp205 might be the C3b receptor. Anti-gp205 also
precipitates a glycoprotein molecule from solubilised membrane
obtained from B cells, neutrophils and monocytes (Fearon 1980)
which again has a molecular weight of 205,000 on SDS polyacrylamide
gel electrophoresis. Scatchard analysis of Fab2 anti-gp205 binding
to various cell types gave values of 950 molecules/erythrocyte;
21,000/B-cell; 57,000/neutrophil; and 48,000/monocyte. These
numbers are comparable to the number of C3 receptors detected using
C3b dimers generated by trypsin cleavage of C3 (Arnaout 1981).
Similar results on human erythrocyte CRl receptors have been
obtained by others using the same procedures (Dobson et al 1981b,
Dierich et al 1981). Thus, isolated radioiodine labelled CRl bound
either C3b or C4b, and on SDS PAGE the receptor protein had a
molecular weight of 195,000 daltons. Furthermore antibody to CRl
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blocked CR1 rosetting by lynphocytes, monocytes and neutrophils but
not CR2 or CR3 rosetting .
Using KBr solubilisation of human erythrocyte membranes a
smaller glycoprotein of 55,000 daltons (gp55) has been obtained
which also binds C3b and inhibits C3b dependent rosetting (Mussel
et al 1982). The gp55 moiety has a major carbohydrate portion which
appears to play an important role in the binding of C3b; thus while
treatment with periodic acid causes loss of C3b binding potential,
treatment with trypsin does not (Dierich et al 1982). Furthermore
C3b binding to CR1 can be inhibited by several moncrreric sugars
including D-glucose, D-galactose, D and L-fucose and D-xylose but
not L-glucose, L-galactose, L-xylose or D-mannose suggesting that
C3b has lectin like properties in binding to its receptor. The
antigenic relationship between gp55 and gp205 suggests that gp55
may in fact represent the binding site of gp205 (Dierich et al
1982). Although the isolated glycoprotein does not depend on its
protein content for C3b binding, the intact receptor in the cell
membrane is trypsin sensitive (Lay and Nussenzweig 1968; Doughaday
and Douglas 1976) and its integrity in situ must therefore depend
on its polypeptide component.
Schneider et al (1981a) have purified a complement receptor
frcm rabbit alveolar macrophages. Radio-iodinated rabbit alveolar
macrophage membrane was solubilised with NP40 and the glycoprotein
purified by adsorption to Sepharose-C3 or C3b. A single peak was
obtained with a molecular weight of 64,000 daltons which had
greater affinity for C3b than for C3.
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A C3d binding glycoprotein has also been isolated from human
Raji cells and identified as the CR2 receptor (Lambris et al 1981).
The glycoprotein was isolated initially fran Raji cell culture
media and shown subsequently to be of membrane origin. SDS PAGE and
gas-liquid chromatography indicate that it has a molecular weight
of 72,000 daltons and contains a single polypeptide chain. The
molecule binds sheep RBC-C3d but not C3b and antibody to the
glycoprotein inhibits rosette formation with EC3d but not EC3b. CR2
was found only on B-cells and not on T-cells, monocytes,
neutrophils or erythrocytes.
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Genetic polymorphism of the complement (CR1) receptor
Recent studies (Dykman et al 1983) of erythrocyte CRl isolated
fran single individuals have demonstrated that the protein shows
structural polymorphism. CRl was purified by C3-sepharose affinity
chromatography from 125 radio-iodine labelled erythrocytes
solubilised in NP40. Subsequent autoradiographic analysis of the
purified protein on SDS PAGE revealed three distinct patterns. In
type a individuals there was a single band of 190,000 daltons, in
type b a single band of 220,000 while in type c both 190,000 and
220,000 bands were found. Both bands had an associated minor band
which was 15,000 daltons greater than the main band. Study of 33
individuals gave a frequency of 70% type a, 3% type b, and 27% type
c. Family studies demonstrated a pattern of inheritance consistent
with the presence of two codominant alleles.
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Ultxastructure of complement receptors
Early studies suggested that ccnplement receptors were
randomly distributed over the surface of endotoxin induced
macrophages (Kaplan 1977). More recent studies snowed that C3b
receptors on human neutrophil polymorphs and monocytes are
distributed in clusters (Petty et al 1981) and unlike Fc receptors
show no lateral mobility within the plane of the cell membrane
(Petty et al 1981, Michl et al 1979). Others using indirect
immunofluorescence and antibody to CR1 receptors on neutrophil
polymorphs confirmed that CRl are non-randcmly distributed in
clusters on the cell membrane at cfc, but at 37C the antibody-ligand
rapidly disappears suggesting that endocytosis has occurred (Fearon
et al 1981). These observations prompted more detailed
ultrastructural studies (Abrahamson and Fearon 1983) of the
distribution of CRl on monocytes and polymorphs using ferritin
labelled Fab2 anti-C3b receptor antibody. These studies show that
CRl receptors are located in clusters on the cell membrane surface
and after ligand binding they are rapidly internalised by
adsorptive endocytosis via so called "coated pits" or cytoplasmic
invaginations. Ligand internalised in this fashion was delivered
finally to lysosames and no uptake was seen via large phagosamal
structures.
An intact cytoskeleton is also of importance in the function
and expression of C3 receptors. Inhibitors of microtubules such as
colchicine and vinblastine as well as microfilament inhibitors such
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as the cytochalasins inhibit rosette formation with complement
sensitised particles (Atkinson et al 1977b). The rosetting of
complement receptors is also temperature dependent, being maximal
« o
at 37C and almost undetectable at 4C (Lay and Nussenzweig 1968).
However as mentioned above, carpiement receptors are detectable on
© ...
the membrane at OC using lnmunofluorescence and inhibition of
rosetting probably reflects reduction in membrane fluidity rather
than reduced receptor expression. Cytoskeletal inhibitors may also
prove to inhibit rosetting by interfering with membrane contact
rather than by preventing receptor expression.
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Function of complement receptors
The functional inportance of ccrnplement receptors parallels
that of the complement system in which a number of inherited
defects have been described and which predispose to serious
infection and iitntune complex diseases. For example deficiencies of
classical pathway components Clr, Cls, C4 and C2 are all associated
with the development of systonic lupus erythematosus; C3 deficiency
(Alper et al 1976; Alper 1970) is associated with life threatening
recurrent infection, C6 and C8 deficiency with gonococcaemia, and
C3bINA deficiency with severe recurrent infection (Table 10,pl45).
Quite apart from the opsonising and cherotactic activities of these
proteins it has also been shown that extracellular IgG and
complement are necessary for killing of opsonised microorganisms
which have already been ingested by monocytes and presumably act by
stimulating surface complement and Fc receptors (Leijh et al 1979).
B-lymphocyte C3b receptors may also play a role in the induction of
antibody responses to certain antigens (Pepys 1976).
Endocytosis and binding via complement receptors
Although it is generally agreed that C3b promotes adherence of
sensitised particles such as erythrocytes or bacteria to phagocytic
cells, there has been controversy over the role of complement in
mediating endocytosis. It is now clear that the function of C3
receptors has to be related not only to the maturation and
functional state of the phagocyte but also to the chemical nature
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of the particle and the presence or absence of other ligands.
Lay and Nussenzweig (1968) demonstrated adherence of C3b
coated sheep erythrocytes to mouse peritoneal macrophages and
showed that the receptor is trypsin sensitive. Griffin et al
(1975a) also using resident mouse peritoneal macrophages and sheep
erythrocytes demonstrated binding but not ingestion. Ehlenberger
and Nussenzweig (1977) also reported binding but not ingestion of
C3 coated erythrocytes to human monocytes but did dsnonstrate that
C3b had a synergistic effect on Fc mediated ingestion. Similarly
van Furth et al (1979) demonstrated that while nearly 100% of human
monocytes bound, only 16% ingested C3 sensitised sheep red cells.
Newman et al (1980) have found that while freshly separated human
monocytes do not ingest C3 coated sheep red cells, after seven days
in culture they acquire the ability to ingest via C3b or C3bi
receptors. Using different test particles ingestion via C3
receptors can be danonstrated without manipulation of the
phagocyte. For exanple E. coli opsonised with complement is
phagocytosed by human monocytes (Horwitz 1980) and the uptake of
heat aggregated IgM by mouse and guinea pig macrophages occurs in
the presence of complement (van Snick and Masson 1978); Kijlstra et
al 1978). Schreiber et al (1982) likewise have shown that E.coli
coated with C3b or C3bi are bound and ingested by human neutrophil
polymorphs while similarly coated sheep erythrocytes are not.
Furthermore, opsonisation of bacteria with agammaglobulinaemic sera
results in both phagocytosis and killing (Williams and Quie 1971),
although this may of course be attributable to serum components
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other than complement.
Although there has been dispute over the ability of C3b
receptors alone to mediate phagocytosis of large particles there is
now good evidence that C3b receptors mediate adsorptive endocytosis
(Fearon et al 1981 ; Abrahamson et al 1983) and thus may provide a
mechanism not only for clearance of complement coated immune
complexes but also of fluid phase C3b generated at sites of
inflammation thus assisting in the limitation of inflammatory
damage. Similar clearance mechanisms may exist for Clq, C3bi, C3d
and C5a (Jesaitis et al 1983).
The discrepancies between these different systems reflect
differences in the maturity and state of activation of the
phagocyte as well as the nature of the test particle since bacteria
and yeast but not sheep red cells may provide additional phagocytic
ligands (vide infra) (Czop et al 1978a & 1978b).
Synergism between complement and Fc receptors
A number of workers have reported that complement receptors
enhance Fc receptor mediated phagocytosis and have shown that in
the presence of complement much smaller amounts of IgG are needed
to mediate ingestion (Ehlenberger and Nussenzweig 1977). Shaw and
Griffin (1981) also provide evidence that while C3 augments Fc
mediated ingestion of sensitised red cells it does not participate
in the ingestion process. In these experiments erythrocytes coated
with IgG and complement were allowed to adhere to mouse peritoneal
macrophages at 4b. The remaining unengaged Fc receptors were then
>
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blocked with an anti-macrophage serum which did not interfere with
C3 receptor function (Bianco et al 1975). After warming to 37C
phagocytosis did not occur. Others (Michl et al 1979) have studied
the modulation and functional interrelation of Fc and C3 receptors
using a different system and obtained contrary results. Normal or
inflammatory mouse peritoneal macrophages were allowed to adhere to
glass cover slips coated with either DNP-antiDNP IgG complexes or
DNP-antiDNP IgG-C3b complexes and then the effect on binding of IgG
or C3b sensitised erythrocytes to the macrophages observed. After
adhering to IgG complexes a reduction in Fc binding and ingestion
was seen but surprisingly adherence to the IgG-C3b coated surface
reduced only C3b receptor binding and had no effect on Fc binding
of IgG coated erythrocytes. Thus C3b appeared to mask the Fc
portion of the DNP-IgG complex making it ineffective as a ligand
for receptor binding. This contradicts the hypothesis of Shaw and
Griffin (1981) and suggests that in the presence of complement,
binding and ingestion occurs via C3b not Fc receptors. A further
unexpected finding was that layering of macrophages onto
DNP-IgG-C3b had no effect on the ability of resident macrophages to
bind complement coated red cells but profoundly inhibited binding
and ingestion by inflammatory macrophages. This observation may
reflect differences in C3b receptor-cytoskeletal linkages in
resident and inflammatory macrophages.
Synergism between complement receptors and "non specific" ligands
In 1968 Lee noted that desialation of sheep and ox
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erythrocytes with neuraminidase increased their adhesion to mouse
macrophages and promoted their ingestion in the presence of
nonimmune mouse serum i.e. desialation had two effects, it allowed
recognition of the erythrocyte by a macrophage membrane receptor
and prcmoted opsonisation by nonimmune serum presumably via
complement activation. The significance of these findings has only
recently been appreciated (Czop et al 1978a, 1978b) and indirectly
has led to the identification of the leucocyte and erythrocyte C3b
receptor. Czop et al (1978) have shown that particles which are
natural activators of the alternate pathway of complement are
ingested by human monocytes in the absence of complement or
immunoglobulin whereas "non-activators" are not ingested. Thus
zymosan, rabbit erythrocytes, mouse C57B and CBA erythrocytes which
are all alternate pathway activators are all ingested. Furthermore,
the rank order of ingestion of these erythrocytes exactly parallels
their rank order of lysis by complement (Rabbit > mouseC57B > mouse
CBA); sheep and guinea pig erythrocytes which are not activators of
the alternate pathway are neither lysed by complement nor ingested
by monocytes. Ingestion of particles by this mechanism can be
inhibited by trypsin using amounts of trypsin which are
insufficient to alter Fc receptor mediated uptake or C3b receptor
binding. Further work has shown that the ability of these particles
to activate the alternate pathway and to be ingested is inversely
related to the amount of sialic acid on their surface. Thus
desialation of sheep erythrocytes by neuraminidase or chemical
conversion to heptulosonic acid increases their "ingestability" in
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a dose dependent fashion. Further, while opsonisation of untreated
sheep erythrocytes with C3b has little or no effect on ingestion,
after desialation, C3b has a synergistic effect on phagocytosis of
these particles. The mechanism of deposition of C3b on the surface
of alternate pathway activators has also been related to sialic
acid content. Using preformed C3bBb convertase a direct
relationship was found between deletion of sheep erythrocyte sialic
acid residues, inhibition of the ^1H and C3bINA mediated C3b degvaAaVio^
and decreasing ability of |3lH to cause decay of the C3bBb
convertase. Thus for alternate pathway activators a direct link is
established between the absence of sialic acid, amplification of
C3b generation by deregulation of j3lH and C3bINA and recognition
and ingestion by monocytes. These observations suggest that the
plasma proteins of the alternate pathway which are responding to
the regulatory effects of alternate pathway activators are
prototypes of the monocyte membrane receptor proteins involved in
the ingestion of these activators (Czop et al 1978a). Further
relationships between C3, macrophages and alternate pathway
activators are discussed in the next section.
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Role of complement receptors in cellular secretion
C3b receptor stimulation causes lysosomal enzyme release from
macrophages and it has been suggested that this may play an
important role in a number of chronic inflammatory conditions. In
vitro it has been shown that many stimulants of chronic
inflammation such as irrmune complexes, dental plaque, zymosan and
mouldy hay dust have two properties in ccmmon - they activate the
alternate pathway of complement with cleavage of C3 to C3b, and
they stimulate prolonged lysosomal enzyme release frcm macrophages
(Cardella et al 1974; Schorlemmer et al 1977). These effects appear
to operate in parallel, are dose dependent and are not associated
with macrophage cytoplasmic enzyme release or death. Furthermore
C3b itself may also stimulate lysosomal enzyme release thereby
amplifying the original signal (Schorlemmer and Allison 1976;
Schorlemitter et al 1976). In addition the mononuclear phagocyte
itself synthesises a number of complement components, including
factor B, factor D, Properdin (P), C2, C3, C4, C5, C3bINA and ^1H
(De CeulcEr et al 1980; Whaley 1980; Ruddy and Colten 1974; Littman
and Ruddy 1977) and some of the enzymes which the macrophage
secretes are able to cleave complement components. For example,
plasminogen activator, produced in large quantities by activated
macrophages (Gordon et al 1974; Unkeless et al 1974; Gordon et al
1978) converts plasminogen to plasmin. The latter can cleave C3 to
C3b, and C5 to the chemotaxin C5a, the net result being self
sustaining generation of inflammatory stimuli. A further
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interrelationship between alternative pathway activators,
macrophage secretion and endogenous C3 synthesis has been suggested
recently (Schorlenmer et al 1981). In these studies E<ab)2-anti-C3
added to serum free cultures of macrophages and alternative pathway
activators was shown to inhibit secretion of hydrolases in a dose
dependent fashion. This strongly suggests that conversion of
endogenous C3 to C3b causes stimulation of hydrolase release via
C3b receptors. Similar inhibition was obtained with added exogenous
blH and C3bINA. It is also possible that a similar mechanism is
involved in the spontaneous phagocytosis of unopsonised alternative
pathway activators or alternatively that activation of endogenous
C3 on the macrophage membrane triggers ingestion without a
requirement for C3b receptors. These possibilities have not been
explored, but are a further potentially interesting interaction of
macrophages and complement.
Oligomers of C3b also modulate the release of other enzymes
and have been shown to inhibit the zymosan induced release of
histaminase frcm neutrophils (Melamed et al 1981 (51)).
Complement receptors also play an important role in
stimulating the oxidative burst of phagocytic cells and evidence
for the involvement of Clq, C3b, C3bi and C5a receptors has been
found. Particle bound Clq but not monaneric fluid phase Clq has
been shown to stimulate chemiluminescence responses in neutrophil
polymorphs but the response is weak compared to C3 and Fc receptor
stimuli (Tenner and Cooper 1982, Schreiber et al 1982).
Chemiluminescence responses are also obtained with sheep
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erythrocytes coated with C4b (Schreiber et al 1982).
However interest in the ability of catrplement to activate the
respiratory burst has centered mainly on the question of whether
C3b, C3bi and |3lH receptors are capable of stimulating oxidative
metabolic responses without a requirement for other ligand binding.
Newman and Johnston (1979) used trypsin generated C3b bound to
sheep erythrocytes (EC3b) to examine whether C3b alone would
stimulate a respiratory burst and degranulation in human neutrophil
polymorphs. EC3b alone did not stimulate release of superoxide
anion, glucuronidase or lysozyme. If small amounts of IgG were also
present on the red cell, neutrophil stimulation occurred and it was
clear that C3b had a synergistic effect on Fc receptor mediated
activity. They confirmed the specificity of C3b receptor binding of
BC3b both by blocking with fluid phase C3b and by the reduction in
rosetting after treatment with C3bINA. However Goldstein et al
(1976) using nonpbagocytosable Sepharose 4B beads coated with C3b
found that CR1 stimulation alone released superoxide frcm
neutrophil polymorphs but degranulation and lysosomal enzyme
release only occurred if IgG were present. The effect on superoxide
release was arrplified if IgG was present. In these experiments
Sepharose was opsonised with normal serum which results in
opsonisation with C3b but also in the adsorption of small amounts
of IgG; the IgG was removed by boiling in 2M Nacl and the absence
of IgG confirmed by immunofluorescence. This data therefore has
been questioned on the grounds that it would be difficult to
exclude the presence of small amounts of IgG on the C3b coated
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beads. However it was also shown that superoxide release was
completely blocked by pretreating the C3b beads with E^E anti-C3.
Schopf et al (1982) have also demonstrated activation of human
monocytes both by oligomeric C3b and by purified (3lH. C3b was
prepared by trypsin cleavage of C3 and any contaminating |31H
removed by affinity chromatography. Both plH and C3b stimulated
chemiluminescence in monocytes but neither caused an increase in
NBT reduction and in fact C3b appeared to have an inhibitory effect
on the latter. They suggested that C3b may act by stimulating
release of plH from monocytes, an effect which has been previously
observed in lymphocytes (Dierich et al 1982). Schreiber et al
(1982) using purified C3b, C3bi and C3d have shown that sheep
erythrocytes coated with C3b or C3bi elicit chemiluminescence frcm
neutrophil polymorphs in a dose dependent fashion but C3d does not.
The specificity of binding was confirmed by inhibition with
purified moncmers and, in experiments using C3bi, protease
inhibitors were included to inhibit neutrophil elastase degradation
of C3bi to C3d. C3b opsonised zymosan also elicited
chemiluminescence in the absence of IgG and they doaonstrated that
C3b polymers but not moncmers caused chemiluminescence. The finding
that moncmeric C3b has no effect is in line with the finding of
Fearon et al (1981) that for C3b mediated absorptive endocytosis
monovalent interactions are insufficient. Dobson et al (1981a) have
also compared the ability of ccmplement components bound either to
sheep erythrocytes (EC3b, EC3bi) or to zymosan (ZymC3b, ZymC3bi) to
release superoxide from human neutrophils. Neither EC3b nor EC3bi
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caused superoxide release while ZymC3b and ZymC3bi did. The ZyinC3b
stimulated release was completely inhibited by Fab anti-C3c or
anti-blH. However Fab antiCRl only slightly inhibited superoxide
released by ZymC3b or ZymC3bi whereas crosslinking of CRl receptors
by Fab2 anti-CRl did not elicit any superoxide release i.e. the
stimulation of CRl alone is insufficient. They conclude therefore
that C3b/C3bi mediated release of superoxide by ZymC3b/ZymC3bi
involves a structure on zymosan which is absent on sheep
erythrocytes.
The bulk of the evidence at present seems to indicate that
engagement of CRl and CR3 receptors by polymeric C3b or C3bi may
elicit a chauiluminescence response but is insufficient without
additional ligands, such as the Fc portion of IgG or sugar residues
on yeast, to elicit superoxide release. The ease of demonstration
of chemiluminescent responses in part reflects the sensitivity of
chemiluminescence techniques and may not always represent a
significant biological event.
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Functions of the isolated complement receptor glycoprotein
A search for a red cell membrane protein which would inhibit
and thus prevent damage to erythrocytes by complement (Hoffman
1968, Fearon 1979) subsequently led to the identification of the
human CR1 receptor (Fearon 1980). This glycoprotein (gp205) has
been shown to inhibit alternate pathway activation by disassembling
the C3bBb convertase and augmenting the cleavage of C3b by C3bINA.
Other studies have shown that gp205 is also a cofactor for
inactivation of C4b by C3b/C4bINA (Iida & Nussenzweig 1981). A
glycoprotein gp55 which nay represent the head portion of gp205
also has regulatory effects and enhances the binding of |3lH to C3b
(Dierich et al 1982). Since receptor glycoprotein is shed from
cells into the fluid phase (Dierich 1976, Lambris et aal 1981)
these molecules may have important regulatory effects in the
extracellular environment as well as on membrane surfaces.
Moreover, recent studies by Medof et al (1982) have shown that
soluble or membrane bound CR1 catalyses C3bINA dependent
degradation of immune complex bound C3b to C3c and C3d and results
in release of C3b-immune complexes from the CRl receptor. The
reaction occurs independantly of blH and represents a novel
function for the immune adherence receptor.
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Modulation of complement receptors
The expression of C3b receptors by monocytes can be enhanced
by a number of agents including lymphokines, and chanotaxins (FMLP,
C5a, endotoxin, HETE); is influenced by physical factors such as
temperature; and alters with the maturity of the cell. In view of
the observations of Hirato and Axelrod (1980), Ogmundsdottir and
Weir (1979) & (1980), and Sorg (1982) discussed previously it is
highly likely that these diverse factors exert their effects by:
(1)activating membrane transmethylation reactions, thereby
increasing membrane fluidity, exposing cryptic receptors and
enhancing receptor coupling with contractile elements
(2)triggering calcium influx and calcium dependent cytoplasmic
biochemical events.
Additionally these agents also trigger PLA2 activation which, by
generating AA, lysophosphatidyl choline and products of the
lipoxygenase and cyclooxygenase pathway exert further enhancing and
inhibiting effects. In most instances the effects on complement
receptor expression are reversible and occur maximally within 30
minutes emphasising that new protein synthesis is not required.
Some examples of complement receptor modulation will be discussed.
Whereas few murine promonocytes (30%) express C3b receptors up
to 90% of blood monocytes do so (van Furth et al 1980). In
addition, the phagocytic capacity of the C3b complement receptor
increases with maturity in culture and in the presence of
inflammatory stimuli (i.e. thioglycollate elicited vs resident
macrophages)(Bianco et al 1975; Newman et al 1980). The poor
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expression of complement receptors on promonocytes may reflect the
low synthetic and activation state of the cell in the early stages
of the monocyte cell cycle as has been observed for other
biochemical activities (Sorg 1982). The enhancement occurring with
maturation in vivo and in culture presumably in part reflects
receptor synthesis but also reflects alterations in membrane
fluidity which facilitate linkage of complement receptors to
cytoskeletal elements. This is supported by the observations of
Michl et al (1979) who showed that while complement receptors were
not mobile in the plane of the membrane of resident macrophages,
they became mobile in thioglycollate or "inflammatory" macrophages.
The rapid changes in complement receptor expression occurring
in response to a number of other stimuli are unlikely to be
attributable to new receptor synthesis. A number of workers have
shown that chemotactic agents cause considerable enhancement of
complement expression in monocytes, neutrophils and eosinophils
over a period of 30 minutes. Anwar & Kay (1977b & 1978) shewed that
eosinophil chemotactic factors (ECF) including the tetrapeptides
val-gly-ser-glu and ala-gly-ser-glu, histamine and its major
metabolite imidazole acetic acid enhanced C3b and C4)>receptors on
human eosinophils. Similarly the N-formylated peptides
F-met-leu-phe, F-met-met-phe and F-met-phe also enhanced C3b
receptor expression on human neutrophils and monocytes whereas the
unformylated peptides had neither chemotactic nor receptor
enhancing effects (Kay et al 1979). Glass & Kay (1980) extended
these findings and showed that other chemoattractants including
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casein, supernatants frcm C parvum and frcm PHA stimulated
lymphocytes enhanced monocyte complement receptor rosette
formation. These agents have little or no effect on Fc receptor
expression. The effect of all these agents was dose dependent, tine
courses showed maximal effects within 30 minutes and after removal
of the stimulus, it was reversible. Lipid chemotactic products of
the lipoxygenase pathway of arachidonic acid metabolism have
similar effects. Goetzl et al (1980) showed that
hydroxyeicosatetraenoic acids (HETE) increased eosinophil and
neutrophil complement receptors but had no effect on Fc receptors.
Conversely the generation of HETE via the lipoxygenase pathway
during stimulation by other chemotaxins such as C5a may therefore
enhance the cells responsiveness and provide an amplifying
mechanism.
The role of lymphokines in this process has also been studied.
Although lynphokines generated by primed T-cells which were
incubated with macrophages and antigen had no effect on resident
macrophage ccxrplement receptors (Griffin & Griffin 1979),
macrophages which had ingested IgG containing complexes stimulated
release of a different lymphokine frcm T-cells. This lymphokine had
no effect on macrophage Fc receptor expression but did stimulate
complement receptor mediated ingestion in resident macrophages
(Griffin and Griffin 1980).
Fearon and Collins (1983) have used immunofluorescence and
dimeric radioiodine labelled C3b as probes of C3b receptors on
neutrophils and monocytes to examine the effect of separation
76
procedures and temperature on C3b receptor expression. They found
that neutrophils separated at 4C had far fewer C3 receptors
(5,500/cell) than those separated at 2<X (21,000/cell). Cells
incubated for a further 30 minutes at 3it had 38,000
receptors/cell. Furthermore, neutrophils kept unseparated in whole
citrated blood at 3~fc without centrifugation showed no increases in
C3 receptors. They also confirmed that both C5a and F-met-leu-phe
caused 8 to 10 fold increases in receptor expression.
The biological importance of the effect of chemotactic agents
and lymphokines is that they provide an important mechanism for
enhancing the bacterial recognition and phagocytic mechanisms of
monocytes and neutrophils moving down a chemotactic gradient
towards an inflammatory focus. Fran a practical viewpoint the
observations of Fearon and Collins (1983) highlight sate of the




Mononuclear phagocytes have "lectin-like" receptors for
carbohydrate residues which provide a simple but specific mechanism
for the recognition of altered "self" molecules as well as foreign
"nonself" molecules. These receptors have been implicated in the
recognition, binding and clearance of serum glycoproteins (Stahl et
al 1978, 1980; Ashwell & Morell 1974; Stockert et al 1976; Lunney &
Ashwell 1976; Baynes & Wold 1976; Winkelhake & Nicolson 1976;
Achord et al 1977; Shepherd et al 1981; Townsend & Stahl 1981;
Schlesinger et al 1980.), lysosomal enzyrres (Stahl et al 1978,
1980; Schlesinger et al 1976, 1978; Achord et al 1977), desialated
erythrocytes (Czop et al 1978a & 1978b; Kolb et al 1978; Nagamura &
Kolb 1980; Jancik 1978; Schlepper-Schaffer et al 1980), IgM-antigen
inmune complexes (Day et al 1980), tumour cells (Weir et al 1979;
Schlepper-Schaffer et al 1981) and bacteria and yeast (Czop et al
1978b; Sung et al 1983; Ogmundsdottir & Weir 1976 & 1978; Freimer
et al 1978; Glass et al 1981; Weir et al 1981). Evidence is also
accumulating for the role of specific carbohydrate recognition
mechanisms in the immune response and in particular in macrophage
T-cell interactions (Muchmore & Blaese 1979; Stewart et al 1982;
McKenzie et al 1977) and cell mediated cytotoxic reactions
(Muchmore & Blaese 1979).
>
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Specificity of receptors for glycoprotein and lysosomal enzymes
The outer sequence of carbohydrate chains of most mammalian
glycoproteins consists of a triad of sugars with a terminal
nonreducing sialic acid residue linked to D-galactose which in turn
is linked to N-acetyl-D-glucosamine. Asial©glycoproteins, which
have a terminal galactose are virtually absent from mammalian serum
and if infused are very rapidly cleared frcm the circulation.
Ashwell and Morell (1974) originally proposed that a specific
recognition mechanism existed for the terminal galactose to account
for the very rapid clearance of these glycoproteins in vivo and it
is now known that this receptor is present on the hepatocyte. The
receptor will recognise and bind asialated, galactose bearing
erythrocytes and tumour cells as well as glycoprotein and also has
sane specificity for glucose conjugated glycoprotein (Schlesinger
et al 1980). From a phylogenetic viewpoint it is interesting to
note that avian and reptilian species have high circulating levels
of asialoglycoproteins and lack the galactose specific receptor.
However, avian and probably reptilian species have a hepatic
receptor for N-acetyl-D-glucosamine which is the residue exposed
after removal of galactose (Lunney & Ashwell 1976).
Subsequently, recognition mechanisms for lysosomal enzymes and
glycoproteins have also been identified in the macrophage which are
predominantly D-mannose and L-fucose specific but which also bind
D-glucose and N-acetyl-D-glucosamine terminated glycoprotein. It
might therefore be considered that the macrophage receptor
represents a phylogenetically older system than the mammalian
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hepatic galactose receptor. A number of workers have shown specific
receptor mediated clearance in vivo of mannose and
N-acetyl-I>-glucosamine bearing glycoproteins (Stockert et al 1976,
Baynes & Wold 1976, Shepherd et al 1981, Schlesinger et al 1980).
Others have shown that lysosomal glycosidases such as
^glucuronidase, jS-galactosidase, fl-mannosidase and
N-acetyl-D-glucosaminidase are cleared by the same receptor (Stahl
et al 1980, Schlesinger et al 1976, 1978, Achord et al 1977). For
example, Sclesinger et al (1978), comparing the clearance of
radioiodine labelled lysosomal enzymes and glycoproteins, found
that ^-glucuronidase, ribonuclease B and agalacto-orosamucoid, all
of which have either a terminal mannose, N-acetyl-D-glucosamine or
both, are cleared by Kuppfer cells whereas asialo-oroscmucoid with
a terminal galactose was cleared mainly by hepatocytes. It has also
been shown that L-fucose, D-mannose and N-acetyl-D-glucosamine
terminated glycoproteins compete for the sane macrophage receptor
(Achord et al 1977, Shepherd et al 1981) and that the receptor will
recognise glucose conjugated to neoglycoprotein (Stahl et al 1978,
Shepherd et al 1981). The order of specificity found by Shepherd et
al (1981) was :
L-fucose & D-mannose > N-acetyl-D-glucosamine & D-glucose >
D-xylose.
The receptor system has also been implicated in the clearance
of IgM-antigen iimmune complexes from the circulation. Unlike most
serum glycoproteins with long half-lives, IgM has mannose residues
and ought in principle to be rapidly cleared by hepatocyte and
80
Kupffer cell receptors. It has therefore been suggested that steric
inaccessibility of the sugar residues is responsible for the long
half life of the immunoglobulins (Day et al 1980). Experiments with
IgM and IgM-BSA complexes have provided evidence for this
hypothesis and show that when IgM binds to antigen the mannose
residues become exposed and mediate clearance of the complex (Day
et al 1980). Thus the rapid clearance of IgM-BSA complexes from the
circulation was inhibited by mannan and ovalbumin but not by
asialofetuin, dextran or depletion of serum complement. Furthermore
while IgM does not normally bind Concanavalin A, it does do so
after ccmplexing with antigen, and both Con A binding and RES
clearance can be abolished by prior treatment of the complex with
flt-mannosidase. Thus binding of antigen appears to induce a
conformational change in IgM resulting in exposure of mannose
oligosaccharide residues which mediate receptor clearance from the
circulation.
Isolation and preliminary characterisations of the
mannose/N-acetyl-D-glucosamine/fucose binding protein by affinity
chromatography have now been carried out. A receptor isolated from
rat liver consisted of a single band with a molecular weight of
approximately 30,000 on SDS PAGE (Townsend and Stahl 1981). Binding
of radioiodine labelled manran to the putative receptor protein was
specific and saturable and could be inhibited by mannose,
N-acetyl-D-glucosamine and L-fucose but not by galactose or
mannose-6-phosphate. The binding of neoglycoprotein conjugates was
also studied; those with a terminal mannose, N-acetyl-D-glucosamine
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or L-fucose were bound 10,000 times more strongly on a molar basis
than the free monosaccharide; glycoprotein with terminal galactose
was not bound. The relative strength of binding observed with
neoglycoprotein conjugates points to highly stereospecific binding
requirements. A similar protein of molecular weight 31,000 has been
isolated fran rabbit liver and shewed a similar spectrum of
inhibition with saccharides (Kawasaki et al 1978).
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Specificity of receptors for desialated erythrocytes
As described above, there is considerable evidence for uptake
of galactose terminated glycoproteins via a hepatocyte receptor and
uptake of mannose/fucose/N-acetyl-D-glucosamine terminated
lysosomal enzymes and IgM-antigen caiplexes via a macrophage
receptor. However, there is also evidence for distinct,
predominantly galactose specific receptors on macrophages which
bind desialated erythrocytes in vitro and are not inhibited by
mannose or N-acetyl-D-glucosamine.
Although in general the presence of sugars enhance cell-cell
interactions by attractive van der Waals forces the
presence of terminal sialic acid on cell membrane oligosaccharides
confers a strong hydrophilic, negative electrostatic charge which
is involved in cell-cell and cell-protein repulsion (Nir & Anderson
1977). Erythrocytes desialated with neuraminidase agglutinate
rapidly in vitro at room temperature and, in vivo, became coated
with complement and immunoglobulin and cleared from the circulation
(Jancik 1978). Similarly, studies of the metastasising potential of
tumour cells has demonstrated that the presence of sialic acid on
the tumour cell potentiates metastasis whereas cells with
N-acetyl-glucosamine or D-galacJose have low metastatic potential
(Fogel et al 1983). The ability of macrophages to recognise
desialated erythrocytes via the exposed galactose residue has been
investigated in same detail (Czop et al 1978a, 1978b, Kolb et al
1978, Nagamura & Kolb 1980, Schlepper-Schaffer et al 1980).
Czop et al (1978a), investigating this phenomenon, found that
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the degree of sialation of erythrocytes and other alternate pathway
activators was inversely related to their ability to be
spontaneously phagocytosed by monocytes and to activate the
alternative pathway of ccrrplement. They also found that the
macrophage recognition mechanism for the aesialated erythrocytes
was trypsin sensitive, suggesting that a membrane protein was
responsible for facilitating the interaction with terminal
D-galactose. Subsequent work confirmed that neuraminidase treated
rat erythrocytes are bound by a receptor on rat Kuppfer cells which
can be inhibited by D-galactose and N-acetyl-D-galactosamine but
not by a number of other sugars. These workers (Nagamura & Kolb
1980, Schlepper-Schaffer et al 1980) have since examined in more
detail the stereochemical requirements for binding by this receptor
using a variety of monosaccharides and their substituted
derivatives; oligosaccharides; and glycoproteins with defined
terminal sugars. In general the sugars which inhibited binding of









These sugars are summarised in Table 5.
TABLE 5 Inhibitors of lectin-like receptor
Inhibitors Noninhibitors
D-galactose D-mannose









Exertions to this generalisation were glucose-6-phosphate and
glucosylated-albumin which, although apparently possessing the
wrong stereochemistry, did inhibit binding. The authors do not
offer an explanation for these exceptions. However the ability of
glucose-6-phosphate to block the receptor must be attributable to
the phosphate substitution. The only difference between D-glucose
and D-galactose is at the carbon-4 position where in the
energetically favoured chair conformation of galactose the C4-0H is
axial while in glucose it is equatorial:
OH H
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Esterification of glucose C6-QH by phosphate could provide the




A similar effect might be postulated in glucose conjugated albumin
where, if the glucose were held in the less favourable chair
conformation by the albumin molecule, the C4-0H would be oriented
in the axial position and might then be available for binding to
the receptor site.
Conversely, D-galactosamine did not exhibit the expected inhibition
of receptor binding whereas the N-acetyl derivative did. Again
stereochemical considerations suggest that the presence of a
negatively charged -NH2 group might inhibit approximation of the
C4-0H to its binding site.
In addition there is evidence for a second galactose specific
receptor -on "activated" macrophages which does not bind




Specificity of receptors for microorganisms and tumour cells
There is also evidence that so called nonspecific binding and
ingestion of a variety of gram positive and gram negative organisms
is mediated in part by "lectin-like" receptors in the phagocyte
membrane which recognise "foreign" sugars on the bacterium
(Ogmundsdottir & Weir 1976, 1978; Freimer et al 1978). These
receptors have been demonstrated on phagocytes fran different
species and of different types including macrophages, neutrophil
polymorphs, eosinophils and monocytes. However study of this
phenomenon is complicated by a number of other factors. Sane
organisms themselves have "lectin-like" receptors for binding to
tissue cells. E. coli for exanple binds to mannose residues on
epithelial cells (Ofek et al 1977) and a "lectin-like" molecule has
been isolated from C. parvum which also has specificity for mannose
(Bogg et al 1981). Others such as Cryptococcus neoformans (Kozel &
Mastrioanni 1976) and encapsulated Pseudmonas species (Oliver &
Weir 1983) release cell wall material which can block the
phagocytic recognition system. Furthermore the bacterium may have
more than one sugar exposed on its surface and therefore engage
multiple phagocyte receptors.
Ogmunsdottir & Weir (1976) demonstrated that binding of C.
parvum to peritoneal exudate cells could be inhibited by a number
of monosaccharides including glucose, glucosamine, fructose,
N-acetyl-D-glucosamine, galactose, fucose, glucuronic acid and
rhamnose. All of these except fucose and rhamnose were detected in
the bacterial cell wall but the latter may have been carpeting with
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sterically similar sugars. It should be noted that glucose and
galactose did not cause synergistic inhibition which suggests that
they are competing for the same binding site. Further studies
(Freimer et al 1978) with a variety of gram positive and negative
organisms danonstrated binding which could be inhibited by glucose,
galactose or both providing the sugars were present on the
bacterial cell wall. Using mutants of S. typhimurium and K.
aerogenes which have various saccharide deletions from their
surface, a clear relation was established between the ability of
monosaccharides to block binding and their presence on the
bacterial cell wall. The only exception was mannose which did not
inhibit even though it is present on each of the Salmonella strains
tested. This may be due bo the additional side linkage of mannose
to abequose which could interfere with its steric accessability to
receptor linkages.
The importance of mannose binding however has been
demonstrated in the phagocytosis of yeast. Lung macrophages bind
and ingest T. krusei and zymosan via a receptor which is
mannose/glucosamine specific (Warr 1980), and Sung et al (1983)
have demonstrated that ingestion of zymosan by peritoneal
macrophages is inhibited by mannans which are a major constituent
of yeast cell wall (Northcote and Home 1952). They also showed
that blockade of the mannose receptor had no effect on Fc or C3
receptor function.
Evidence has also been found for binding of macrophages to
tumour cells (Weir et al 1979) particularly during the growth phase
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before they become confluent. As in the case of bacteria,
galactose, glucose, galactosamine and glucosamine were found to be
the principal inhibitors of binding of macrophages to target cells.
Likewise Schlepper-Schaffer et al (1981) have shown galactose
specific receptors on Kuppfer cells and hepatocytes which will bind
tumour cells.
The pattern of inhibition obtained with monosaccharides
differs in seme respects frem that obtained with the less complex
glycoproteins and desialated erythrocytes and suggests that
lectin-like binding sites in addition to those described for
galactose and mannose/fucose/N-ac-D-glucosamine may be involved. It
should also be noted that inhibition by monosaccharides never
exceeded about 30% emphasising the importance of other
physico-chemical interactions between bacteria and macrophages
(Capo et al 1979).
Muchmore and Blaese (1979) have made related observations on
the cytotoxic effects of monocytes on xenogeneic target
erythrocytes. Testing the hypothesis that macrophages are
interacting with target cell carbohydrates they found that for a
given target, a predictable spectrum of oligosaccharides would
inhibit cytotoxicity, and that a different spectrum was found for
different target species. Thus the monocyte displayed the ability
to recognise a range of sugars and the pattern of inhibition was
dictated by the saccharide ccrrponents of the target cells. Others
however have found evidence against this mechanism of target
recognition (Vose et al 1983).
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Relation between "lectin-like" receptors and la (DR) antigens
Several lines of evidence point to an important role for
oligosaccharides in the functioning of la molecules both in the
initial contact of macrophage with antigen and in subsequent
macrophage /T-cell interactions and induction of irtmunity.
Firstly there is evidence that there are both carbohydrate and
protein antigenic components to the MHC antigens (McKenzie et al
1977, Higgins et al 1980, Parish et al 1976a, 1976b, 1978, Mann &
Muchmore 1980); secondly, proliferative responses of immune T-cells
to antigen bearing macrophages may be inhibitable by simple
carbohydrates (Muchmore & Blaese 1979); thirdly, macrophage binding
of unopsonised bacteria may be mediated in part through la antigens
with lectin-like properties (Stewart et all982); fourthly, human la
(DR) molecules may bind to carbohydates (Mann & Muchmore 1980).
Previously it has been suggested that the regulation of
cell-cell interactions in a wide range of contexts, including
growth and differentiation of tissues, proliferative responses of
normal and tumour cells, and in pathophysiological events such as
adhesion of platelets to damaged tissue, are mediated by cell
membrane bound glycosyl transferases (Shur and Roth 1975).
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The general model they have proposed for binding and separation of
cells involves recognition of "acceptor" oligosaccharide molecules
by specific glycosyl transferases;
In this model, initial binding of "receptor" transferase to an
"acceptor" molecule is followed by monosaccharide transfer from the
appropriate nucleotide and is followed in turn by cell separation.
Since transferases are highly specific for both sugar donor and
acceptor a unique saccharide chain is constructed and specified by
the available transferases. This model allows cells to mutually
create as well as to recognise self.
The application of this model to the function of the MHC locus
was suggested by the observation that MHC controlled antigens have
both protein and carbohydrate constituents. McKenzie et al (1977)
demonstrated that certain defined la molecules (Ial, 3, 7 & 15) had
a major carbohydrate determinant and that recognition of these
molecules by anti-la antibody could be blocked in a highly
stereospecific fashion by certain monosaccharides. The
"iirmunodcminant" monosaccharides for these la antigens were
Ial/N-acetylglucosamine; Ia3/a-D-galactose; Ia7/L-fucose;
Ial5/N-ac-D-glucosamine. These observations have been extended and
confirmed and have led to the hypothesis that the MHC gene products
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are glycosyl transferases which construct the MHC carbohydrate
antigens (Parish et al 1976a, 1978, Higgins et al 1980). The
possibility that the protein MHC antigens are these transferases
has not yet been tested. This model of inmune macrophage/T-cell and
T-cell/T-cell interaction proposes the glycosyl transferase as the
anti-self receptor and has a second "antibody" like receptor for
recognition of foreign antigen.
Further evidence to support this view is suggested by the
observations of Muchmore and Blaese (1979) who found that immune
T-cell proliferative responses to antigen presenting macrophages
could be inhibited by seme carbohydrates but not by others. The
phenomenon was not attributable to nonspecific effects and a
different set of sugars were required to block PHA induced
proliferation. Studies of DRw alloantisera reactivity with human
monocyte DR antigens have demonstrated that certain sugars inhibit
the cytotoxicity of antisera to sate DR antigens and not others and
conversely anti-DR sera blocked the attachment of these sugars to
the monocyte. The authors conclude that the DR antigen appears to
have receptor like properties for certain saccharides.
Indirect clinical evidence for the ability of saccharides to
interfere with the regulation of cell mediated immunity (Oil) is
illustrated by chronic mucocutaneous candidiasis (Fisher et al
1978). These patients often have high antibody levels to Candida
but depressed OH, and the cellular defect does not appear to be
primary since it improves after anti-fungal therapy. Moreover it
has been shown that serum frcm some patients with active infection
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contains polysaccharide antigens which block specific
candida-antigen induced lymphocyte proliferation.
Stewart et al (1982) have also provided evidence that la
molecules may play a role in the unirmtunised state by contributing
to binding of unopsonised bacteria. It was shown that binding of S.
albus to peritoneal macrophages could be blocked by anti-la region
allo-antibodies and that glucose or galactose which also inhibit
binding did not cause synergistic inhibition with anti-la. Thus it
appears that glucose and galactose are competing with anti-la for
the la molecule binding site.
Evidence for a role for saccharides in lymphokine-monocyte
interactions has also been suggested. Studies of MIF showed that
V-L-fucose blocks recognition by MIF of a saccharide determinant on
monocytes and that treatment of monocytes with fucosidase abolishes
the response to MIF (Ronold 1973). Further studies have shown that
both L-rhamnose and L-fucose inhibit MIF as well as the action of
chemotactic lymphokines. They had no effect on the action of C5a or
C3a (Amsden et al 1978).
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Molecular characteristics of "lectin-like" receptors
A number of workers have studied the chemical characteristics
of macrophage lectin receptors and preliminary isolations have been
achieved.
Binding to the receptor is reduced by trypsin and pronase
(Stahl et al 1978, 1980, Ogmundsdottir & Weir 1978, Weir et al
1979) as well as by mild oxidation with periodate suggesting that
it is a glycoprotein. Moreover, the inhibitory effect of periodate
which removes two terminal carbon atoms from sialic acid and
oxidises the C7 hydroxyl to aldehyde, can be reversed with
borohydride (BH4-) which will reduce the C7 aldehyde back to an
alcohol group; this suggests that -CO groups play a role in
binding. Other sugars such as galactose might be expected to
provide OH groups and this is supported by the inhibitory effect of
^-galactosidase. Neuraminidase treatment however enhanced binding
to lectin-like receptors but this may be due to reduction of the
net negative electrostatic charge conferred on the membrane by
sialic acid.
Calcium ions were also shown to be important for binding to
the receptor and this supports the view that lectin receptor
binding involves interactions between -OH groups via Ca-H- bridges
(Stahl et al 1978, 1980, Shepherd et al 1981, Nagamura & Kolb 1980,
Ogmundsdottir & Weir 1976, Weir et al 1979, Warr 1980). The
importance of Ca-H- bridging between carbohydrates in cell surface
events such as adhesion and agglutination has been studied widely
(Cook & Bugg 1975). Furthermore the formation of Ca-OH bridges
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between carbohydrates in an aqueous environment has highly
stereospecific requirements which would therefore confer
specificity on receptor binding. The stereospecificity of lectin
receptor binding with respect to D-galactose has already been
discussed (Nagamura & Kolb 1980, Schlepper-Schaffer et al 1980).
However the stereospecificity of binding of sugars to la molecules
has also been studied (McKenzie et al 1977). Ia3 was found to bind
D-galactose as well as a variety of structurally related sugars
which enabled the stereochemistry of the interaction to be
examined. The binding of D-galactose and related oligosaccharides
and glycosides to Ia3 was shown to be heavily dependent on the
galactose C4 conformation i.e.
and to a lesser extent on the alcohol group at C5. The orientation
of the C2 -OH group was also shown to play a minor role.
Preliminary isolation and characterisation of the
mannose/fucose binding protein has been achieved. Townsend and
Stahl (1981) isolated a 30,000 molecular weight protein band on SDS
PAGE of rat liver extract and demonstrated typical receptor
binding, saturation and inhibition characteristics. Kawasaki et al
(1978) have also isolated a similar 31,000 molecular weight protein




The enhancement of macrophage phagocytosis by serum opsonins
had been recognised for many years (Briscoe 1908) before the
discovery that this was related to the presence of antibodies
(Vaughan 1965) and, in particular to macrophage receptor sites for
the Fc component of IgG (Howard and Benacerraf 1961; Berken and
Benaccerraf 1966). IgG-Fc receptor binding has been identified in a
wide variety of cells including human monocytes (Huber and
Fudenberg 1968), lyirphocytes (Nussenzweig 1974, Moeller 1981),
neutrophil polymorphs (Messner and Jelinek 1970), eosinophils
(Anwar and Kay 1977), platelets (Pfueller et al 1977a), basophils
(Segal et al 1981), as well as non-haemopoietic tissues such as
placenta (Johnson et al 1981) and intestinal epithelium. Binding of
cytophilic IgE to mononuclear phagocytes has also been described
(Joseph et al 1978).
In mononuclear phagocytes the Fc receptor facilitates
phagocytosis of foreign (Reynolds 1974) and autologous material
(Kay 1975), mediates AEXX (Haskill and Fett 1976 , Shaw et al
1978), and stimulates secretory activity such as superoxide anion
generation (Goldstein et al 1975), release of prostaglandins
(Kurland and Bockman 1978; Bonney et al 1980), acid hydrolases
(Cardella et al 1974) and neutral proteinases (Unanue 1976,
Passwell et al 1980). The biological activities and character of
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cytophilie antibodies has recently been comprehensively reviewed
(Leslie and Alexander 1979).
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Specificity of Fc receptors
The presence of Fc receptors on cells has been demonstrated
mainly by erythrocyte rosetting assays using antibody sensitised
erythrocytes (EIgG). Ultrastructural studies have also been carried
out using peroxidase or ferritin labelled immune ccnplexes
(McKeever et al 1976; Papadimitriou 1972); others have used
fluorescence conjugated labels (Schwartz et al 1976). Numbers and
affinity of Fc receptors can be demonstrated using binding and
competitive inhibition of radiolabelled immunoglobulins or
antigen-antibody ccrplexes (Arend and Mannik 1973, Unkeless and
Eisen 1975).
A number of studies have suggested that macrophages have two
IgG-Fc receptors distinguished by different physicochemical
properties, different sensitivities to proteases and lipases and
different specificities for subclasses of cytophilic antibody and
antibody-antigen immune ccrrplexes. In general immune ccnplexes bind
with higher affinity than moncmeric IgG (Segal and Horwitz 1977)
but as discussed below, monomeric IgG can none the less interfere
with binding of immune ccnplexes. Probably the earliest observation
to suggest the presence of two different Fc receptors was that of
Kossard and Nelson (1968). They noted that erythrocytes sensitised
with "early" antisera following immunisation formed rosettes with
macrophages via a trypsin sensitive receptor whereas if they ware
sensitised with "late" hyperimmune sera the binding could no longer
be prevented by treating the macrophages with trypsin. Askenase
(1974) confirmed this observation and found that only the trypsin
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sensitive binding could be blocked by IgG2a subclass antibody.
Subsequent evidence which supports the view that there are
least two Fc receptors is based on the demonstration of selective
cytophilic binding of certain IgG subclasses, competitive
inhibition studies using myeloma proteins of defined subclass, the
demonstration of mutant cell lines with selective loss of certain
receptor characteristics, and partial purifications of the putative
receptor proteins.
Affinity studies have shown that human monocytes bind
subclasses IgGl and IgG3 with equal and high affinity (Huber &
Fudenberg 1968, Huber et al 1971, Alexander et al 1978a, Abramson
et al 1970, Hay et al 1972) and IgG4 with somewhat lower affinity.
y -i
The association constant for IgGl (10 M) is high and all available
receptor sites will be occupied by monameric IgG under
physiological conditions (Alexander et al 1978a). Thus rosetting of
EIgG by human monocytes is easily inhibited by low concentrations
of monameric IgG (Alexander et al 1978a). Mouse macrophages bind
monomeric IgG2a and IgG2b but not IgGl, IgG3, IgA or IgM (Unkeless
1977, Lane et al 1980, Anderson & Grey 1977, 1978, Unkeless & Eisen
1975, Segal & Titus 1978, Unkeless 1979, Unkeless et al 1978,
Walker 1976) and bind ccmplexed or aggregated IgGl, IgG2a or IgG2b
strongly and with equal affinity (Heusser et al 1977). Guinea pig
macrophages bind monomeric and ccnplexed IgG2 (Alexander et al
1978a, Leslie & Cohen 1974, 1976) and to a lesser extent IgGl
(Leslie et al 1976).
A number of studies have shown that binding of immune
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canplexes to mouse macrophages (Steinman & Cohn 1972), guinea pig
macrophages (Howard & Benacerraf 1961), rabbit macrophages (Arend &
Mannik 1973) and human monocytes (Lobuglio et al 1967) is not
inhibited by prior trypsinisation of the macrophage. Unkeless
(1977) using a kinetic system to study binding of myeloma proteins
to mouse macrophages (Unkeless and Eisen 1975) confirmed that while
binding of rabbit IgG-antigen complexes to mouse macrophages is
trypsin insensitive, cytophilic binding of monomeric IgG2a is
trypsin sensitive thus suggesting that two types of receptor are
present. Further studies (Unkeless et al 1978) used mutant
macrophage cell lines selected for their poor ability to bind EIgG
rosettes. These variant cells not only formed fewer rosettes with
EIgG cells than the parent line, but the rosetting was now trypsin
sensitive and was completely inhibitable by moncrreric IgG2a.
Furthermore these cells no longer formed rosettes with erythrocytes
opsonised with a cloned anti-erythrocyte IgG2b antibody. They
therefore inferred the presence of two receptors; FcRI which binds
cytophilic IgG2a and is trypsin sensitive, and FcRII which binds
IgG2b. Both types of receptor bound immune complexes and FcRII was
selectively lost in the mutant cell line. Comparable evidence for
the binding of complexes to both receptors was found by Diamond et
al (1978) who showed that both IgG2a and IgG2b were required to
inhibit rosette formation of ElgG.
Anderson and Grey (1977, 1978) and Heusser, Anderson and Grey
(1977) have also found evidence to support the view that there are
two distinct receptors using myeloma proteins and macrophage cell
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lines. In normal mouse macrophages and two cell lines, strong
cytophilic binding of monameric IgG2a and to a lesser extent IgG2b,
but not IgGl or IgG3 was found. However aggregated IgGl, IgG2a and
IgG2b but not IgG3 all bound to a similar degree and were each
inhibited by aggregated IgG in a subclass unrestricted fashion.
However when monorreric inhibitors were used, IgG2b preferentially
inhibited binding of aggregated proteins of all three subclasses 10
times more efficiently than monameric IgG2a and IgGl. Conversely
binding of monameric IgG2b could be inhibited by aggregated IgG of
any class but only by monameric IgG of subclass 2b. Binding of
aggregated IgG2b was increased up to threefold with increasing
molecular weight whereas binding of aggregated IgGl and IgG2a was
unaffected by size. Studies of other cell lines revealed variants
which showed no binding of monaneric IgGl, 2a, 2b or 3, normal
binding of aggregated IgGl and 2b but reduced binding of aggregated
IgG2a. They therefore postulate two receptors - one which binds
IgG2a (monomeric and aggregated) and another which binds aggregated
IgG2b strongly and preferentially, monomeric IgG2b weakly but will
also bind aggregated IgGl and 2a. These findings are essentially in
agreement with those of Unkeless and others described above.
In addition to binding subclasses of IgG it has also been
shown that human monocytes (Joseph et al 1978) and rat macrophages
(Capron et al 1975) carry an Fc receptor for IgE which can mediate
binding and killing of schistoscmula. Others (Dessaint et al 1979)
have shown that aggregated IgE binds to rat macrophages and causes
release of ^-glucuronidase. Ifelewicz et al (1981) have further
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characterised the receptor and found that 20% of human monocytes
and 50 to 90% of rat macrophages formed rosettes with IgE
sensitised erythrocytes; the receptor mediated antibody dependent
cytotoxicity (ADOC) of IgE sensitised cells and was class specific.
After denaturation by heating at 56C or mild reduction and
alkylation of IgE the receptor no longer bound IgE.
Some studies have been performed on the structural requirement
for binding of the Fc fragment. It seems that the intact covalently
bound Fc fragment is essential for binding and requires the
presence of the CH2 domain (Alexander et al 1976, Diamond et al
1979, Dorrington and Klein 1982).
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Isolation of Fc receptors
Attempts to isolate the two macrophage receptors (FcRI &
FcRII) have resulted in varying degrees of success. Some studies
have isolated two distinct FcR-like binding proteins with varying
loss of receptor specificity (Anderson & Grey 1977, 1978, Anderson
1980, lane et al 1980, lane & Cooper 1982, Unkeless 1979, Mellman
1980, Kulczyckie et al 1980) while others have failed to isolate
distinct subclass receptors (Schneider et al 1981). The molecular
weight for these proteins has varied between 35,000 and 120,000
daltons.
Using affinity chromatography, Anderson and Grey (1977, 1978)
did not achieve complete purifications but isolated two fractions
containing receptor activities which preferentially bound to either
aggregated IgG or monomeric IgG2a. The physicochemical properties
of the receptor activities were also different. On sucrose
gradients, the IgG2a receptor (FcRI) activity had a sedimentation
coefficient of 4S while that of the aggregated IgG receptor (FcRII)
was 20S i.e. of the sane size as high density lipoprotein. This
suggested that the 20S "FcRII-like" activity might be due to a
lipoprotein molecule which had aggregated after removal of the
detergent used to solubilise the membrane. In support of this, the
FcRII activity was found to be destroyed by phospholipase C, but
FcRI was not. Other studies on the activity of the solubilised
membrane Fc receptor have shown that after destruction of its
activity with phospholipase C the activity can be reconstituted by
the addition of liposomes consisting of either
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phosphatidylethanolamine or phosphatidylinositol (Anderson 1980).
The lack of trypsin sensitivity of FcRII in the intact cell may
therefore be due its hydrophobic lipid environment. Both isolated
receptor activities are trypsin sensitive confirming that both
contain protein.Suzuki et al (1982) have provided further evidence
that the IgG2b receptor is "lipophilic". Using lysates from a
murine macrophage cell line they isolated two proteins by affinity
chromatography on columns coated with either aggregated IgG or with
an analogue of phosphatidyl choline. After further purification on
Sephadex G100 and isoelectric focussing they found that the
lipophilic protein bound IgG2b not IgG2a whereas aggregated IgG
bound IgG2a and not IgG2b.
Lane et al (1980) and Lane and Cooper (1982) have used
aggregated IgG2a, IgG2b or IgGl bound to sepharose to separate Fc
receptors from thioglycollate mouse peritoneal macrophages or
macrophage cell lines. Small amounts were used to avoid the problem
of copurification of different receptors (Schneider et al 1981).
Lane et al (1980) isolated two receptors from thioglycollate
macrophages; one protein had FcRI-like activity and a molecular
weight of 67,000 and the second FcRII-like protein, which bound
IgG2b or IgGl, had a molecular weight of 54,000. Prior treatment of
the macrophages with trypsin abrogated the isolation of FcRI
activity but not FcRII. Proteins of slightly different molecular
weight were obtained using the same technique on macrophage cell
lines J774 and P388D. They also separated FcR activity from cell
lines using affinity columns bound with a rat monoclonal anti-FcRII
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antibody (Unkeless 1979). With this method a protein of molecular
weight 65,000 and a lesser band of 47,000 were obtained. The
isolates were trypsin insensitive but the specificity of the
putative FcRII preparation was not tested.
These latter results are in agreement with those of Mellman
and Unkeless (1980) who also used the rat monoclonal antibody as an
affinity reagent. They obtained 60,000 and 47,000 dalton
glycoproteins which bound to Con A and were neuraminidase
sensitive. However after isolation there was loss of subclass
specificity and although the proteins did not bind to IgG3 they did
bind IgGl, IgG2a and IgG2b.
Kulczyckie et al (1980), using Sepharose affinity columns have
isolated an FcR-like protein from rabbit alveolar macrophages. The
molecular weight on PAGE varied with the gel; using 5.6% acrylamide
gel it was 50,000-70,000 while in 9% gel it was 35,000-55,000.
Their observations illustrate the difficulty of making valid
comparisons between different sets of reported results where
different methods have been used.
At the present time it is still not clear whether the putative
FcRI and FcRII receptors are distinct or are one gene product which
has been modified by glycosylation or cleavage on the cell
membrane.
Attempts to isolate a human Fc receptor protein are still at
an early stage. There is one report (Anderson 1982) describing
the isolation of Fc receptor protein from the human macrophage cell
line U937 which obtained two protein bands of 72,000 and 40,000;
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the 72,000 dalton protein showed FcR binding for human IgGl but not
IgG2.
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Numbers of Fc receptors
The approximate number of Fc receptors in mononuclear
phagocytes is around Iff to lO^and varies between species and
according to whether the cells are stimulated or not. A recent
comparative study showed that guinea pig peritoneal macrophages
have 50x more Fc receptors (10//cell) than neutrophil polymorphs
(2xlO/cell) and that the latter bind only guinea pig IgG2 (Coupland
& Leslie 1983). The association constants in general are higher for
polymeric than for moncmeric IgG. Typical data is illustrated in
Table 6 (plOf).
Functional significance of subclass receptors
The functional significance of different receptors for
mediating binding of different classes and subclasses of cytophilic
antibody and aggregated or ccnplexed antibody is not yet clear.
It is possible that cytophilic receptors (FcRI) may be
important in mediating antibody dependent cytotoxicity whereas
FcRII may be more relevant to phagocytosis. Although Haskill and
Fett (1976) found that macrophage ADGC of tumour cells was blocked
by IgG2a this was not found by Walker (1977) who showed that ADOC
was blocked by IgG2b and phagocytosis was mediated via IgG2a. The
latter seems unlikely however in view of the selectivity of the
IgG2b receptor for ccnplexed antibody. Others (Ralph et al 1980)
found that all subclasses of murine IgG mediate phagocytosis and
ADOC. The observations of Nitta & Suzuki (1982a, 1982b) and Suzuki
et al (1982) however, strongly support the concept that the IgG2a
107
IgG2a (FcRI) and IgG2b (FcRII) receptors mediate different effects.
In addition to the lipophilic characteristics of the IgG2b
receptor, they have also shown that the IgG2a receptor (FcRI) is
directly linked to adenyl cyclase and ligand binding causes a
prompt rise in cAMP. The isolated IgG2b receptor however has PLA2
activity and ligand binding triggers arachidonic acid and PGE
synthesis. In the intact cell the rise in PGE triggers a delayed
rise in cAMP via PGE receptor stimulation.
Leijh et al (1979), using an assay of monocyte bacterial
killing which is independent of the phagocytic phase, have shown
that the presence of extracellular cytophilic binding of IgGl, IgG3
and C3b enhances intracellular killing; this may reflect
stimulation of respiratory burst activity. The possible role of the
Fc receptor for IgE in killing of schistoscmula has already been
mentioned.
TABLE 6 Number & affinity of Fc receptors on
mononuclear phagocytes
IgG Cell Temp Ka
Species class type °C xlO Reference
Man 1 Monocyte 20 1.0 Alexander
3 II II 0.8 et al
4 It II 0.4 (1978)
Mouse 2a P388D ■1 0.7 Unkeless &











































The differential sensitivity of Fc receptors to proteases and
lipase has been discussed. In addition the activity of the Fc
receptor also depends on the presence of functional sulphydryl
groups, which are sensitive to iodoacetamide and
p-chloromercuribenzoate (Howard and Benacerraf 1961), and also on
carbohydrate components.^-glucosamine is incorporated into the
receptor in vivo (Kulczycki et al 1980) and the receptor is
sensitive to neuraminidase (Mellman and Unkeless 1980).
Prostaglandins E2, Fl, and F2ei have variable effects, tending
to cause enhancement of phagocytosis at physiological
concentrations and inhibition at higher levels (Razin et al 1978).
Levamisole has an enhancing affect on monocyte receptor function
probably by triggering cholinergic receptors and a rise in cGMP
(Schmidt and Douglas 1976).
The effect of corticosteroids on mononuclear phagocyte
receptors has been studied in different ways with different results
depending on the techniques used. Early studies (Kaplan and Jandl
1961) on rat in vivo "RES" clearance of serum sensitised
erythrocytes (opsonin not specified) demonstrated reduced hepatic
but not splenic sequestration after 2Cmg cortisone/kg for six days.
The authors emphasise the potential effects of changes in blood
flow on organ sequestration. Mollison et al (1962) in a study of
human volunteers found little evidence that a six day course of
lOCtrig cortisone/day had any effect on clearance of IgG sensitised
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erythrocytes. Atkinson et al (1973) were able to show steroid
induced reduction of clearance of both IgM and IgG sensitised
erythrocytes, but the dose of cortisone was so great (20 to
lOOmg/kg) that their observations bear little resemblance to
pharmacological therapy in humans.
In general, studies in vitro have shown effects on Fc and C3
receptor expression only with relatively large doses of steroid.
Rinehardt et al (1974) showed that two hours preincubation with
16ug/ml of hydrocortisone succinate had no effect on phagocytosis
of complement coated cryptococci or binding of IgG sensitised
erythrocytes (EA) while high doses (120ug/ml) caused only slight
reduction of complement mediated phagocytosis. Kurlander (1981)
-I
showed that 10 to 10 M hydrocortisone had no lirmediate effect on Fc
or C3 receptor expression by monocytes, but after two days in
culture with hydrocortisone, enhanced Fc and C3 receptor expression
was seen. Schreiber et al (1975) found depression of Fc and C3
"V -J
receptor rosetting but used vast doses (300ug/ml or 10 to 10 M) of
corticosteroid in cholesterol-phospholipid liposomes to achieve the
effect.
Two recent studies illustrate best the potential complexity of
the effect of steroids. Rinehardt et al (1975) studied blood
monocyte function in vitro before and after administration of 5Cmg
prednisolone 12 hourly for three days to normal volunteers. After
transient initial monocytopenia, a sustained doubling in the
monocyte count was seen. Phagocytosis of caiplement opsonised
cryptococci was enhanced three-fold after therapy and no impairment
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was found in hexose monophosphate shunt activity. Furthermore,
chemotaxis was significantly increased. The only function to be
depressed was killing of staphylococci and Candida, which suggests
that lysosomal function may have been impaired. More recently Ralph
et al (1978), using a macrophage cell line, showed that 10 M
hydrocortisone had no effect on latex or Fc mediated phagocytosis
or ADCC. However hydrocortisone did block activation of the cells
by lipopolysaccharide (LPS) or PPD and reversed the growth
inhibitory effect of LPS. Other studies have also shown that while
glucocorticosteroids block the egress of monocytes from the marrow
and their migration to inflamed tissues in the tissues, they do
not block proliferation or maturation (van Furth 1970).
These observations can be summarised as follows.
Pharmacological doses of corticosteroids have no direct inhibitory
effect on Fc or complement receptor expression. Studies of the in
vivo effect of corticosteroids on monocyte function must be
interpreted in the knowledge that profound changes in monocyte
traffic are occurring and that the egress of more mature monocytes
frcm the circulation may be inhibited. This is highlighted by the
very marked monocytosis seen in human studies. Studies of steroids
on in vivo "RES" clearance are hard to interpret in view of the
potentially multiple sites of action of steroids and in particular
on organ blood flow, and studies in animals using very large doses
of steroid must be viewed with caution.
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Modulation of mononuclear phagocyte receptors by immune complexes
To examine the modulating effect of iirmune complexes on
mononuclear phagocyte receptor expression, some workers have used
soluble irrmune conplexes while others have used inrrobilised irrmune
carpiexes.
Several studies have shown that plating macrophages onto IgG
coated glass causes marked loss of Fc receptor rosetting and
phagocytic capability (Rabinovitch et al 1975; Douglas 1976; Kaplan
et al 1978; Ragsdale and Arend 1980; Arend and Massoni 1981; Michl
et al 1979). Some studies (Ragsdale and Arend 1980; Michl et al
1979) suggest that, at least with activated macrophages, Fc
receptor phagocytic function is more sensitive to this procedure
than Fc receptor rosetting. The studies of Michl et al (1979)
suggest that the loss of phagocytic function reflects selective
loss of the trypsin resistant, IgG2b-Fc receptor (FcRII) leaving
residual FcRI receptors available for rosetting. All these studies
agree that loss of FcR activity is selective and neither affects
carpiement receptor rosetting by resident cells nor complement
mediated phagocytosis by thioglycollate elicited cells.
Some studies have also looked at the effect of the presence of
complement in the immobilised complexes. Two studies, show that
corrplement binding to the immune complexes has no modulatory effect
on complement receptor activity in either resting or activated
macrophages (Kaplan et al 1978; Ragsdale and Arend 1980). One study
however (Arend and Massoni 1981), using human monocytes, showed a
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minimal reduction in complement receptor rosetting when fresh
monocytes were plated onto carplement-fixed immune complexes, but
that the effect could be enhanced by prior culture of the cells for
several days in serum. In another study (Michl et al 1979), where
murine macrophages were plated onto camplemant-fixed immune
complexes, no modulating effect was found if resident peritoneal
macrophages were used, whereas thioglycollate elicited macrophages
lost both complement receptor rosetting and phagocytic function.
Two studies with soluble immune complexes have also produced
conflicting results with respect to complement receptor modulation
but have both demonstrated Fc receptor modulation. Kavai et al
(1981) used soluble carplexes of BSA or ovalbumin with IgG prepared
in various ratios and with antibody of varying avidity. The
experiments were also performed after complement fixation by the
immune complexes. Exposure of human monocytes to Fc bearing immune
complexes caused inhibition of Fc rosetting and Fc mediated
phagocytosis of erythrocytes but had no effect on complement
receptor mediated phagocytosis of C3 coated yeast. The effect was
most marked when antibody of high rather than low avidity was used
and when carplexes were prepared at antibody-antigen equivalence or
slight antibody excess. After exposure of cells to complexes which
had fixed complement, inhibition of phagocytosis of C3b coated
yeast was seen. Griffin (1980) on the other hand found that IgG
containing complexes with or without complement blocked Fc receptor
mediated phagocytosis but did not inhibit complement mediated
phagocytosis.
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Ragsdale and Arend (1980) investigated the possible mechanism
of Fc receptor modulation and found evidence to suggest that it is
mediated by a rise in intracellular cAMP. The loss of Fc receptor
activity on binding to an immune complex coated surface could be
abrogated by incubation with 2-deoxyglucose (2DG) which blocks
synthesis of ATP and prevents the rise in cAMP. The effect of 2-DG
could be reversed by the addition of exogenous ATP and similar
results were obtained with other metabolic inhibitors.
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SECRETORY PRODUCTS OF MONONUCLEAR PHAGOCYTES
Intreduction
The mononuclear phagocyte secretes a wide range of products
(Table 7, pll6) which participate in inflairmation, immunity and the
regulation of connective tissue cells and their matrix. In
rheumatic disease, the generation of prostaglandins and the
interaction of macrophages with connective tissue have assumed
considerable importance and a brief review of these areas is
therefore relevant to this thesis.
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TABLE 7 Secretory products of mononuclear phagocytes


























































Prostaglandin secretion by mononuclear phagocytes
Macrophages from a wide variety of sources have a very high
arachidonic acid content and produce significantly greater amounts
of E type prostaglandins (Kurland and Bockman 1978, Goodwin et al
1977a, Scott et al 1980, Stossel et al 1974) and leukotrienes
(Scott et al 1980, Rouzer et al 1980b, Valone et al 1980) than
other leucocytes. There are a wide range of stimuli which activate
macrophage prostaglandin synthesis and include IgG-Fc (Rouzer et al
1980a) and IgE-Fc (Rouzer et al 1982) receptor stimulation,
lymphokines (Gordon et al 1976), endotoxin (Ogmundsdottir and Weir
1979, Kurland and Bockman 1978), complement activation products
(Rutherford and Schenkein 1983), C. parvum (Ogmundsdottir and Weir
1979), zymosan (Humes et al 1980) and phorbol nyristate acetate
(PMAMBonney et al 1980b).
Although phagocytic stimuli including immune complexes
stimulate prostaglandin secretion and synthesis, the latter can be
clearly separated functionally from the process of endocytosis.
Scott et al (1980) have shown that although the rate of PG
secretion is proportional to the concentration of a phagocytic
stimulus, inhibition of interiorisation of IgG opsonised particles
by cytochalasin D or inhibition of phagoscme-lysoscme fusion with
dextran has no effect on PG release. Conversely, uptake of
unopsonised polystyrene beads is not accompanied by PG release
while "frustrated phagocytosis" of large IgG coated sephadex beads
again causes PG release emphasising the importance of membrane
receptor-ligand interactions.
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PG secretion has also been shown to be distinct from the
enhanced cytotoxicity seen in activated macrophages. In vivo
activation of peritoneal exudate macrophages (PE4) by injection of
either C. parvum, pyran or glucan results in increased turnoricidal
capability 4 days after injection. However, of these three stimuli,
only C. parvum is associated with increased PGE2 production in PEM
and spleen cells (Barlin et al 1981). Thioglycollate elicited
macrophages also demonstrate enhanced secretory and pinocytotic
activity (Cohn & Benson 1965, Werb and Gordon 1975, Werb and Gordon
1975a, Unkeless et al 1974) but, unlike macrophages activated with
immune stimuli such as C. parvum, they exhibit reduced resting
rates of PGE2 secretion and reduced rates of stimulated PG release
to inmune complexes, PMA or zymosan compared with resident
macrophages (Bonney et al 1979, 1980b, 1981, Hurrves et al 1980). It
has been suggested (Bonney et al 1981) that this may be due to
inactivation of the PG cyclooxygenase and PGI2 synthetase by toxic
oxygen species (Egan et al 1976) however it may simply reflect the
fact that thioglycollate macrophages are recently recruited from
the blood stream and represent a different population of cells. It
is clear however that while a range of functional activities are
associated with changes in PG synthesis they may not be directly
linked.
Although prostaglandin production can be clearly dissociated
from other apparently synchronous events there may none the less be
a common initiating pathway for increased arachidonic acid
synthesis and activation of cytoplasmic effector mechanisms.
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Activation of macrophages whether by nonimmune (eg endotoxin) or
immune lymphoid,ne dependent mechanisms results in increased
turnover of membrane phosphatidyl choline (Ogmundsdottir and Weir
1979). Hydrolysis of the latter by phospholipase A2 generates
arachidonic acid but is also accompanied by an influx of divalent
calcium which initiates cGMP synthesis and the cytoplasmic events
associated with cellular activation. Paradoxically, PGE2 may
stimulate opposing effects in macrophages by activating adenyl
cyclase and the synthesis of cAMP (Gemsa et al 1979), and the
function of PGE2 may therefore be to act as an endogenous
modulator.
As discussed already, studies on murine cell lines have
provided strong evidence that the IgG2b-Fc receptor (FcRII) has
phospholipase A2 activity which is enhanced by ligand binding thus
providing a direct link to arachidonic acid synthesis (Nitta &
Suzuki 1982a, 1982b). Furthermore, there is also direct evidence to
support the hypothesis that Fc receptor-ligand coupling directly
stimulates cationic influx into the phagocyte. It has been shewn in
intact cells that membrane depolarisation secondary to sodium
influx follows rapidly after Fc-ligand coupling and this is
followed by ouabain sensitive hyperpolarisation. Experiments with
isolated cell vesicles and synthetic proteoliposames incorporating
purified IgG2b-Fc receptor confirm that the isolated receptor
behaves as a ligand dependent ionophore triggering changes in
membrane permeability and selective cationic fluxes (Young et al
1983).
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The iirportance of prostaglandin production by macrophages lies
in their regulatory effects on other cell populations as well as on
the macrophage itself. For example, Wahl et al (1974) showed that
the stimulation of guinea pig macrophages by endotoxin to produce
collagenase could be abrogated by indomethacin and that the blocked
cultures could be reactivated by the addition of PGE2. PGs also
have profound effects on lymphokine generation by lymphocytes and
on antibody synthesis. In a variety of model systems it is clear
that the macrophage can suppress lymphocyte function via PGE2
secretion and that this can be blocked by removal of the macrophage
or addition of indamethacin (Ellner 1981). Gordon et al (1976)
demonstrated that lymphokines from antigen sensitised lymphocytes
stimulated PGE2 release from macrophages and that PGE2 had a
"feed-back" inhibitory effect on lymphokine (MIF) secretion. The
feed-back inhibition could be abrogated by indomethacin. In animal
models it has also been demonstrated that PGF.2 production by
macrophages causes suppression of lymphocyte responses. Injection
of C. parvum, pyran or glucan, as mentioned above, causes
macrophage activation and enhanced cytotoxicity but only in C.
parvum injected animals is this associated with increased PGE2
synthesis by macrophages and spleen cells (Barlin et al 1981, Grimm
et al 1978). In parallel with the rise in PG production the
proliferative response of spleen cells to Con A is suppressed and,
at least initially, this is reversed by indanethacin or removal of
macrophages. Later, by eight days after injection, the suppression
persists but is no longer indomethacin sensitive and may be
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attributable to hydrogen peroxide mediated suppression (Metzgar et
al 1980).
There is also evidence to suggest that products of the
lipoxygenase pathway may have enhancing effects on lymphocyte
proliferative responses. Kelly et al (1979) demonstrated that
lipoxygenase inhibition caused reduced lynphocyte transformation to
PHA and more recent reports (Dinarello et al 1983) have shown that
the enhancement of thymocyte proliferation by macrophage derived
interleukin 1 (leucocyte pyrogen or LAF) is inhibited by BW755C, a
selective lipoxygenase inhibitor.
Depressed lymphocyte proliferation in vitro and immune anergy
in vivo has been attributed in anumber of diseases in man and
animals to excessive PG production by macrophages. The diminished
response of peripheral blood lymphocytes to PHA in Hodgkins disease
is reversed by indomethacin or removal of adherent cells (Goodwin
et al 1977b). Similarly in rheumatoid arthritis, peripheral blood
monocytes synthesise considerably higher levels of PGE2, TXB2 and
6-keto-PGF2a compared with controls and is associated with
depression of con A induced lymphocyte proliferation. However
although the effect is reversed by reducing the number of monocytes
present it is not reversed by indomethacin suggesting that other
mechanisms may also play a part (Seitz 1982).
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Interactions of mononuclear phagocytes with connective tissue
Introduction
Although mononuclear phagocytes play a prominent role in
chronic inflammatory responses and secrete a range of potentially
destructive neutral proteinases and acid hydrolases, the evidence
that they play a direct role in degradation of the extracellular
matrix is of necessity largely indirect.
The rheumatoid joint often shows extensive evidence of
cartilage and soft tissue destruction which is associated with the
presence of exuberant pannus containing macrophages, lymphocytes
and lymphoid follicles and, intermittently, a neutrophil infiltrate
exudate in the synovial fluid. In addition, a wide variety of
potential stimuli to macrophage secretion are found in the joint
which include immune complexes, complement activation products and
lymphokines. However while a variety of cellular and humoral
mediators of connective tissue damage are clearly present the
relative contribution of the macrophage and its products is still
poorly understood. Interest in the macrophage has focussed on two
different facets of its function. Firstly the secretion of enzymes
which might directly degrade connective tissue, and secondly the
secretion by macrophages of intercellular hormones which may
modulate the activities of connective tissue cells and thus
indirectly influence the connective tissue matrix.
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Mononuclear phagocyte derived enzyires
The mononuclear phagocyte has a rich content of lysosomal acid
hydrolases (Cohn and Wiener 1963) and is capable of active
secretion of neutral proteinases including plasminogen activator
(Gordon et al 1974), elastase (Werb and Gordon 1975b) and
collagenase (Werb and Gordon 1975a). When stimulated, for example
by immune ccrrplexes, they also exhibit prolonged secretion of
lysosomal enzymes (Cardella et al 1974). It is likely that because
of their pH optima that the neutral proteinases will play a
dominant role in initial extracellular degradation while lysosomal
enzymes will be predominantly engaged in the completion of
digestion within the phagolysosome following endocytosis of
partially degraded connective tissue (Werb et al 1980a).
A variety of factors influence the capacity of macrophages to
secrete neutral proteinases and include the immunological and
inflammatory status of the experimental animal or system and the
presence of added stimuli in vitro. For example peritoneal
macrophages elicited with an inflammatory stimulus such as
thioglycollate secrete greater amounts of plasminogen activator
(Unkeless et al 1974), elastase (Werb and Gordon 1975b) and
collagenase (Werb and Gordon 1975a) than resident macrophages.
Resident macrophages on the other hand can be induced to secrete
these enzymes by feeding thorn with non-degradable phagocytosable
particles such as latex beads (Werb and Gordon 1975a,1975b).
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A comparison of the relative activities of various enzymes in
resident and inflammatory or "elicited" macrophages is shown in
Table 8.
TABLE 8 Relative activities of resident and inflammatory
macrophages (thioglycollate elicited)
Cohn (1978)









The inmunological status of the animal is also important.
Peritoneal macrophages from mice injected with endotoxin secrete
very little plasminogen activator spontaneously in vitro but show
greatly enhanced rates of plasminogen activator release to a
subsequent phagocytic stimulus such as latex particles (Gordon et
al 1974) Perhaps of greater importance to inmunological disease
such as rheumatoid arthritis is the observation that T-cell
lymphokines cause enhanced plasminogen activator secretion frcm
unstimulated resting macrophages. Similarly, enhanced plasminogen
activator release is seen in macrophages from animals receiving
secondary antigenic challenge with BOG or T. cruzei and suggests an
important role in delayed hypersensitivity (Gordon et al 1978).
Werb and others (Jones and Werb 1980, Werb et al 1980b, 1980a)
have studied the capacity of both macrophages and purified
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macrophage proteinases and acid hydrolases to degrade connective
tissue matrix synthesised in vitro by smooth muscle and endothelial
cells. Smooth muscle cells synthesise a
glycoprotein/elastin/collagen matrix while the latter produce
glycoprotein and collagen alone. Purified macrophage plasminogen
activator in the presence of added plasminogen generates plasmin
which degrades a large portion of the glycoprotein. This step was
shown to be important as it facilitated the access of elastase to
its major substrate elastin and in the absence of plasmin, elastin
degradation proceeded very slowly. Elastase also contributed to
sore extent to glycoprotein breakdown while collagenase degraded
only collagen. Plasmin also plays a role in the activation of
collagenase which is secreted in latent form (Werb et al 1977).
Macrophage conditioned medium was much less efficient than purified
enzyme in degrading matrix and probably reflects the fact that over
90% of these enzymes are secreted in latent form. It is also
important to note that there were differences in the capacity of
macrophages elicited with different stimuli to degrade the matrix.
Resting cells caused minimal degradation of glycoprotein only;
endotoxin or pyran copolymer elicited macrophages secreted
plasminogen activator only and therefore caused glycoprotein but
not elastin degradation, while thioglycollate or periodate elicited
macrophages secreted plasminogen activator, elastase and
collagenase. The soluble fragments created by the neutral
proteinase digestion were relatively large and complete degradation
to amino acids and oligopeptides required the action of cathepsins
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at acid pH. In vivo this almost certainly occurs intracellularly or
in the pericellular space where the local pH may be sufficiently
low. Morphological studies of live macrophages in this system
showed that matrix breakdown occurred mainly in the imrediate
vicinity' of macrophages, emphasising the importance of pericellular
events where local enzyme concentrations will be highest,
inhibitors are likely to be saturated and other factors such as
free radical damage may play a role in the initial degradative
attack. Membrane bound enzymes may also play an iirportant role in
this regard (Lane et al 1980). In RA synovium, imnunofluorescence
studies have confirmed that active collagenase is present at the
pannus-cartilage junction but not elsewhere in the synovium
(Woolley et al 1977).
Studies of the characteristics of macrophage elastase revealed
that it is a metalloproteinase with a number of interesting
properties (Banda and Werb 1979, 1980a, 1980b). The enzyme is
secreted in latent form by the macrophage but it is not known how
it becomes activated in vivo. Apart from elastin it also degrades
other connective tissues including laminin (a basement membrane
component), microfibrillin (a glycoprotein associated with elastin)
and fibronectin as well as both fibrin and fibrinogen. Two other
substrates suggest that the enzyme may have important regulatory
properties in inflammation. It was found to attack the heavy chain
of IgG2a but not IgM, A or G2b and in view of the specificity of
IgG2a for the FcRI receptor this could reflect an autoregulatory
role in inflammation. Additionally, it is not inhibited by
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alphal-proteinase inhibitor and in fact degrades this inhibitor and
prevents it from inhibiting granulocyte elastase (Banda et al
1981). The latter observation suggests that it may play an
inportant role in emphysema.
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Mononuclear phagocyte derived inter-cellular hormones
An alternative view of connective tissue matrix breakdown has
been proposed by Krane and others (reviewed by Krane 1981) and Fell
and others (reviewed by Dingle 1981) who have found strong evidence
to suggest that the macrophage and its constituent enzymes is not
directly responsible for matrix destruction. This model proposes
that release of intercellular hormones or "cytokines" by monocytes
stimulates other synovial, fibroblast-like cells to generate
collagenase and mediate tissue degradation.
Early studies of rheumatoid synovium had shown that active
collagenase could be recovered from the synovial fluid (Harris et
al 1969; Harris et al 1970), that cartilage and soft tissue
destruction was related anatomically to sites of synovial pannus
formation (Kulka et al 1955) and probably that synovial derived
collagenase and neutral proteases were involved in tissue damage
(Harris and Krane 1974).
Tissue culture studies of synovial dispersates revealed that a
population of large stellate adherent cells were present which
contained abundant collagenase and PGE2, while the macrophages
present had little or no detectable collagenase (Dayer et al 1976;
Wooley et al 1978; Wooley et al 1979). Furthermore, on longer
culture, loss of the mononuclear population was associated with
diminution but not loss of collagenase synthesis by the stellate
cells which suggested that the mononuclear cells were in some way
indirectly stimulating collagenase synthesis. Further studies
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confirmed that although monocytes and lymphocytes were not
producing collagenase (Dayer et al 1980) the inclusion of monocytes
or monocyte conditioned medium caused a considerable increase in
collagenase and PGE2 production by stellate adherent cells (Dayer
et.al 1980; Dayer et al 1977; Dayer et al 1979; Dayer et al 1979a).
Attempts to purify the mononuclear cell factor (MCF) responsible
for this effect have so far revealed a single product which is
partially characterised and shares biological and biochemical
properties with interleukin 1 (IL1); the effect on PGE2 and
collagenase release appears to be attributable to the one product
(Dayer et al 1979; Dayer et al 1979a; Dayer et al 1981; Mizel et al
1981). A similar observation has been made by Postlethwaite et al
(1983) who have shown that ILl stimulates collagenase production by
dermal fibroblasts.
A further level of control of collagenase production has been
demonstrated in that monocyte synthesis of MCF can be modulated by
lectin activated lymphocytes or their supernatant media; small
numbers of T-cells enhance while large numbers inhibit MCF
production suggesting suppressor-helper like effects (Krane 1981).
Also of relevance to RA is the observation that Fc fragments or
aggregated IgG stimulate both PG production and MCF release by
macrophages and that blocking PG production with indcmethacin does
not affect MCF release (Passwell et al 1979; Dayer et al 1980).
The production of PGE2 by synovial cells and monocytes
provides a further level of control over the system by stimulating
cAMP synthesis which limits the actions of MCF. However while
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exogenous PGE2 causes a sharp rise in cAMP in cultures of synovial
cells alone, the effect is not nearly as marked on cocultures of
synovial cells with monocytes. The suggested explanation for this
phencrrenon is that endogenous PGE2 synthesis in the
monocyte-synovial cell system causes "down-regulation" of PGE2
receptors. This can be overcome, and the response to exogenous PGE2
restored, by including indomethacin to eliminate endogenous PGE2
from the system (Dayer et al 1979; Goldring et al 1980). PGE2, not
MCF, is solely responsible for the rise in cAMP; blocking of the
PGE2 induced rise in cAMP with indamethacin "unmasks" other actions
of MCF on synovial cells including a proliferative effect and
enhancement of collagen and fibronectin synthesis (Dayer et al
1979).
Parallel observations using an organ culture system (Fell &
Barrett 1973, Fell & Jubb 1977, Dingle et al 1975, Barrett et al
1977, Fell et al 1976) to study the effect of synovial tissue on
live cartilage matrix have produced a similar picture. The ability
of normal and rheumatoid synovium to degrade cartilage matrix was
first shown by Hamerman et al (1967), and subsequent work has
confirmed that normal synovium in culture causes cartilage
degradation (reviewed by Fell 1978). The initial changes are of
rapid loss of metachromatic proteoglycan followed by a slower loss
of collagen. The appearance of the chondrocytes also changes and
they became basophilic and divide forming groups of cells within
the cartilage. Eventually these cells leave the cartilage forming a
layer of fibroblast-like cells. Although these changes are maximal
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when the synovium is in direct contact with the cartilage, they
also occur, albeit more slowly, when the synovium and cartilage are
not in direct contact. Furthermore, dead cartilage is less quickly
degraded than live cartilage containing viable chondrocytes under
these conditions.
These observations suggested that soluble mediators were being
released from synovium which stimulated chondrocytes to degrade
their own matrix and subsequently to proliferate. A number of
subsequent studies have demonstrated that supernatants from
cultured synovial tissue or synovial cells in monolayer contain a
protein of molecular weight approximately 17,000, provisionally
termed "catabolin" which mediates these effects on chondrocytes in
nanogram quantities (Saklatvala and Dingle 1980). The mechanism of
matrix degradation by the chondrocyte is not certain but is
associated with the action of pericellular proteinase secretion
(Dingle and Dingle 1980). The relationship of "catabolin" to other
cytokines such as MCF and IL1 is not known although they may form a
family of proteins analogous to the interferons. Furthermore it is
not certain whether the synovial cell responsible for producing
catabolin-like activity is the macrophage or seme other cell or
cells.
In conclusion, the relative role of macrophage derived
proteinases and the indirect effects of the macrophage on other
connective tissue cells have not been resolved, but it is likely
that both play a ccmplerrentary role in mediating tissue
degradation.
CHAPTER 3
AETIOPATHOGENESIS OF RHEUMATOID ARTHRITIS
AND SYSTEMIC LUPUS ERYTHEMATOSUS
132
AETIOPATHOGENESIS OF RA AND SLE
Introduction
Both RA and SLE are systemic diseases characterised by a
number of iirmunological abnormalities including autoantibody and
immune ccmplex formation (Koffler et al 1971; Zvaifler 1981;
Nydegger & Lambert 1982) as well as abnormalities of cell mediated
iirmunity (Paty et al 1975; Horwitz 1972, 1982; Hahn et al 1973).
The aetiology of both diseases is unknown but it is likely
that environmental triggering agents as well as host genetic
susceptibility play a role. The evidence for this view will be
discussed shortly and it is perhaps pertinent to begin with a
review of the role of exogenous agents in the development of one or
two other examples of chronic inflammatory arthritis and autoimmune
disease.
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The role of infection - introduction
The microbe-host interaction is complex and a multitude of
factors determine the outcare. A number of well characterised
viruses and bacteria cause arthritis, vasculitis and other allergic
sequelae in humans and serve to illustrate potential pathogenetic
mechanisms which may be relevant to RA and SLE. For example,
recovery fron hepatitis B virus infection is associated with a
phase of intense production of immune complexes containing viral
antigen shed from infected cells and is manifested clinically by
serum sickness like syirptoms with arthralgia, arthritis and
urticaria (Malawista & Steere 1981). Similar events may occur
during meningococcal infection (Greenwood & Whittle 1976). Chronic
hepatitis B virus infection has also been implicated in a
significant proportion of patients with systemic vasculitis
(Sergent et al 1976). Other organisms such as vaccinia and rubella
which are arthrotropic viruses trigger arthritis by direct
infection of joints. Rubella arthritis may relapse intermittently
over periods of several months and although the virus is
recoverable frcm joint fluid during a relapse (Grahame et al 1981)
it is undetectable during remissions. "Reactive arthritis" which
may be triggered by certain enteric organisms such as Shigellae,
Yersiniae and Salmonellae occurs predominantly in genetically
predisposed individuals carrying the HLA-B27 tissue type (Ford et
al 1983), but despite this clear association the pathogenetic
mechanism is obscure.
Lyme disease is another interesting example of a host-parasite
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interaction which may be associated with chronic erosive arthritis.
Lyme disease which was first described in Connecticut in 1975,
occurs during summer months and begins with a unique skin lesion -
erythema chronicum migrans - which may be accompanied by headache,
myalgia, fever, arthalgia or lymphadenopathy (Steere et al 1983). A
proportion of patients subsequently develop neurological and
cardiac complications and recurrent attacks of frank arthritis
which may become chronic and erosive (Steere et al 1979, 1980). The
disease is associated with a number of immunological abnormalities
including circulating immune complexes, and chronicity is
associated with the B cell alloantigen DR2 (Steere et al 1979). The
seasonal incidence and initial skin lesion suggested an arthropod
vector and this led to the discovery that the disease was
transmitted by a tick - Ixodes dairmini. Very recently it has been
shown that the infectious organism responsible for the disease is a
previously unrecognised spirochaete (Steere et al 1983). The
antibody response to the organism in seme patients is abnormal in
that they show a persistent specific IgM response and a delayed IgG
response suggesting impairment of the T-helper cell dependent
switch frcm IgM to IgG. Although the disease is distinguishable
from "immune-mediated" disease such as RA, it none the less mimics
a number of immunological disorders such as juvenile chronic
arthritis, multiple sclerosis, Reiters syndrcme and Guillaine-Barre
syndrome and illustrates the importance of host HLA-DR antigens in
predisposing to chronic inflammatory disease.
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Role of infectious agents in SLE
Although there is a clear relation between sore forms of
chronic arthritis and infectious agents there is at present no
definite evidence for an infectious cause of SLE in man or mouse.
Sane studies of murine lupus have shown that certain
"autoimmune" strains (NZB; NZB/W F1 hybrids; MRL/1) have high
circulating levels of Type C retrovirus glycoprotein (gp70) (Izui
et al 1978) which suggests that retrovirus might be responsible for
the development of autoimmunity. However other genetic studies of
NZ mice have failed to support an association between viral
expression and autoimmunity and furthermore other autoimmune
strains such as Swan mice do not produce xenotropic C type viral
particles (Blaineau et al 1978). However it is possible that
increased retrovirus antigen expression and immune complex
formation, occurring as a consequence of abnormal immunoregulation,
may play a role in the evolution of immune complex mediated
glomerulonephritis in murine lupus (Yoshiki et al 1974). Latent
Herpes viruses may similarly cause immune complex mediated
glomerulonephritis in immunosuppressed humans (Schooley et al
1983). Viruses may alter the course of murine lupus in other ways.
For example infection with pathogens such as Sendai virus
accelerates production of autoantibody (Steinberg et al 1981) while
infection with lactate dehydrogenase virus retards autoimmunity
(Oldstone and Dixon 1972). Extensive searches for a retroviral
cause of human SLE have so far been unsuccessful (Pincus 1982).
Serological studies of human SLE have shown increased antibody
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titres to numerous RNA and DNA vuruses including parainfluenzae,
measles, mumps, rubella, reovirus, polio, adenovirus, Herpes
sinplex, CMV and EBV but there is no evidence that any of these are
aetiologically responsible (Pincus 1982). Increased antibody titres
may reflect polyclonal B-cell activation, crossreacting anti-DNA
antibody to common, repeating epitopes such as phosphodiester
groups (Shoenfeld et al 1983), or defective cell mediated immunity
allowing increased expression of latent DNA viruses and a secondary
rise in humoral responses (Henle and Henle 1981). None the less,
circumstantial evidence for a viral aetiology including increased
alpha-interferon production (Friedman et al 1982) and
cross-reactivity of SLE sera with virus specific RNA (Lerner et al
1982) is tantalising and provides a continuing impetus to research
in this area.
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Role of infectious agents in RA
In RA, as in SLE, there is no definitive evidence that the
disease is due to an infectious agent or microbial product.
Isolation of diptheroids and mycoplasmae from synovial tissue by
earlier workers have not been substantiated and although
mycoplasmae cause arthritis in animals (Cole & Cassel 1980) there
is no convincing evidence that mycoplasmae cause RA. A search for
bacterial cell wall components in RA tissue using mass spectroretry
has also proved negative (Pritchard et al 1980). As in SLE,
attention has focussed on the possible role of retroviruses but no
evidence of infection of RA lymphocytes (Norval et al 1979, Hart et
al 1979) or synovial cells (Hart et al 1980) has been found.
The observation that RA serum appeared to contain a unique
immune precipitin (RAP) directed against Wil2, an EBV infected cell
line (Alspaugh & Tbn 1976; Alspaugh & Henle 1979), and the
demonstration by inmunofluorescence of an antinuclear antibody
(RANA) directed against EBV infected B-cell lines (Alspaugh et al
1979) fuelled a search for an aetiological association between RA
and EBV. Furthermore the tropism of EBV for B-cells and its ability
to induce B-cell proliferation makes it a candidate virus for
activation of "autoimmune" B-cell clones in vivo. Although it is
now clear that EBV is not aetiologically related to RA, a review of
recent studies in this area will illustrate seme of the problems of
interpretation of viral studies in patients with diseases of
disordered inmunity.
The tropism of EBV for B cells is determined by a specific
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membrane receptor closely associated with the C3a receptor. Uptake
of the virus via this receptor generally results in latent
"nonproductive" symbiotic infection which "freezes" the
differentiation of the host cell and gives it unlimited growth
potential (Klein & Purtilo 1981); following primary infection a
small number of B-lymphocytes remain latently infected for life
(Depper & Zvaifler 1981). In a small proportion of cells lytic
"productive" infection occurs which results in release of infective
virions and cell death.
Expression of viral associated antigens after infection of B
cells follows a similar pattern both in vivo and in vitro. However,
antigen expression during "lytic" infection of B cells is different
frcm that following "nonlytic" latent B cell transformation. This
difference is reflected in the irrmune response to these two events
and is partly responsible for the different patterns of immunity
between normal individuals with latent infection and those with
varying degrees of immunodeficiency in whom lytic "productive"
infection may become more intense (Henle & Henle 1981).
Following lytic "productive" infection of B cells three
antigens appear - Membrane Antigen (MA), which is expressed both on
the cell membrane and on the virus envelope; Early Antigen (EA),
which has two components and is either restricted to the cytoplasm
(R) or diffusely located in both nucleus and cytoplasm (D); and
Viral Capsid Antigen (VCA). After nonlytic blast transformation of
B cells by EBV two antigens (or groups of antigens) appear -
Lymphocyte Derived Membrane Antigen (LYDMA) and EB Nuclear Antigen
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(EBNA). LYDMA is operationally define! using specific cytotoxic T
cells and EBNA is serologically defined.
Primary EBV infection is characterised by the appearance of
IgM and IgG antibodies to VCA and transient antibody to EA(D). IgG
anti VCA persists and is a standard epidemiological marker for
previous EBV infection, but IgM anti VCA and IgG anti EA(D) subside
within weeks. Anti heterophile antibody and neutralising antibody
to MA also develop during the acute phase. During convalescence,
usually months after the primary infection, antibodies to EBNA
appear which subsequently remain stable for years (Henle & Henle
1981). In addition to these humoral responses several cell mediated
immune defence mechanisms are initiated. Natural killer cells,
interferon activated killer cell activity and antibody dependent
cellular cytotoxicity (ADOC) play a role in nonspecific lysis of
infected cells entering the lytic phase and are therefore
particularly evident during Infectious Mononucleosis (Tosato et al
1982). On the other hand proliferation of EBV transformed
"nonproductive" cells is inhibited by EBV specific T cell mediated
iirmunity directed against LYDMA (Rickinson et al 1981). Both
specific and nonspecific mechanisms are probably important in
maintaining a stable symbiotic state in the normal subject and
prevent uncontrolled B cell proliferation.
Studies of the role of EB virus in RA have addressed the
following questions: 1) Is there seroepidemiological evidence of
increased exposure to EBV in RA patients? 2) Is there evidence of
defective cellular immunity to EB virus in RA? 3) Is the RAP/RANA
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antibody-antigen system unique to RA patients? 4) Does the RAP/RANA
system represent inmunity to a unique EBV encoded antigen? 5) Is
there evidence of increased EB virus shedding from patients with
RA?
Serological studies have shown a more or less similar
frequency of anti-VCA and anti-EBNA in RA patients and controls and
furthermore about five percent of RA patients have no serological
evidence of primary EBV infection at all (Venables et al 1980,
1981; Elson et al 1979; Phillips et al 1973; Silverman et al 1981).
This must imply that an aetiological role for EBV in all RA
patients is very unlikely. Increased titres to VCA and EA,
especially EA(D), have been found in several studies (Alspaugh et
al 1981; Ferrel et al 1981), but as noted above, these changes
almost certainly reflect minor impairment of cellular immunity and
a secondary increase in numbers of cells entering the lytic phase.
On the other hand evidence to support the view that there is
defective EBV specific cellular immunity in RA is substantial. The
ability of various concentrations of T-cells to induce regression
of spontaneous proliferation of B cells in vitro is used as a
quantitative measure of EBV specific T cell immunity (Rickinson et
al 1981) and has been used to demonstrate defective EBV specific
cellular immunity in RA patients (Tosato et al 1981). It has been
shown that peripheral blood mononuclear cells frcm RA patients have
an increased tendency to spontaneous B cell proliferation in vitro
(Slaughter et al 1978; Bardwick et al 1980) and this almost
certainly reflects diminished T cell control rather than an
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increased proliferative capacity of the B cell per se (Depper &
Zvaifler 1981). Although this defect is not restricted to RA
patients, and is found in chronic infectious mononucleosis and
Duncans disease (Masucci et al 1981), the evidence at present
suggests that the defect in RA may be restricted to the T cell
specific EBV response whereas in other diseases the cellular defect
may be more generalised and involves NK cell and interferon induced
K cell activity. At present there is insufficient data to be
certain that a restricted defect of EBV specific T cell immunity is
unique to RA.
Other workers have examined whether the RAP/RANA system
(Venables et al 1981) is unique to RA. The first description of RAP
suggested that it was unique to RA (Alspaugh & Tan 1976; Alspaugh &
Henle 1979), but it is now clear frem subsequent studies that RAP
and RANA are frequently found in control subjects (Venables et al
1980, 1981; Catalano et al 1980; Ng et al 1980).
Seme studies have asked whether the RAP/RANA system is unique
to EB virus antigens and whether anti-RANA is found in patients
with no serological evidence of primary EB virus infection.
Although one study (Catalano et al 1980) found concordance between
anti-VCA and RANA, others (Venables et al 1980, 1981; Ng et al
1980) have identified a small but significant number of patients
who have no serological evidence of primary EB virus infection but
do have RANA. Conversely seme RA patients with anti-EBNA do not
have anti-RANA (Silverman & Schumacher 1981). Similar observations
have been made by Alspaugh et al (1979) who found a lack of
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concordance between anti-RANA and anti-EBNA in RA patients, normal
controls and patients with Burkitts lymphoma, and also showed that
anti-EBNA and anti-RANA gave different patterns of
inmunofluorescent nuclear staining. Furthermore Venables et al
(1981) demonstrated by adsorption studies that at least a part of
anti RANA activity could be removed from high titre RA sera using
non EB virus infected cell lines which therefore suggests that RANA
may not be a singlet antibody-antigen system, and may contain non
EB virus antigens as well.
An increase in EBV shedding from the throat might be expected
if there is impairment of immunity to the virus, but this
phenomenon has not been detected in RA patients (Depper et al
1982). However any defect of specific cellular irrmunity may be more
than adequately compensated for by nonspecific cellular mechanisms
and increased levels of antibody and therefore make recovery of
virus difficult. Increased viral shedding from the pharynx, as well
as spontaneous polyclonal B-cell lymphoproliteration, is however
usually only seen in severely ixtmunosuppressed patients such as
those receiving organ transplants (Hanto et al 1982).
In conclusion the available evidence suggests that EB virus is
not aetiologically related to rheumatoid arthritis. However, the
possibility remains that the defect of cellular immunity to EB
virus is only one example of aberrant control of latent DNA viruses
in RA patients and the appearance of certain "auto-antibodies"
directed against nuclear constituents may simply represent an
entirely appropiate response to the expression and release of
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latent DNA virus encoded nucleoproteins. The recent demonstration
that "autoantibodies" to the soluble cellular antigen "La" will
imnunoprecipitate ribonucleoprotein (rnp) particles containing EB
virus encoded RNA's (EBER 1 and EBER 2) from EB virus infected
cells, and similarly rnp particles containing adenovirus encoded
RNA's (VAI and VA II) from adenovirus infected cells lends support
to this hypothesis (Lerner et al 1982).
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Role of host factors
Introduction
While there is no direct evidence for an exogenous triggering
agent in RA or SLE there is considerable evidence that genetic
factors confer susceptibility to both these diseases. Both RA and
SLE are found with increased frequency in association with certain
HLA-D and DR antigens and SLE is also associated with certain
inherited complement deficiencies. Such associations are of course
not unique to RA and SLE and a number of other exaitples are shown
in Tables 9 & 10 (pl45).
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TABLE 9 KLA antigens and disease
(Adapted from Panayi 1982)
CLASS I
DR2 Goodpastures syndrome, multiple sclerosis
DR2/3 SLE
D3/DR3 Coeliac disease, Graves, Addisons, chronic active
hepatitis, M. gravis, primary Sjogrens syndrome
DR3 Juvenile onset diabetes mellitus
DR4 " " " " , RA,
hydrallazine induced SLE
CLASS II
B27 Seronegative spondarthritis & reactive arthritis
CW6 Psoriasis
A3 Haemochromatosis
TABLE 10 Complement deficiency and disease
(Adapted from Zvaifler 1981)
Deficiency Association
Clq combined immunodeficiency
Clr glomerulonephritis, SLE, infection, arthritis
Cls SLE
C4 SLE, normality
C2 normality, SLE, JCA, asthma, vasculitic
purpura, nephritis, infection, RA
C3 serious infection
C5 Heisseria infection, SLE
C6 " " , normality
C7 " " , Raynauds/sclerodactyly
C8 , SLE
CI INH hereditary angiooedema, SLE
C3b INA infection.
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HIA system and disease
Since the HLA system has played a dominant role in recent
studies of both RA and SLE, the structure and function of the HIA
system will be briefly reviewed.
The major histocompatibility complex (MHC) is situated on the
short arm of chromosome 6 and is divided into D, B, C and A loci
(Figure 8).
Figure 8 The human leucocyte antigen (HIA) locus:
HLA locus - 6th chromosome
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The complex also contains the genes coding for complement
components C2, C4 and Factor B. The HLA genes exhibit considerable
polymorphism but the complement genes exhibit one or two common
alleles only. Furthermore the HLA antigens are very complex and
each molecule carries multiple antigenic determinants, the sum of
which identifies each gene product. The presence of multiple
alloantigenic specificities suggests that there are several
independently polymorphic regions on each molecule.
The class I genes (HLA-A, B, C) are analogous to the H2-K and
D MHC genes of the mouse and their corresponding antigens are
expressed on all nucleated cells in association with beta2
microglobulin (Howard 1978). The A, B and C antigens show
considerable sequence homology suggesting that they have arisen by
tandem reduplication of their corresponding genes. Furthermore A
and B antigens also show sequence homology with IgG heavy chain
suggesting that they are distantly related molecules. Similar
homology is seen between beta2 microglobulin and immunoglobulin
(Howard 1978). The principal function of the HLA-A, B and C
antigens seams to be in cell-cell interactions and they play an
essential role in cytotoxic T-cell lysis of viral infected cells
(Snell 1978). They imay also play a role in other cell-cell
interactions (Meruela and Edidin 1980) and this may be the basis
for the association of HLA-CW6 with Psoriasis.
The class II HLA-D (MLR defined) and HLA-DR (serologically
defined) antigens are analogous to the I region antigens of the
mouse and are expressed in a more restricted fashion principally on
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macrophages, B-cells, soma T-cells, spermatozoa and Langhans cells.
The D/DR antigens are inportant in the initiation and induction of
immunity and control macrophage-lymphocyte interactions and
T-helper and suppressor cell functions. Following uptake and
"processing"of antigen by macrophages, antigen is presented in
association with la or HLA-D antigen to responding lymphocytes.
Delayed type hypersensitivity (DTH) and T-helper cell responses are
specific for small peptide sequences (3-4 amino acids) only
(Benacerraf 1978); thus destruction of tertiary protein structure
does not interfere with antigen recognition in a secondary DTH
response while alteration of primary amino acid sequences abolishes
recognition. This specificity may be conferred by the la or DR
molecules which may act as receptor or binding sites for these
foreign sequences. Mutual sharing of la or DR alloantigen is
essential for antigen recognition; thus secondary proliferative
responses of monocyte depleted T-lymphocytes to PPD are restored
only when monocytes sharing identical HLA-D alleles with the
T-cells are added whether or not the macrophages are from an
unrelated donor (Sonderstrop et al 1978). Furthermore recognition
of foreign antigen by responding lymphocytes is blocked by antisera
against the D or la molecule. A further important point is that for
certain antigens, immune response genes are expressed at the level
of the macrophage and operate by specifying the antigenic
determinant on a foreign molecule which are presented to the
lymphocyte (Rosenthal et al 1977, 1979). Proliferative responses of
T-helper cells to macrophages bearing antigen also require soluble
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stimuli such as interleukin-1 (Fauci 1982). T-helper/B-cell
interactions are also governed by histocompatibility restrictions
and recognition of the antigen-la complex is essential for helper
cell activity.
More recently a number of additional class II antigens have
been identified and include the MB, MT, TE, SB and DS
specificities. Whether these are products of distinct D-region
genes or are "supertypic" specificities is not known (Rodnan &
Schumacher 1983). Certain MB and MT types are very closely
associated with certain DR antigens (Table 11, pl£©) (Winchester &
Nunez-Roldan 1982).
In addition to the HLA loci, the genes coding for C2, C4 and
Factor B are also found in the MHC. Same hereditary complement
deficiencies are in linkage disequilibrium with certain HLA. genes;
for example C2 deficiency with A10/B18/DW2/DR2 (Schur 1982).
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TABLE 11 Relationship of novel class II alloantigen
specificities to PR alloantiqens.
(From Winchester & Nunez-Roldan 1982)








MT2 3 5 6
TE22 4 5
MB3 4 5 6 9
MT4 4 5 8
MT3 479
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Role of host factors in RA
Numerous studies have confirmed an association between
seropositive RA and HLA-DR4 and scrre 60% of patients carry this
antigen compared with about 30% of controls (Stastny 1980). Other
D/DR associations include disease severity and side effects of
penicillamine and sodium aurothiomalate therapy. Panayi et al
(1978) demonstrated that RA patients with more severe disease,
higher rheumatoid factor (RF) titres and nodules had an increased
frequency of DRw3 while those with milder disease and lower RF
titres were DRw2 positive. Furthermore there was an overall
reduction of DRw2 in the RA group as a whole suggesting that DRw2
has a protective effect. Wooley et al (1980) found that a high
proportion (19/24) of patients with proteinuria induced by
penicillamine or sodium aurothiomalate were B8/DRw3 positive and
that 13/13 with heavy proteinuria (>2grr/24 hours) were B8/DRw3
positive. Overall however the DR4 antigen is a relatively weak risk
factor for RA with a relative risk of only 6-9X that of the general
population.
Other genetic factors may also play a part in determining
disease severity and an association between early onset severe
erosive RA and heterozygosity for alphal antitrypsin deficiency has
been noted (Cox & Huber 1980).
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Role of host factors in SLE
The role of genetic factors in SLE has recently been well
reviewed (Winchester & Nunez-Roldan 1982). Classical genetic
studies of the occurrence of SLE in monozygotic and dizygotic twins
clearly demonstrate the existence of a genetic predisposition.
Analysis of twin pairs in which at least one twin had lupus
revealed that in 69% of monozygotic twin pairs both members had
clinical lupus while only 3% of dizygotic twin pairs were
concordant for lupus. However since 31% of monozygotic twins did
not have overt lupus, environmental factors are also necessary for
disease expression. Calculations based on this data give an
approximate estimate of four co-occurring disease susceptibility
genes for expression of the disease. Studies of parent-child
inheritance patterns suggest very strongly that the disease
susceptibility is inherited as a dominant trait.
Further information on the nature of the gene products
involved in susceptibility have ccme frcm population genetic
studies of known polymorphic genes such as the HLA system. Pooled
data from a number of North American studies show a highly
significant increase in frequency and relative risk for DR2 and DR3
alleles with reduced relative risk for DR4 and DR5, and the
association suggests that one of the susceptibility genes
postulated in the classical family genetic studies is located
within the MHC. A further important point is that DR2 and DR3 may
be markers for one of the more recently identified nonDR class II
alloantigens and it has been suggested that MI'l or MB1 may be the
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relevant specificity. In support of this, a recent study has
demonstrated a relative risk of 18.8 for the MT1 antigen. The
curious combined association of DR2 and DR3 with SLE is not readily
explained and some features of the disease such as antibody to
dsDNA and Ro are associated with DR3 while others such as
thrombocytopenia are associated with DR2. It is not known whether
co-occurrence of DR2 and DR3 in the sane individual is associated
with increased disease susceptibility. The complexity of the MHC
association is further illustrated by the fact that in European
studies an association has been noted with DR3 but not DR2 while in
the UK the association is reversed. This may be due to differences
in population genetics and the relative genetic homogeneity found
within European geographical regions as compared with North America
where there may be greater genetic mixing.
Various inherited defects of the complement system have also
been described in SLE (Table 10, pl45) but the most canton
association noted is with C2 deficiency. There is an increased
frequency of the C2 deficient heterozygous state in SLE and
furthermore 37% of homozygous C2 deficient subjects develop SLE. It
should be noted however that patients with SLE and homozygous C2
deficiency have a lower incidence of renal disease which probably
reflects failure of classical pathway activation by immune
complexes (Schur 1982).
The mechanism of the association between complement deficiency
and SLE is not entirely clear. Early components such as C2 play a
role in viral neutralisation and deficiency could predispose to
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viral infection. It is also possible that failure of solubilisation
of inmune complexes by complement (Miller & Nussenzweig 1975) could
predispose to iirmune complex disease. However the association of
SLE with heterozygous C2 deficiency in which C2 levels are
generally adequate suggests that C2 deficiency is msrely a genetic
marker rather than a biological cause of SLE. This hypothesis is
supported by the existence of linkage disequilibrium between C2
deficiency and HLA-A10,B18,DW2,DR2 haplotype.
An illustration of the way in which several genes may interact
with an environmental agent to produce SLE is hydrallazine induced
lupus. Studies by Batchelor et al (1980) have clearly shown that
slow acetylator status co-occurring with HLA-DR4 in a female is
associated with a very high incidence of hydrallazine induced SLE.
An intriguing aspect of this work is the finding that DR4 is a risk
factor, whereas in spontaneous SLE DR4 has a protective effect with
a relative risk of -2.2.
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Immune complex formation in RA and SLE
Introduction
Although the initiating causes of RA and SLE are unknown, it
is clear that a major pathogenetic mechanism in both diseases is
the production of immune complexes (IC) which interact with
inflammatory cascades, neutrophil polymorphs, and other
inflammatory effector cells to cause tissue damage. A complete
discussion of the nature and biological properties of the immune
complexes found in RA and SLE is beyond the scope of this thesis,
but there are sore basic concepts which should be reviewed.
General considerations
Formation of ICs by reaction of antibody with antigen is
reversible and obeys the law of mass action. The affinity of the
antibody is a major determinant of the equilibrium constant, and
low affinity antibody shifts the equilibrium to the left i.e.
towards dissociation of the IC.
Ab + Ag = (Ab-Ag)
The nature of the antigen, including its size, charge and the
number and accessibility of antigenic determinants also determine
the stability and biological properties of the IC. Studies of
inbred strains of mice with high and low affinity antibody
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responses have shown that "low" responders are much more
susceptible to chronic IC disease and glomerulonephritis (Steward &
Devey 1981). It has been proposed that this type of genetically
determined, antigen nonspecific chronic disease should be viewed as
part of the spectrum of immunodeficiency (Soothill & Steward 1971).
The genetic basis for the affinity of antibody responses is likely
to be complex, and may involve macrophages (Passwell et al 1974;
Morgan & Soothill 1975), T-helper cells (Soothill & Steward 1971)
or B-cells (Steward et al 1974). Furthermore, macrophage clearance
defects (Passwell et al 1974; Morgan & Soothill 1975) while
predisposing to defective antigen handling and low affinity
antibody responses, may also contribute to defective clearance of
the ICs so produced.
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Immune complexes in RA
A major immunological feature of RA is the production of
rheumatoid factors (RF) which are antiglobulins directed against
the Fc portion of IgG. The target for RF on the Fc portion is
probably the isotypic Ga autoantigenic determinant (Johnson &Faulk
1976). RFs are predominantly of IgG and IgM classes although all
classes have been described. Although the stimulus to RF production
is unknown, its inevitable consequence is the formation of ICs
produced by the reaction of RF with native IgG. In the plasma, the
ambient concentration of native IgG is relatively high and small
di- and trivalent complexes tend to form between IgG class RFs and
native IgG. These are low in inflammatory potential and do not fix
complement, do not trigger inflanmatory cells and bind poorly to
IgM RF. With increasing titres of IgG RF, the complexes tend to
increase in size, fix complement, are more readily crosslinked by
IgM RF and trigger inflammatory cells (Carson et al 1979; Weisman &
Zvaifler 1975). Under these circumstances, intravascular
inflairmation may be triggered by deposition of ICs in small
arterioles (Conn et al 1972) and is manifested clinically as
vasculitis affecting a variety of organs including skin, nerves,
eyes and lung, and pathologically by inflammatory necrotising
lesions of the blood vessel walls. The presence of circulating
inflammatory ICs is also marked by falling levels of haemolytic
complement, consumption of C3 and rising levels of complement
degradation products (Mongan et al 1969; Weinstein et al 1972).
In general however, inflammatory events in RA occur
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predominantly in the extravascular space such as the synovial and
serosal cavities, and Ine triggered by the local synthesis of RFs
(Zvaifler 1973). The factors which lead to the accumulation of
lymphoid cells and RF synthesis are not known, but once
established, a self perpetuating sequence of IC formation and
inflammation occurs. RFs synthesised in extravascular sites have no
native IgG to react with and therefore form large self associating
polymers which readily trigger inflammation. Rheumatoid synovial
fluid is therefore characterised by intense complement consumption
which attracts neutrophil polymorphs and mononuclear cells while
the synovial lining becomes hypertrophied with increasing numbers
of infiltrating lymphocytes and macrophages (synovial A cells)
(Zvaifler 1973). The interactions of these chronic inflaimmatory
cells with humoral factors and other connective tissue cells to
cause connective tissue degradation has already been discussed
(pll5).
It is likely that in relation to IC formation and clearance in
RA, Kupffer cells and splenic macrophages may be most relevant to
protection against intravascular inflammatory events, while in
joints and extravascular spaces, the resident synovial A cells and
blood derived mononuclear phagocytes will be more important.
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Immune complexes in SLE
In contrast to RA, a large proportion of the inflammatory
organ damage seen in SLE is caused by intravascular deposition of
ICs, formed either locally or in the circulation, and the basic
pathological event is therefore vasculitis. This is reflected both
in the nature of the tissue damage as well as in the diversity of
organ involvement. Thus while in RA, joint erosions and destruction
by recurrent "Arthus-like" reactions are ccnmon, in SLE, although
synovitis is frequent, erosions are rare. Similarly, while in SLE
any organ can be involved, in RA certain organs such as the brain
and kidney are only rarely involved by the inflammatory process.
The diversity of autoantibodies found in SLE creates the
potential for IC formation with a wide range of antigenic
determinants in the membranes, cytoplasm and nuclei of cells, as
well as soluble antigens such as globulins, and at least three
different mechanisms of IC production can be identified.
For example antibody against "solid phase" determinants on
erythrocytes and platelets contribute to haemolytic anaemia and
thrombocytopenia and it has been suggested that autoantibodies
directed against neuronal tissue may mediate sate features of CNS
disease in lupus (Zvaifler & Bluestein 1982). It is likely that the
ability of anti-neuronal antibodies to fix complement and activate
the membrane attack complex (MAC) is a critical requirement for
pathogenicity of these antibodies (Koffler et al 1982). A second
mechanism of immune complex formation is for circulating antibody
to react with antigen which has been released from damaged tissue
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and has becama deposited in a site of predilection elsewhere in the
body. Evidence for this mechanism cotres from animal models of
glomerulonephritis (Mannik 1982). The third mechanism of immune
complex formation is via reaction of antibody with antigen in the
fluid phase, and transport via the circulation to sites of tissue
deposition. At least one antigen involved in this type of mechanism
is DNA (Agnello & Mitamura 1982), and IC deposition has been
demonstrated in a wide variety of tissues including kidney, skin,
lung, spleen, bladder and placenta (Brentjens & Andres 1982) as
well as choroid plexus (Zvaifler & Bluestein 1982). It should be
emphasised however that demonstration of deposits of immunoglobulin
and complement do not always correlate with tissue damage and it
has been suggested that the ability of ICs to activate the MAC may
be critical in this regard (Koffler et al 1982).
In conclusion, although many of the pathological features of
SLE can be attributed to tissue deposition of ICs, there are a
variety of potential pathogenetic mechanisms which do not
necessarily involve circulating preformed ICs. Thus the clearance
function of the splenic and hepatic ccnponents of the mononuclear
phagocyte system may not be relevant to all manifestations of the
disease process. Where local formation of ICs is occurring the
function and local accumulation of blood derived monocytes and
macrophages may be most important in removing ICs.
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Mononuclear phagocyte system (MPS) immune clearance function
Introduction
Since RA and SLE are diseases in which irrmune complexes play a
central role in the pathogenesis of inflammatory tissue damage, the
function of the MPS in sequestering potentially harmful immune
complexes (IC) is of great importance and has been studied in both
these diseases as well as in animal models of IC disease. Studies
in animal models have focussed on the factors which modulate MPS
function and the characteristics which lead to their clearance or
deposition in the tissues. In man a variety of model ICs have been
used to examine the effect of IC disease on the MPS and to
determine whether MPS dysfunction plays a significant role in the
persistence of ICs. Other studies have been performed on monocytes
and macrophages in vitro with the aim of determining whether
phagocytic defects are present in cells taken frcm patients with IC
disease or, alternatively, whether serum from these patients
induces defects in phagocytic cells from normal subjects.
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In vivo studies of (MPS) function in animals
Animal models have demonstrated that handling and clearance of
circulating immune complexes (IC) is a function both of MPS
function and the immunochemical characteristics of the ICs. The
concentration of circulating IC at a given moment is a function of
the rate of formation and removal. Formation of ICs is dependent
both on the availability of antigen, the rate of antibody synthesis
and theoverall affinity of the antibody "population" (Steward &
Devey 1981). Removal of ICs by the MPS is dependent on the IC
lattice size, the type of antigen, the characteristics of the
antibody and the status of the MPS (Mannik 1982).
The role of lattice size in MPS immune clearance has been
studied by infusing preformed ICs of known size into experimental
animals (Haakenstad and Mannik 1976; Mannik et al 1971; Finbloom
and Plotz 1979a, 1979b). "Large" lattices are defined as complexes
containing more than two antibody molecules (i.e.>Ab2Ag2) and
"small" lattices as complexes containing Ab2Ag2 or less. After
infusion, large carplexes are cleared rapidly in an exponential
fashion while small corplexes are cleared much more slowly.
Saturation of clearance mechanisms by increasing the dose of ICs
can be achieved only with the use of large lattice complexes and no
plateau in clearance is seen with increasing amounts of small ICs
(Haakenstadt and Mannik 1974, Mannik et al 1971). Furthermore
whereas hepatic uptake of small complexes causes no inhibition of
MPS clearance of aggregated IgG, large lattice ICs readily cause
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"blockade" (Jimenez et al 1983). Clearance of such complexes is
entirely mediated by the Kuppfer cells of the liver which are
ideally suited for this purpose. The Kuppfer cell membrane and its
receptors are exposed directly to the blood stream and unlike the
splenic macrophage have no covering of endothelium. The spleen on
the other hand clears particulate material such as erythrocytes
which must enter the extravascular space before making contact with
specific phagocytic cells.
Tbe antigen contained in the immune complex also plays a role
in clearance - uncamplexed ssDNA for example is cleared more
rapidly than large lattice ICs in mice (Emlen and Mannik 1978). The
structure and type of antibody also plays a key role. For example
reduced and alkylated ICs with damaged Fc portions and mouse IgA
complexes which are not bound by macrophage Fc receptors have slow
rates of clearance and become deposited in the glomerular mesangium
causing nephritis.
A number of factors alter the innate capacity of the MPS to
clear ICs and include prior blockade by ICs (Haakenstad and Mannik
1974), drugs (Haakenstad et al 1975), intrinsic strain specific
factors (Ford 1975) and treatment with agents which activate the
MPS (Raij et al 1981, Barcelli 1981).
As discussed already, blockade of the MPS can be achieved
using large lattice ICs but not small lattice ICs (Jimenez et al
1983), an observation which is of seme importance vis a vis the
significance of small soluble ICs circulating in human disease. The
effect of steroids on monocyte phagocytosis is controversial and
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has been discussed already (vide supra) but whatever the mechanism
steroids do seem to impair in vivo hepatic clearance of ICs
(Haakenstad et al 1975) and thus secondarily increase the incidence
but not the severity of glomerulonephritis in animal models. The
observation that steroids ameliorate splenic clearance defects in
man must be contrasted with these observations and suggests that
blood flow and vascular permeability may play a role in these
differential effects on organ IC clearance. Animal studies (Ford
1975) have also demonstrated strain differences in MPS function
which can be related to a disposition to IC mediated
glomerulonephritis. However it shoi^l be noted that in animal models
of IC mediated glomerulonephritis, there is an association with
defective clearance in sane but not all studies (Finbloam and Plotz
1979, Pappas et al 1981, Hoffsten et al 1979) and other mechanisms
such as antigen deposition followed by in situ IC formation may
also play a role (Ford and Kosatka 1979).
Several studies have demonstrated that MPS clearance function
can be significantly enhanced by MPS activating agents. Atkinson
and Frank (1974) demonstrated that following BCG immunisation the
pattern of complement mediated clearance of ICs by guinea pig
Kuppfer cells altered. Prior to immunisation complement coated
erythrocytes were rapidly cleared by the Kuppfer cells but later
released back into the circulation, whereas after BCG the cells
were cleared completely. Two other studies (Raij et al 1981,
Barcelli et al 1981) have shown that prior injection of zymosan or
C. parvum into animals ameliorates or prevents the development of
glomerulonephritis due to passively infused ICs.
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Clinical studies of MPS function in vivo in RA, SLE and other
autoimmune diseases
Early studies of human "RES" function using lipid enulsions
showed enhanced clearance in patients with SLE, RA, rheumatic fever
and other inflaixmatory diseases (Salky 1965).
Others have used heat damaged autologous erythrocytes to study
splenic "noninmune" phagocytic function in vivo. Williams et al
(1979) demonstrated reduced clearance in 11/13 patients with active
RA and a correlation between reduced clearance and iitirrune complex
levels (Clq binding activity). 13 patients with inactive RA, sane
of whom were on penicillamine or gold therapy, had normal splenic
function. Henderson et al (1981) and Gordon et al (1981) using the
same technique demonstrated minor reductions in erythrocyte
clearance in 3/14 and 8/20 patients respectively. In neither study
was a correlation found with disease activity or Clq binding
activity. A study of 10 patients with SLE (Elkon et al 1980)
identified only one patient with delayed erythrocyte clearance
while another patient with normal clearance had very high
circulating IC levels.
It is likely that this technique is measuring the capacity of
the spleen to filter out deformed spherocytic erythrocytes which
are sequestered primarily because of lack of deformability
(Mohandas et al 1979). Studies in vitro on heat damaged
erythrocytes show alterations in size (usually increases) and no
evidence to suggest that they become opsonised with immunoglobulin
167
or complement. It is not known however whether other opsonins such
as fibronectin play a role in the in vivo clearance of these
particles and the clinical significance of these studies is
uncertain.
In an attempt to test immune Fc receptor mediated clearance'
mechanisms, chromium labelled autologous erythrocytes opsonised in
vitro with human anti-Rh(D) IgG antibody have been used as
artificial ICs. Anti-Rh(D) do not fix complement (Rosse 1968) and
their rate of clearance is proportional to the degree of
opsonisation (Elkon et al 1982). A number of studies on patients
with SLE have demonstrated that a high proportion of patients have
defective MPS clearance of these particles and this has been
attributed to abnormal Fc receptor function. Frank et al (1979)
reported that 13/15 SLE patients had reduced Fc mediated clearance
and 6 of these patients had normal or even increased clearance of
noniitmune particles (radioiodine labelled aggregated albumin).
Reduced Fc mediated clearance correlated with increased disease
activity and weakly with Clq binding activity (Clqba). A subsequent
study ccmpared subgroups of SLE patients with and without renal
disease (Parris et al 1982). Again SLE patients had slower rates of
clearance than normal controls but in addition, patients with renal
disease had slower rates than those without. However, the
differences were not great and no control group of patients with
other nonimmune causes of renal failure was included. No
correlation was found between clearance and anti-DNA antibodies, or
tests for ICs (Clq ba, Raji cell and Staph A binding assays). A
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study of 19 patients with Sjogrens Syndrome demonstrated reduced
clearance in 12/19 patients and a correlation between the defect
and disease activity (Hamburger et al 1979). In general defects of
Fc clearance were seen in those with extra-salivary gland disease
but again no correlation was found with circulating ICs or serum
complement levels.
Two recent studies have reported the results of longitudinal
tests of MPS Fc receptor mediated clearance in patients with SLE.
Hamburger et al (1982) studied 13 patients, 11 of whom had
diminished Fc mediated clearance the severity of which correlated
with disease activity and tests for immune complexes. Paired
studies on these patients demonstrated that clinical improvement
was associated with improvement in clearance rates and, in one
patient whose disease flared, clearance rates became slower. Tests
for ICs also changed concordantly. Kimberley et al (1983) similarly
reported concordance between improvement in disease and improved
clearance but found no concordance with tests for ICs including
CH50, Staph. A binding, Clqba and Raji cell assays. Although it
appears that the magnitude of the defect of Fc clearance in SLE
alters with time and disease activity there is no agreement as to
whether this correlates with levels of ICs and most studies have
found no or only weak correlations.
Reduced Fc mediated clearance has also been reported in
patients with n<phritis and vasculitis, which has improved
following plasma exchange (Lockwood et al 1979). Very little data
is available on patients with RA, one report Kimberly and Ralph
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(1983) suggesting minor reductions in Fc mediated clearance in a
few patients with active disease.
The basis for the defect of putative Fc mediated MPS clearance
demonstrated in these studies is necessarily speculative. Clearance
is a function of a number of factors including organ blood flow and
size, as well as the state of activation of the MPS. Clearance may
also be modified not only by "saturation" of clearance mechanisms
(Haakenstad and Mannik 1974) but also by depletion of soluble
circulating fibronectin, and pharmacological factors. In acute
severe illness such as trauma and septicaemic shock, profound
abnormalities of blood flow and "RES" clearance have been noted
which are associated with depletion of circulating fibronectin, an
opsonic glycoprotein. Transfusion of fibronectin rich
cryoprecipitate results in dramatic improvement in blood flow and
clearance (Saba 1980). The difficulty in demonstrating a
correlation between clearance and ICs is perhaps not surprising as
animal studies have shown that large carpiexes which are rapidly
cleared can induce MPS "blockade" whereas small circulating ICs do
not (Mannik 1982). Thus circulating ICs may not be representative
of ICs being actively removed by the spleen. In patients with
subacute bacterial endocarditis with clinical and serological
evidence of circulating ICs, Fc receptor mediated clearance is
enhanced rather than depressed, and again arphasises the difficulty
in trying to associate the presence of circulating ICs with MPS
clearance defects. The enhancement almost certainly reflects
"activation" of the MPS and is comparable to observations made in
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animals (Atkinson and Frank 1974, Raij et al 1981, Barcelli 1981).
A further question in the interpretation of these studies is
whether clearance of IgG sensitised erythrocytes represents an
immune clearance rrechanism relevant to IC disease such as RA or
SLE. Soluble ICs bearing both complement and Fc-portions or other
ligands are cleared in the liver rather than the spleen. This has
been demonstrated in the various animal models already discussed as
well as in human studies (Atkinson & Frank 1974). Furthermore the
Kuppfer cell is ideally suited for this purpose as it lies in
direct contact with plasma as it circulates through the liver. The
use of a particle coated both with complement and a second,
phagocytic ligand (carbohydrate or Fc-portion) which would be
phagocytosed by Kuppfer cells would be a more physiological probe
of MPS clearance function.
In addition to these studies which have essentially considered
defective splenic clearance as a secondary manifestation of IC
disease it has been suggested by analogy with animal models (Ford
1975), that there may be intrinsic defects of MPS receptor function
which predispose bo IC disease. Lawley et al (1981) demonstrated
defective splenic clearance in a group of normal individuals with
the B8/DRw3tissue type and suggested that this might represent an
inherited predisposition to abnormal MPS function. None of these
individuals had any evidence of circulating ICs or serological
evidence of immunological disease. However it has since been
reported that blood monocytes from individuals with the B8/DRw3
tissue type have normal numbers of Fc receptors with normal
171
affinity making it extremely unlikely that abnormal Fc clearance is
due to an intrinsic defect of Fc receptor expression. These
observations must cast further doubt on the validity of the
technique as well as the method of selecting "normal controls".
C3b receptor MPS clearance
Studies have also been performed to try and delineate the role
of complement receptors in mediating in vivo clearance of
circulating ICs in man. Autologous chromium labelled erythrocytes
coated with IgM antibody and C3b are rapidly cleared by the Kuppfer
cells of the liver (Atkinson and Frank 1974). After the initial
clearance phase, a proportion of the labelled cells are released
back into the circulation where they have a normal survival time as
C3d coated Coombs positive erythrocytes. Kinetic studies
demonstrate that rates of clearance are proportional to the degree
of sensitisation (Meryhew and Runquist 1981). In animal models a
similar pattern of clearance and release has been observed but
which can be enhanced by prior MPS activation (vide supra)(Atkinson
and Frank 1974).
Reports of clinical studies are limited. One report
demonstrates reduced C3b mediated clearance in primary biliary
cirrhosis and no abnormality in controls with other forms of liver
disease (Jaffe et al 1978). In addition these patients did not have
a defect of nonimmune clearance of aggregated albumin and 4/6 had
increased rates of Fc mediated splenic clearance. No correlation
between delayed C3b clearance and circulating ICs was noted.
172
Other approaches to the study of C3b receptors have been used
and several groups have reported evidence of defective C3b receptor
(CRl) expression in erythrocytes and renal glomerular cells.
Miyakawa et al (1982) have reported that over 60% of a group of 56
patients with SLE had very low densities of CRl expression on their
erythrocytes as detected by iirmune adherence and antiCRl antibody
and that the abnormality did not improve with amelioration of the
disease. Moreover a similar abnormality was found in a high
proportion of a small group of relatives of these patients but only
a small proportion of the normal controls. On this basis they
suggest that the defect may be intrinsic or inherited. However they
did not satisfactorily exclude the possibility that the abnormality
might be acquired as a result of exposure to complement bearing
ICs. Iida et al (1982) similarly found reduced CRl expression using
anti-CRl antibody on erythrocytes from patients with SLE and RA and
that the defect in SLE patients correlated with C4 haemolytic
titres and Clqba. Although the data suggests that the abnormality
is secondary, the data does not preclude a genetic component.
A larger study of erythrocyte CRl expression in 113 normal
subjects, 38 patients with SLE, four of their spouses and 47
relatives has also been reported (Wilson et al 1982). Anti-CRl
antibody and C3b dimers were used to quantify receptor numbers. The
frequency of distribution of CRl expression in normals suggested a
trimodal pattern which was interpreted as representing three
phenotypes - 34% had high (HH), 54% intermediate (HL) and 12% low
(LL) phenotypes respectively. The observed frequencies correspond
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well to the predicted frequencies of a two codominant allele model
of inheritance. The mean number of CRl on erythrocytes from both
SLE patients and their relatives was significantly lower than
controls, but their spouses resembled the normal subjects.
Furthermore they excluded the possibility of receptor occupancy by
ICs as well as differential effects due to maturity of
erythrocytes.
The functional significance of CRl on erythrocytes vis a vis
the MPS is two fold. Firstly the erythrocyte bears approximately
85% of cellular CRl in the peripheral blood and may therefore play
a significant role in transporting ICs to the MPS. Nelson (1956)
observed that virtually 100% of pneumococci injected with antibody
into monkeys became associated with erythrocytes and were cleared
completely from the plasma. Cinanatographic studies demonstrated
polymorphs removing bacteria from the surface of erythrocytes
leaving the erythrocyte intact (Robineaux and Pinet 1960) suporting
the concept that erythrocytes may play a significant role in intnune
clearance.
The second implication of an inherited defect of CRl
expression on erythrocytes is that other marrow derived cells
including mononuclear phagocytes may be similarly affected, again
with important consequences for the clearance of opsonised ICs. In
support of this hypothesis, iirmunohistochemical studies of the
human glomerulus using anti-CRl antibody have shown that CRl is
absent from diffuse proliferative nephritic SLE kidneys, but is
present in kidneys with several other forms of glomerulonephritis
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including membranous SLE nephritis (Kazatchkine 1982). Furthermore
data to be presented in this thesis also suggests that blood
monocytes from patients with SLE have defective C3 receptor
expression.
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Clinical studies of MPS phagocytic function in vitro in RA and SLE
Introduction
Early studies used Roebuck skin window techniques to study the
phagocytic function of exudate inflanmatory polymorphs and
macrophages in RA. Jessop et al (1973) found that the phagocytic
activity of macrophages and neutrophil polymorphs was increased in
RA and suppressed during treatment with gold salts or steroids.
Parallel experiments on rats confirmed the effects of gold and
prednisolone and showed that these drugs had a gross inhibitory
effect on both humoral and cellular components of inflammation
(Vernon-Roberts et al 1973). However while these studies provide a
useful overall view of the inflammatory response, individual
components such as adherence, chemotaxis, spreading and
phagocytosis and the contribution of humoral factors cannot be
separated. In general most subsequent studies have employed blood
monocytes in various degrees of purity to study phagocytic
function.
Fc receptor expression in SLE and RA
There have been relatively few studies of phagocytosis by
monocytes from SLE patients and most have examined the role of
serum opsonisation factors (Svensson 1975, 1980a, 1980b, 1980c;
Svensson and Hedburg 1973; Temple and Loewi 1977). Kavai et al
(1979, 1980, 1983) have demonstrated enhanced Fc receptor (FcR)
expression in monocytes from SLE patients and also shown that this
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returns to normal after incubation in vitro for four hours (Kavai
1980). The enhancement of FcR was correlated with several facets of
monocyte function and activation, including increased
^-glucuronidase content and a rise in serum lysozyme levels.
Studies of RA patients (Molleraimussen et al (1982)) using
radio-iodine labelled moncmeric IgG demonstrated a significant
increase in numbers of FcR/monocyte in 14 untreated patients
compared with 15 normal controls. Katayama et al (1981) similarly
found increased numbers of FcR/monocyte and evidence of increased
catabolism of aggregated IgG in RA monocytes. The increase in FcR
correlated with rheumatoid factor latex titres. Hoch and Shur
(1981) found increased EA rosetting and increased Fc recptor
dependent phagocytosis but no increase in uptake of aggregated IgG.
FcR rosetting and phagocytosis by monocytes from patients on
steroids were no different frctn the controls. Conversely however
they found that incubation of normal monocytes with RA sera caused
reduced rosetting and phagocytosis. Other functional studies
demonstrating increased ADCC by RA monocytes also suggest increased
Fc receptor expression (Waytz and Douglas (1979)).
Enhanced FcR expression on monocytes has been noted in a
number of other chronic inflammatory diseases including
sarcoidosis, Crohns disease and tuberculosis, and has been
attributed to monocyte activation (Zuckerman and Douglas (1979)).
However the functional significance of this increase is uncertain
and it is not clear whether it results in increased phagocytic
activity or whether the FcR mediate other functions such as
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superoxide generation or cytotoxic effects. The available evidence
suggests that the latter is the correct interpretation but more
information with regard to the type of Fc receptor involved and its
function is clearly required.
A comparison of in vivo MPS function with in vitro monocyte
function was recently reported (Salmon and Kimberly 1983). Srrall
but significant reductions in monocyte Fc mediated phagocytosis but
increased Fc rosetting with EAIgG were found. Measurement of FcR
numbers using radio-labelled aggregated IgG showed a small but
statistically insignificant increase in FcR expression and no
change in affinity. There was no correlation between these in vitro
findings and in vivo MPS clearance of IgG sensitised erthrocytes.
Complement receptor expression in SLE and RA
In two studies of SLE patients defects of phagocytosis of
serum opsonised bakers yeast were demonstrated and attributed to an
abnormality of C3b receptor expression (Kavai et al 1979, 1980).
Landry (1977) using an oil emulsion of E. coli lipopolysaccharide
as the test particle and normal serum as the opsonising agent found
reduction of initial rates of phagocytosis by both neutrophil
polymorphs and monocytes from patients with SLE. Although it is not
specified which opsonins were present on the emulsion, it seems
likely that C3b generated by alternative pathway activation was a
major opsonic component and that C3b receptors were responsible for
the phagocytic defect.
In a study of RA patients Hoch and Shur (1981) found no change
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in monocyte complement (C3b) receptor expression using EAC
rosettes.
In conclusion, there is evidence from in vivo studies of SLE
and to a lesser extent RA patients, to suggest impaired Fc-receptor
mediated clearance by splenic macrophages. However in vitro studies
of their precursors, blood monocytes, which are presumably exposed
to the same humoral environment, shew definite enhancement of Fc
receptor expression. This apparent contradiction may reflect
differences in methodology. In rosetting studies no indication of
the functional phagocytic capacity of Fc receptors is obtained, and
increased numbers of Fc receptors cannot be equated with increased
phagocytic capacity. In vivo studies are carpiicated by a number of
factors and the end result i.e. disappearance of erythrocytes frcm
the circulation, may not directly reflect macrophage receptor
function. Perhaps the clearest indication that monocyte immune
phagocytic function is abnormal in SLE is given by studies using
opsonised oil emulsion or yeast which suggest that complement
receptor expression may be defective, and this is supported
indirectly by the recent demonstration of abnormal CR1 expression
on erythrocytes from SLE patients.
The question of whether there are primary or secondary defects
of MPS phagocytic function which might contribute to persistence of
inmune complexes in SLE and RA is by no means resolved and it was
in this context that the studies of monocyte phagocytic function
reported in this thesis were undertaken.
CHAPTER 4
AIMS OF THE STUDY
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AIMS OF THE STUDY
The principle aim of these studies was to determine whether
defects of irrmune phagocytosis by mononuclear phagocytes could be
identified in patients with rheumatoid arthritis (RA) and systemic
lupus erythematosus (SLE) which might exacerbate or predispose to
immune complex disease. The potential significance of abnormalities
of immune phagocytosis, if present, is discussed in the preceding
chapter. Since blood monocytes are the precursors of tissue
macrophages it seemed appropriate to examine the function of these
cells as a first step towards achieving this aim. Furthermore if
intrinsic defects of the mononuclear phagocyte are present in
either of these diseases they should be apparent in precursor cells
as well as mature tissue macrophages and would perhaps be less
likely to exhibit abnormalities secondary to local disease
processes.
The experiments performed fall into the following categories.
1) The establishment of methods for measuring the kinetics of
phagocytosis by blood monocytes which would be suitable for use in
a clinical setting.
2) The application of these methods to the study of blood
monocytes from patients with RA and SLE .
3) Correlation of phagocytic data with serological parameters
including serum complement levels and tests for immune complexes.
4) FYirther studies aimed at elucidating the nature of any




SECTION I: BUFFERS , STAINS AND IDENTIFICATION OF MONOCYTES
1.0 BUFFERS
SORENSENS PHOSPHATE BUFFER.
M/15 disodium hydrogen phosphate was prepared by dissolving
9.465gm in 1 litre of distilled water, and M/15 potassium
dihydrogen phosphate by dissolving 9.08gm in 1 litre of distilled
water. Mixing of these two solutions in various proportions gave
buffer of the required pH.
HANKS BALANCED SALT SOLUTION
Hanks balanced salt solution (HBSS) was adjusted to pH 7.4
with 1.4% sodium bicarbonate and preservative free heparin (5
units/ml) added.
HEPES.
1M Hepes buffer was prepared by dissolving 23.83gms of Hepes
buffer in 90mls of distilled water and the pH adjusted to 7.6 with
5N NaOH. The final volume was adjusted to lOOmls with distilled
water.
EAGLES MINIMUM ESSENTIAL MEDIUM.
Eagles minimum essential medium (MEM) was prepared by dilution
of 10 times concentrated Eagles MEM (Flow Laboratories), with the
addition of 1ml of 0.2M glutamine, 0.1ml of penicillin and
streptomycin (200,000 units/ml), 3ml of 1M HEPES, and adjustment of
the final volume to 1 litre with sterile distilled water.
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RPMI 1640.
RPMI 1640 + 2gm/l NaHC03 (Flow Laboratories) (XI cone) was
supplemented with 1ml of 0.2M glutamine, 0.1 ml Penicillin and
Streptomycin (200,000 units/ml).
FETAL CALF SERUM
A single batch of fetal calf serum (FCS) (Flow Laboratories)
was used throughout.
EDTA
To prepare a 4.5% solution of EDTA, 4.5gms of ethylene
diamine tetra-acetic acid (disodium salt) were dissolved in lOOmls
of phosphate buffer and adjusted to pH 7.4 with IN NaOH.
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2.0 STAINS
WHITE CELL COUNTING FLUID
White cell counting fluid was prepared by dissolving O.lgm of
gentian violet in 1 litre of 2% acetic acid.
TRYPAN BLUE
0.9rnls of a solution of 0.4% trypan blue in PBS was mixed with
O.lmls of cell suspension.
JENNER-GIEMSA STAIN
Slides were fixed for 5 minutes in methanol, stained for 5
minutes in Jenners stain diluted 1:1 with buffer (pH 6.8), for 10
minutes in Giemsa diluted 1:10 with buffer (pH 6.8) and finally
washed with buffer (pH 6.8).
NON SPECIFIC ESTERASE STAIN
Monocytes were stained for non specific esterase according to
the method of Yam et al 0171).
MATERIALS:
1) Stock fixative was prepared by dissolving 20Cmg of Na2HP04
and lgm of KH2P04 in 45Crnls of acetone, 25Cmls of formalin and
*
300mls of distilled water. The fixative was stored at 4C.
2) Stock pararosanilin solution was prepared by dissolving 2gm
of pararosanilin in 5Crnls of 2N HCL with warming.The solution was
cooled and filtered.
3) Stock sodium nitrite solution was prepared by dissolving
8gm of sodium nitrite in 20Cmls of distilled water.
4) Stock M/15 phosphate buffer pH 7.4 (Sorensens).
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5) A fresh solution of lOOmg of alpha napthyl acetate in 5mls
of 2-methoxyethanol was prepared daily as required.
6) A 2% aqueous solution of rrethyl green extracted with
chloroform was used as the counterstain.
METHOD:
Fresh cytocentrifuge slides were prepared using 200ul of
mononuclear cells at a concentration of 10^ /ml. The slides were
O
air dried, fixed for 30 seconds at 4C, washed three times with
distilled water and dried. 36mls of phosphate buffer were mixed
with 2mls of the alpha napthyl acetate solution in a Coplin jar.
2mls of stock pararosanilin solution were mixed with 2mls of stock
sodium nitrite and after 1 minute 2.4mls of this were added to the
Coplin jar. The mixture was adjusted to pH 6.1 and filtered before
use. The slides were then stained for 30 minutes, washed thoroughly
with distilled water and counterstained with 2% aqueous methyl
green for 20 minutes.
AS-D CHLQRQACETATE ESTERASE STAIN.
MATERIALS:
1) AS-D chloroacetate (Sigma).
2) Fast blue BB salt (Sigma).
3) N-N dimethyl formamide (Sigma).
METHOD:
Fresh cytocentrifuge slides were prepared and fixed as for NSE
staining. Where dual NSE/chloroacetate staining was required, the
chloroacetate stain was performed after NSE staining but before
counterstaining with methyl green.
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lC*T>g of AS-D chloroacetate are dissolved in 5mls of dimethyl
formamide in a glass tube. 2mls of this solution are mixed with
38mls of M/15 phosphate buffer and 40mg of fast blue BB salt in a
Coplin jar. The cytocentrifuge slides are stained for 20 minutes,
rinsed with distilled water and counterstained with 2% methyl green
for 20 minutes.
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3.0 COULTER SIZING SIUDIES OF MONONUCLEAR CELLS
A ZBI Coulter counter was used to perform studies of the size
distribution profile of blood mononuclear cells.
CALIBRATION OF COULTER COUNTER
A ZBI Coulter Counter fitted with a 70 micron aperture was
calibrated according to the makers instructions using the "half
count method" on standard latex particles of known volume. Latex
particles (Coulter) of mean diameter 13.8 and 4.84 microns were
used and the calibration constant obtained from the formula:
(K/d) = (A x I x t) ;
where K = calibration constant, d = diameter of test particle, A =
amplification, I = current, t = threshold setting.
Having determined the calibration constant using particles of
known volume, the volume and number of particles of unknown size in
suspension can then be obtained.
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4.0 IMMUNOFLUORESCENCE STUDIES
IMMUNOFLUORESCENCE STUDIES ON MONONUCLEAR CELLS
Cytocentrifuge slides of mononuclear cells were dried and
fixed in absolute alcohol for 15 minutes. After thorough drying the
cells were stained with a few drops of diluted (1 in 20) FITC
labelled goat anti-human gamma globulin or anti-human carpiement
((3lc/a) (Nordic Iirmunodiagnostics) for 20 minutes at room
temperature in a humidified chamber. The slides were then washed
three times with PBS and mounted in 75% glycerol in PBS under a
coverslip. The slides were examined under the fluorescence
microscope using PLOEM illumination (Leitz Ortholux) for the
presence of intracytoplasmic inclusions of ganma globulin or
ccrrplement.
IMMUNOFLUORESCENCE STUDIES ON PREOPSONISED YEAST
Cytocentrifuge slides of preopsonised yeast were fixed in
absolute ethanol for 15 minutes. After thorough drying the yeast
were stained with a few drops of diluted (1 in 20) FITC labelled
goat anti-human IgG, IgM, IgA or complement (filc/a) (Nordic
Iirmunodiagnostics). The slides were then washed three times with
PBS and mounted in 75% glycerol in PBS under a coverslip. The
slides were examined under the fluorescence microscope.
Appropriate positive and negative controls were used
throughout.
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SECTION II PURIFICATION Of CELLS
1.0 SEPARATION OF MONONUCLEAR CELLS ON A DENSITY GRADIENT
Mononuclear cells (monocytes and lymphocytes) were separated
according to the method of Boyum (1968). lCmls of venous blood were
anticoagulated with 2.0mls of 4.5% EDTA and placed in a 4CstlL
siliconised glass centrifuge tube (M.S.E.). 14mls of Ficoll-Hypaque
(Lymphoprep, Nyegaard, Oslo) was layered under the blood using a
plastic quill and 2Qml disposable plastic syringe. The blood was
c
then centrifuged at 800g for 30 minutes at 20C. The upper platelet
rich plasma was discarded and the mononuclear cell layer collected
along with approximately half the underlying Ficoll-Hypaque. The
mononuclear cells were diluted with 3Cmls of HBSS+0.1% gelatin and
o
centrifuged at 400g for 20 minutes at 20C. The supernatant was
discarded, the pellet resuspended in 5mls of HBSS+0.1% gelatin and
o
the cells centrifuged at lOOg for 10 minutes at 20C. The pellet was
finally resuspended in the required volume.
2.0 MONOCYTE PURIFICATION USING MICROEXUDATE COATED FLASKS.
PREPARATION OF MICROEXUDATE COATED FLASKS.
Microexudate coated flasks were prepared as previously
described (Ackerman & Douglas 1978). Hep-2 cells were grown to
confluence in tissue culture flasks (Sterilin, 75cm2) in MEM + 10%
F.C.S. for 3 to 4 days. The culture medium was decanted, replaced
with 10 to 15 mis of lOmM EDTA and incubated for 15 to 20 minutes.
The detached cells were then decanted, the flasks thoroughly rinsed
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with HBSS arid inspected to ensure complete reToval of all cells.
The flasks were stored at 4°C until ready for use.
PURIFICATION OF MONOCYTES
After separation of mononuclear cells from 20mls of venous
blood the cells were resuspended in lQmls of MEM + 20% F.C.S. and
transferred to a microexudate coated flask.The flask was incubated
©
for 1 hour at 37C, following which nonadherent cells were washed
out with three, 10ml aliquots of warm (3~fc) MEM + 20% FCS. The
adherent monocyte rich population was recovered by 20 minutes
further incubation at 37C with 2.Cmls of lCmM EDTA and 5mls MEM +
20%FCS. The cells were then washed out with three, lCml aliquots of
MEM + 20% F.C.S., centrifuged at 200g for 10 minutes at 2cfc and the
pellet resuspended in 3mls MEM + 20% AB serum.
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SECTION III: PREPARATION OF PHAGOCYTIC PARTICLES
1.0 PREPARATION OF YEAST
PREPARATION OF CANDIDA ALBICANS
C. albicans was grown aerobically in nutrient broth with 1%
6
glucose at 37C for three days, washed three times in normal saline
and killed by heating at 9CC for 40 minutes.The killed yeast were
washed three times in saline
PREPARATION OF SACCHARQMYCES CEREVISIAE (BAKERS YEAST)
Commercial bakers yeast were suspended in saline and dispersed
by repeated syringing through a hypodermic needle. The yeast were
killed by heating at 9db for 40 minutes, then washed three times in
saline.
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SECTION IV: MEASUREMENT OF RATES OF PHAGOCYTOSIS
1.0 GENERAL CONSIDERATIONS AND DESIGN OF METHOD.
It was decided that any method chosen for the study of rates
of phagocytosis by monocytes should meet the following
requirements.
i) Phagocytosis by monocytes should be measured in cells in
suspension rather than in adherent cell monolayers to avoid
artificial selection of more activated subpopulations of cells.
ii) To avoid in vitro activation and alteration of functional
properties which might mask the true in vivo functional state of
monocytes, the method should use cells freshly obtained frcm
subjects and long incubations should be avoided.
iii) The method, while following kinetic principles, should also
be reasonably rapid and appropriate for use in a clinical setting.
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2.0 MEASUREMENT.1 OF RATES OF PHAGOCYTOSIS USING A DIRECT MICROSCOPIC
METHOD.
Monocytes were separated from 20mls of venous blood using
microexudate coated flasks as described above. The cells were
6
resuspended to 10 /ml in Eagles MEM + 20% AB serum.
Heat killed C. albicans were used as the phagocytic particle
6 .
ana were resuspended to make a stock suspension of 2x10 /ml.
The phagocytic assay was carried out as follows. O.lmls of
cell suspension, 0.3mls of MEM + 20% AB serum and 0.1ml of yeast
suspension were added to screw topped plastic tubes (NUNC, 3.0ml).
Pairs of tubes were incubated for 15, 30, 60 and 120 minutes in a
shaking water bath at 37C. Each tube was mixed thoroughly and an
aliquot of suspension used to prepare a cytocentrifuge slide. The
slides were stained with Jenner-Giemsa and mounted under
coverslips. To assess phagocytosis at each time interval the number
of intracellular yeast in 100 monocytes, and the percentage of
monocytes actively phagocytosing were counted under the light
microscope.
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3.0 MEASUREMENT OF CELL LOSSES FROM SUSPENSION DURING INCUBATION.
Using the above method it was apparent that after incubation
o
of cells at 37C there was rapid loss of cells frcm suspension and
therefore incomplete recovery of monocytes for assessment of
phagocytosis.
To quantify cell losses from suspension during incubation,
mononuclear cells were incubated as before, but without the
addition of yeast. At timed intervals the supernatant was sampled
and the number of cells in suspension counted using the Coulter
counter. After 90 minutes of incubation 0.5mls of 5mM EDTA was
added to each tube and the tubes incubated for a further 30 minutes
before sampling the supernatant again.The incubations were
performed either in plastic NUNC tubes (3.0ml), siliconised glass
tubes (5.0ml), moulded Teflon (PTFE) (5.0ml) tubes or in round
bottomed wells machined frcm a small block of Teflon (Klinger
plastics). The volume of each well was 500ul, and diameter 8mm.
In sane experiments the Coulter Channeliser was used to
determine the relative numbers of lyrrphocytes and monocytes in
suspension at each tine interval.
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4.0 MEASUREMENT OF RATES OF PHAGOCYTOSIS USING AN INDIRECT
MICROSCOPIC METHOD.
Mononuclear cells were separated from 20mls of venous blood as
described and resuspended in 1ml of HBSS+10%AB serum to an
approximate final concentration of 10 monocytes/ml unless otherwise
indicated. The exact concentration of monocytes was determined
using the Coulter Counter as described. Heat killed C. albicans
were resuspended in HBSS+O.1% gelatin to a final concentration of
7.5xl07/ml. 300ul of mononuclear cells and 20ul of yeast suspension
O
were incubated in the well of a Teflon block at 37C on a turntable
at 20rpm, canted at 45degrees. 40ul of cell suspension were removed
at 0, 15, 30 and 60 minutes, diluted in 200ul of counting fluid and




5.0 INVESTIGATION OF ERRORS DUE TO VARIATION IN HAEMACYTOMETER
COUNTS.
In the preliminary experiments it was found that there was
considerable variation in yeast counts between individual
haemacytometers and this was clearly a potential source of error in
the measurement of rates of phagocytosis. To determine the number
of haemacytometer counts which should be performed to minimise
errors due to inter-haemacytometer variation the following
experiment was conducted. 150ul of yeast suspension and 150ul of
HBSS were dispensed into the six wells of a Teflon block without
mononuclear cells. lOOul of yeast were removed from each well,
diluted in a single lQnls aliquot of counting fluid, and the
suspension loaded into one chamber of each of twelve double-chamber
haemacytometers. The procedure was then repeated and the opposite
chamber of each haemacytometer loaded. To determine the number of
haemacytometers required to obtain an identical mean count frcm
opposite chambers, 12 separate counts were performed and the number
of yeast counted in each haemacytcmeter chamber recorded
separately. The experiment was performed six times.
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6.0 ELECTRON MICROSCOPIC S1UDIES ON PHAGOCYTOSED YEAST
To obtain qualitative confirmation that yeast phagocytosis was
occurring, electron microscopic studies on mononuclear cells were
carried out after incubation of mononuclear cells with yeast for 5
and 10 minutes using the assay conditions described above.
After incubation the cells and yeast were diluted with cold
fixative (5% glutaraldehyde in 0.1M sodium cacodylate buffer pH7.2)
and then pelleted by centrifugation. The pellet was washed three
times in 0.3M sucrose in 0.1M sodium cacodylate buffer and then in
O
0.05M sodium cacodylate with 1% osmium tetroxide for 1 hour at 4C.
The pellet was then given three, 5 minute washes in each of 10%
ethanol, absolute ethanol and epoxypropane. Following this, the
€
pellet was mounted in araldite and allowed to set at 40C prior to
the preparation of thin sections for electron microscopy.
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7.0 MEASUREMENT OF PHAGOCYTIC RATE CONSTANT USING PREOPSONISED
YEAST.
METHOD FOR MEASUREMENT OF PHAGOCYTIC RATE CONSTANT IN CONTROLS AND
PATIENTS
Mononuclear cells were separated from lOmls of venous blood
and resuspended in approximately 1.3mls HBSS+0.1% gelatin giving a
final concentration of between 2.0 and 4.0x106monocytes/ml. The
exact concentration of monocytes was determined on the Coulter
Counter. 150ul of monocyte suspension and 150ul of preopsonised
yeast (vide infra) were dispensed into the six wells of a Teflon
block. lOOul aliquots were removed immediately after mixing and all
six aliquots added to a single lOmls aliquot of counting fluid.
O
After 20 minutes incubation at 37C on a turntable a further lOOul
aliquot was raroved from each well and added to a second 10mls
aliquot of counting fluid. The number of yeast remaining
extracellular at the two time points were counted in opposite sides
of twelve haemacytometers.
The phagocytic rate constant "K" was calculated from:
K = (1/t/Mo) x ln(Yo/Yt) mls/min/monocyte,
where t = minutes, Mo = monocyte/ml, Yo and Yt are the
extracellular yeast concentrations at 0 and t minutes respectively.
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PREPARATION OF PREOPSONISED YEAST PARTICLES
The optimum ratios of yeast to opsonins were established by
dose response control studies described in the results.
OPSONISAT10N OF CANDIDA ALBICANS WITH HUMAN SERUM
0.1ml of heat killed C. albicans (7xlC? yeast/ml) were
preopsonised prior to each experiment in 2.5mls of human AB serum
O
at 37C for 30 minutes. The opsonised yeast were then washed in
excess HBSS and resuspended in 1ml of HBSS+0.1% gelatin giving a
final concentration of between 1.0 and 1.5xl07/ml.
OPSONISAT'ION OF CANDIDA ALBICANS WITH POOLED HUMAN IgG
Heat killed C. albicans were opsonised in bulk with purified
human IgG (S.E.Scotland & Edinburgh Blood Transfusion Service) in a
g
ratio of 10 C. albicans/50mg IgG/2mls of PBS. Opsonisation was
o
carried out at 37C for 60 minutes in plastic universal containers
(Sterilin), following which the yeast were washed twice in
HBSS+0.1% gelatin, resuspended to 107/ml and stored in 1ml aliquots
in liquid nitrogen until ready for use.
Tnis particle was used for measurement of Fc receptor mediated
phagocytosis.
OPSONISATION OF SACQiARQMYCES CEREVISIAE WITH HUMAN SERUM
Heat killed S. cerevisiae were opsonised in bulk with fresh
normal human serum frcm a single donor in a ratio of
? 0
5x10 yeast/2Cmls serum. Opsonisation was carried out at 37C for 30
minutes in plastic universal containers (Sterilin), following which
the yeast were washed twice in HBSS+0.1% gelatin, resuspended to
198
107/ml and stored in 1.0ml aliquots in liquid nitrogen until ready
for use.
This particle was used for measurement of "complement"
receptor mediated phagocytosis.
199
CONTROL STUDIES ON THE TYPE OF OPSONINS PRESENT ON YEAST' PARTICLES
In these experiments preopsonised yeast (serum treated S.
cerevisiae or IgG treated C. albicans) were incubated with F(ab)2
fragments of IgG anti-complerrent and anti-Fc antibodies (American
Hospital Supplies) prior to offering the yeast for ingestion in the
direct phagocytic assay. The inhibitory effects of anti-Clq,
C4, C3/C3c, ^1H and Fc on phagocytosis were then studied.
Preparation of Flpti/2 fragments:
Eh$2 fragments of IgG antibodies were prepared as previously
described (Nisonoff et al 1960). The IgG was dialysed against
several changes of acetate buffer (0.07M acetate buffer pH4.0 in
0.05M sodium chloride) for 24 hours. The IgG was incubated with
pepsin (3mg pepsin/lOQmg protein) in a water bath at 3it for 18
hours. The pH was then adjusted to 8.0 with IN NaOH and dialysed
against several changes of borate buffered saline pH 8.0. The F(aloj2
fraction was further purified on a Sephadex G150 column, and
concentrated by pervaporation. The protein concentration was
obtained from the absorbance at 28Qrtu using an extinction
coefficient of 13.8.
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8.0 MEASUREMENT OF PERCENTAGE OF PHAGOCYTIC CELLS IN MIXED
MONONUCLEAR CELL POPULATIONS USING A DIRECT' MICROSCOPIC METHOD.
To assess the percentage of "complement" receptor and Fc
receptor positive phagocytic cells in a mixed mononuclear cell
(lymphocytes and monocytes) suspension the direct microscopic
method of measuring phagocytosis (Section 2.0) was used in modified
form.
Mononuclear cells were separated from lQmls of venous blood
and resuspended in approximately 1.3mls HBSS+O.1% gelatin giving a
6
concentration of between 2.0 and 4.0x10 monocytes/ml. The exact
concentration of cells was determined both by Coulter sizing and
NSE staining. 150ul of monocyte suspension and 150ul of either
complement coated S. cerevisiae or IgG coated C. albicans were
a
dispensed into the wells of a Teflon block, and incubated at 37C on
a turntable, at a 45 degree cant, rotating at 12RPM. After 40
minutes of incubation a lOOul aliquot was removed diluted in lCmls
of cold HBSS+0.1% gelatin and cytocentrifuge slides prepared. The
slides were stained with nonspecific esterase and the percentage of
phagocytic cells was estimated microscopically frcm a count of at
least 200 mononuclear cells.
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9.0 IN VITRO CULTURES OF MONONUCLEAR CELLS
For experiments in which mononuclear cells were studied in
monolayers in vitro the following procedure was used. Mononuclear
cells were suspended in RK4I 1640 supplemented with 20% fetal calf
O
serum (heat inactivated 56C for 60 minutes), glutamine (20mM),
penicillin ana streptomycin. 1.0-2.Cmls of mononuclear cell
£
suspension (10 /ml) were plated onto glass coverslips in round
flatbottomed plastic culture dishes (Linbro, 12 well, 2.4xl.7cms,
C
capacity 7.5mls), and incubated in 5%C02/air at 37C. After one hour
the nonadherent cells were washed off with 2 or 3 aliquots of warm
media.
Monolayers were assessed at different tines for %age of
phagocytic and NSE positive cells. To determine the %age of
phagocytic cells duplicate coverslips were overlaid with either
"complement" or IgG coated yeast (0.5-1.0mls of stock suspension)
for 40 minutes, the coverslips washed gently to remove excess yeast
and then stained with NSE/methyl green. A count of at least 200
cells was performed to determine the %age of phagocytic cells.
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SECTION V . METHODS FOR DETECTING AND MEASURING SERUM COMPLEMENT,
IMMUNE COMPLEXES AND AUTOANTIBODIES.
1.0 STORAGE OF SERUM AND EDTA PLASMA.
Serum was separated from whole blood which had been clotted at
roctn temperature for 20-30 minutes. The serum was then stored
immediately in 0.5ml aliquots in liquid nitrogen until ready for
use.
EDTA plasma was obtained by collecting 4mls of whole blood
into potassium EDTA tubes (Brunswick BS4851) and centrifugation at
room temperature. Plasma was stored in 0.5ml aliquots in liquid
nitrogen until ready for use.
2.0 MEASUREMENT OF SERUM C3 AND C4.
Serum C3 and C4 were measured by radial inmunodiffusion using
commercially available kits (Seward Laboratories Immunostics).
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3.0 MEASUREMENT OF SERUM ANTICOMPLEMENTARY ACTIVITY.
Test sera are incubated with guinea-pig serum (GPC) and extent
of ccnplement consumption assayed by measurement of reduction in
hae-rolytic activity using sensitised erythrocytes (RBC). Complement
fixation diluent (CFr) is used throughout as buffer.
Sensitised erythrocytes (EA) are prepared by incubating RBC
e>
at 37C with a predetermined subagglutinating concentration of
anti-SRBC haemolysin, followed by two washes and dilution to give a
10% suspension.
GPC is reconstituted with 2ml of distilled water and allowed
to stand for 15 minutes, following which the solution is diluted to
1/10 with 18mls of CFD at 4C.
The GPC is next titrated to determine the highest dilution
which causes complete SRBC lysis. Dilutions of GPC are prepared by
dilution with GPC (1/10, 1/20, 1/30.. .1/100). 50ul of each dilution
is transferred to a "U" microtitre plate. 50ul of CFD and 50ul 2.5%
O
EA are added to each well, mixed and incubated at 37C for one hour,
with further agitation after 30 minutes. The plate is spun at
l,000rpm for 5 minutes. The highest dilution of GPC causing
complete EA lysis is recorded (100 H.D.).
Test sera, including a positive and negative control, are
taken from liquid nitrogen and heat inactivated for exactly 30
minutes at exactly 56C.
TO perform the anti-ccmplementary assay, 50ul of CFD is added
to each test well followed by 50ul of heat inactivated serum to
well number one. Using a 50ul microdilutor, the samples are double
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diluted to well twelve. Next 50ul of CFD and 50ul of 2X100 H.D. are
O
added and the wells mixed and incubated at 4C overnight. 50ul 2.5%
O
EA are added to all wells, mixed and incubated at 37C for 1 hour.
The plates are shaken again after 30 minutes. The plates are then
spun for 5 minutes at lOOOrpn.
Each well is scored according to the extent of EA lysis on a
scale (100% lysis = 0; 75% lysis = +1; 50% lysis = +2; 25% lysis =
+3; No lysis = +4). The anticomplementary titre is the last
dilution of serum exhibiting 50% lysis (i.e. a score of +2).
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4.0 MEASUREMENT OF SERUM Clq BINDING ACTIVITY.
PURIFICATION OF Clq
Clq was prepared according to the method of Yonanasu and
Stroud (1971).
The following buffers are used:
0.026M EGTA pH7.5
0.06M EDTA pH5.0
0.75M NaCl, 0.02M acetate, O.OIM EDTA pH5.0
0.75M NaCl, 0.02M acetate, O.OIM EDTA pH7.5
40Cmls of blood was obtained from a starved volunteer and
collected into 2 blood bottles treated with Repelcote and filled
with paper clips. The blood was then defibrinated, the serum
separated and centrifuged at 10,000g (J2.21, angle head rotor, 15ml
O
Corex glass tubes, 9,000 rpm) at 4C for 20 minutes.
The surface layer of lipid is removed and discarded. The
volume of serum is noted and a 0.5ml aliquot saved.
The serum is dialysed against 0.026M EGTA pH7.5: 11. for 1
O
hour, 21. for 2 hours, 21. overnight at 4C. The dialysed serum is
centrifuged at 10,000g for 20 minutes at 4*b in 3Cml Corex glass
tubes, the supernatant removed, a small aliquot saved and the
remainder discarded. The precipitate is washed with 30ml 0.026M
EGTA pH7.5, and the centrifugation repeated. Again the supernatant
is discarded except for a small aliquot.
The precipitate is creamed into 0.75M NaCl, 0.02M acetate
buffer containing O.OIM EDTA pH5.0. The redissolved protein is
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O
pooled to a final volume of 3Cml, centrifuged at 5,O0Og at 4C for
20 minutes, and the supernatant decanted. An aliquot is saved.
The supernatant is dialysed against 0.06M EDTA pH5.0: 11. for
one hour, 21. for one hour, 21. for two hours at <fc. The dialysate
is centrifuged at 10,00Og for 20 minutes at 4^, the supernatant
removed, an aliquot saved and the remainder discarded. The
precipitate is washed with 30ml 0.06M EDTA, and centrifuged at
10,000g for 20 minutes at <fc. The supernatant is reroved, an
aliquot saved and the remainder discarded. The precipitate is
creamed into 15ml of 0.75M NaCl in 0.02M acetate buffer containing
0.01M EDTA pH7.5. The resolubilised protein is centrifuged at
5,000g for 20 minutes at $Z, and the supernatant decanted avoiding
insoluble aggregates. The supernatant is dialysed overnight at 4C




Each fraction is analysed by radial immunodiffusion (RID). For
analysis of immunoglobulin fractions, buffer A (Tris hydroxynethyl
methyl amine 2.42g + glycine 6g + disodium 3.72g + NaCi 8.78g to 1
litre) is used and for Clq, buffer B (sodium barbitone 9.3g
barbitone 1.3g to 1 litre) is used.
Protein Buffer Antibody Volume Dilution of normal
to be (DAKO) of serum for standard
estimated antibody
IgA B A092 170ul 1/1, 2, 4, 8, 32.
IgG B A090 55ul 1/16, 32, 64, 128, 512
IgM B A091 55ul 1/1, 2, 4, 8, 32.
Clq A A136 lOul 1/1, 2, 4, 8.
Radial immunodiffusion plates are prepared with 10ml of Seakem ME
agarose (1%) per plate, a well diameter of 3nm and a sample volume
of 5ul. The plates are incubated in a humid atmosphere for 48
hours, washed, pressed and stained.
The protein concentration of the Clq fraction is obtained from
the optical density at 280nm (0D280 at lmg/ml is 0.682).
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PREPARATION OF RADIOLABELLED Clq
O
Reagents are prepared on the day of use and kept at 4C in iced
water:
1) Lactoperoxidase 5mg (SIGMA) - lOOul + 400ul PBS
2) Hydrogen peroxide 30% w/v - 2ul + lCml PBS
3) 2-mercaptoethanol 3.5ul + lCtnl PBS
4) Potassium iodide lOrrg + lCml PBS
O
An aliquot of Clq is thawed rapidly at 37C in a water bath,
transferred to a glass tube and placed in ice. The following
reagents are then added in order:
50ul of lacboperoxidase, 500 uCi (5ul) of IMS—30 (125)iodine, 50ul
O
of hydrogen peroxide, mixed well and incubated at 4C for 15
minutes. Then add 2.5ml of 2-mercaptoethanol and 250ul of potassium
iodide and mix well. The reaction mixture is transferred to visking
tubing and dialysed overnight against PBS.
The radiolabelled Clq is diluted with 1%BSA/PBS to a final
volume of lCml. Aliquots are stored in the vapour phase of liquid
nitrogen.
209
125-10DINE Clq BINDING ASSAY FOR IMMUNE COMPLEXES
In the assay, test sera are incubated with purified
radiolabelled Clq; irrmune complexes binding to Clq are selectively
precipitated from solution with polyethyleneglycol.
The following reagents are required:
1%BSA/PBS - O.5mls 20% BSA + 9.5ml PBS; 0.2M EDTA pH7.5; 0.1M
borate buffer pH8.3.
An aliquot of labelled Clq in 1%BSA/PBS is transferred to a
15ml glass Corex tube and centrifuge at 18,000g (J2-21, 16,000 rpm)
for 1 hour at 4C. 50ul test serum and lOOul 0.2M EDTA are added to
°
duplicate LP3 tubes, mixed and incubated for 30 minutes at 37C. The
tubes are transferred to an ice bath, 50ul of the spun Clq added to
each and mixed. 1ml of 3% PEG in borate buffer is added immediately
and the tubes incubated on ice for 1 hour. The tubes are
o
centrifuged at 1500g for 20 minutes at 4C, and the supernatant
decanted. Each tube is capped and then counted in a garrma counter
(minimum count 10,000 in every tube). A control tube of known Clq %
binding activity is assayed in each run and unknowns are calculated
in relation to this control. Duplicates varying by more than 10%
are repeated. (Normal range 0-20%).
210
5.0 MEASUREMENT OF RHEUMATOID FACTOR TITRES.
Rheumatoid factor titres were measured by agglutination of
human erythrocytes (RBC) sensitised with subagglutinating titres of
sheep IgG anti-human group O, Rhesus negative RBC (Pudliachouk et
o
al 1958). All sera were heat inactivated at 56C for 30 minutes and
tested at doubling dilutions (lowest 1/20) on an agglutination
plate. Occasional control wells showed agglutination of
unsensitised RBC and in these cases the sera (1/20) was adsorbed
o
with an equal volume of unsensitised RBC for 1 hour at 37C before
retesting.
6.0 MEASUREMENT OF ANTI-NUCLEAR ANTIBODY TITRES.
Antinuclear antibodies were detected by indirect
inmunofluorescence using human blood polymorphonuclear neutrophils
as substrate (Alexander et al 1960). Smears of human capillary
blood were made on methanol cleaned glass slides, fixed in 95%
ethanol for 15 minutes and air dried for 15 minutes.
Test serum saxqples (minimum dilution 1/20) and positive and
negative controls were placed on marked areas of the smear and
incubated at room temperature for 30 minutes in a damp chamber.
Slides are washed X3 in PBS, following which swine anti-human
gamma-globulin (FITC) (1/20) is added and the slides further
incubated for 30 minutes. The slides are washed X3 in PBS and
examined under PLQEM illumination for nuclear fluorescence.
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7.0 DETECTION OF PRECIPITATING ANTIBODY TO SALINE SOLUBLE CELLULAR
ANTIGENS.
Antibodies to Sm and nRNP were detected using human spleen
extract and antibodies to Ro and La using calf thymus extract
(Mattioli & Reichlin 1971).
Fresh human spleen extract was homogenised in PBS, centrifuged
to remove debris and the soluble extract dialysed against O.OIM
O
phosphate buffer pH7.2 for 6 hours at 4C. After dialysis the
extract was equilibrated with with DE52 gel in O.OIM phosphate
O
buffer pH7.2 at 4C. The gel was vacuum filtered and washed with
o
O.OIM phosphate buffer pH7.2 at 4C. The gel was then placed in
0.15M NaCl/O.OlM phosphate pH7.2 at 4C overnight with stirring. The
gel was again filtered at the Buchner and then placed in 0.5M
NaCl/O.OlM phosphate buffer pH7.2 overnight with stirring. The gel
was filtered and the filtrate collected and centrifuged to remove
any DE52 particles and then concentrated by pervaporation. After
concentration, the extract was dialysed against 0.15M Na/Cl/O.OIM
phosphate buffer pH7.2 overnight. The extract was then used
directly in Ouchterlouny plates for detection of ant-Sm or anti-RNP
antibodies using control sera showing a line of identity with sera
obtained frati Drs Tan and Reichlin.
Commercially available dried calf thymus extract (Pel-Freeze)
was rehydrated with PBS, homogenised and centrifuged to remove
debris. The soluble supernatant was concentrated by pervaporation.
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7.0 MEASUREMENT OF ANTI-DNA BINDING ACTIVITY
Serum anti-DNA binding activity was performed using the Farr
technique (Amersham Radiochemicals). These measurements were
performed by Dr K.C. Watson, Dept of Bacteriology, Western General
Hospital, Edinburgh.
9.0 STATISTICS.
Parametric and non-parametric statistics were applied as
appropriate and the precise methods used are indicated where




SECTION I: PURIFICATION OF CELLS.-
1.0 MONOCYTE YIELDS FROM FICOLL-HYPAQUE DENSITY GRADIENT AND
MICROEXUDATE COATED FLASKS.
A pilot study of the method for mononuclear cell separation
from 2Cmls of normal blood (n=7) (Table 6.1) showed that recovery
of monocytes from a Ficoll-Hypaque gradient was greater than 90%
and gave a mononuclear fraction comprising 20% monocytes and 80%
lyirphocytes. After further purification of adherent cells in
microexudate coated flasks, a monocyte enriched fraction was
obtained containing 85% monocytes but with reduction of overall
monocyte recovery to 50%. The viability of cells assessed by trypan
blue was greater than 94%.
Table 6.1 Mean monocyte yields (+/-SD) from density gradient and
microexudate coated flasks (n=7).
FRACTION TOTAL WBC Mo % Mo yield Recovery
Whole 120x10* 6.1 7.1x10* -
blood (+/-29) (+/-2)
Mononuclear 32x10* 20.4 6.5x10* 91.5%
fraction (+/-7) (+/-5)
Adherent cell 4.2x10* 84.5 3.6x10* 50.1%
fraction (+/"2) (+/-5)
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SECTION II: IDENTIFICATION OF MONOCYTES AND LYMPHOCYTES.
1.0 INTRODUCTION.
The size distribution of mixed mononuclear cells, purified
lymphocytes, and purified monocytes were studied by performing cell
counts within different "size window" settings on the Coulter
counter ranging from 5.6 to 11.3 microns. Additionally sate size
distribution studies were performed using a "Coulter Channeliser"
(loaned by the Coulter Company Inc). The latter enabled a
continuous size-number distribution curve to be plotted on an X-Y
plotter.
Numbers and percentages of monocytes and lyirphocytes
estimated by Coulter sizing were compared with NSE stains on (i)
mixed mononuclear cells (ii) lymphocytes and monocytes purified in
microexudate coated flasks.
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2.0 SIZE DISTRIBUTION- OF MONONUCLEAR CELLS AND IDENTIFICATION OF
MONOCYTES BY VOLUME AND STAINING FOR NON SPECIFIC ESTERASE.
A typical size histogram of mononuclear cells obtained after
Ficoll-Hypaque sedimentation is shown in Fig II.1A. The majority of
mononuclear cells have a diameter greater than 6.2 microns. After
depletion of adherent cells in microexudate coated flasks, the
majority of large cells with diameter greater than 7.8 microns have
been removed (Fig II.IB). Staining of the non-adherent cells with
NSE confirmed that less than 5% were NSE positive monocytes. After
recovery fran the flasks, the adherent cells were found to be
composed mainly of large cells with diameter greater than 7.8
microns (Fig II. 1C) and 80% were NSE positive monocytes. The same
result is graphically illustrated by use of the Coulter Channeliser
which demonstrate the presence of two cell populations - one small
and nonadherent, the other large and adherent; size distribution
curves before and after depletion of adherent cells are shewn in
Fig II.2. The size distribution of adherent cells after recovery
with EDTA is shown in Fig II.3
Differential counts of monocytes in mononuclear cell
populations obtained frcm normal subjects determined by NSE
staining (Fig II.4) correlated well with counts obtained by Coulter
sizing in which lymphocytes were defined as cells of diameter 6.2
to 7.8 microns and monocytes were defined as mononuclear cells with
diameter greater than 7.8 microns (i.e. volume >250 cub
microns)(Fig II.5) (n=19;r=0.78;p<0.001).
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Figure II.1 Size (cell diameter,'microns) distribution histogram of
mononuclear cells:
A - Mixed lymphocyte and monocyte population frcm
Ficoll-Hypaque density gradient (20% NSE positive)
B - Mononuclear cells after depletion of adherent cells (<5%
NSE positive)
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Figure II.2 Coulter "Channeliser" plot of size distribution of
mononuclear cells before and after depletion of adherent cells:
("Channel number" represents arbitrary units of cell size)
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Figure II.3 Coulter "Channeliser" plot of size distribution of
adherent mononuclear cells after recovery with EDTA:
("Channel size" represents arbitrary units of cell size)
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Figure II.4 Typical appearance of monocytes stained with
nonspecific esterase (NSE) and alpha-chloroacetate esterase.
Monocytes stain diffusely brown for NSE and occasionally have blue,
paranuclear, chloroacetate-positive staining as well. Lynphocytes
are counterstained with methyl green and same contain one or two
NSE positive granules:
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Figure 11.5 %ages of monocytes in mixed mononuclear populations.
Differential counts obtained by NSE staining correlate well with
the Coulter "sizing" method in which monocytes are defined as cells
of volume greater than 250 cub microns (n=19;r=O.78;p<0.001):
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SECTION III. RESULTS OF PHAGOCYTIC S1UDIES -
DEVELOPMENT OF METHODS AND CONTROL STUDIES
1.0 MEASUREMENT OF RATES OF PHAGOCYTOSIS USING DIRECT MICROSCOPIC
ME'IHOD.
TIME COURSE.
The method is described above (pl90). The time coarse of
phagocytosis of serum opsonised C. albicans over 120 minutes is
shown in Fig III.l. Each point represents the mean (+/- s.e.m.) of
three experiments. The mean (+/- s.d.) monocyte concentration was
6 6
0.2x10 /ml (+/- 0.01) and mean yeast concentration 0.4x10 /ml. The
phagocytosis of unopsonised yeast was also studied (n=l);
unopsonised yeast were phagocytosed, but at a very slow rate.
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Fig III.l Time course of phagocytosis of C. albicans by monocytes
in presence (X) or absence (o) of 20% human AB serum.




Several problems were apparent with this method. Firstly
because of the formation of clumps of cells and yeast, particularly
at later stages in the time course, it was difficult to determine
whether,yeast were ingested or not (Fig III.2). This may have been
due in part to the generation of complement activation products by
the action of yeast on fresh serum, and in later experiments using
a direct microscopic method of assessing phagocytosis, preopsonised
particles were used. Furthermore, calculation of the percentage of
phagocytosing monocytes was liable to error because the Jenner
Giemsa stain does not reliably distinguish between lymphocytes and
monocytes and it was difficult to determine the number of monocytes
present in clumps. The method was also time consuming and a single
experiment, including cell separation, took approximately five
hours. Finally it was apparent from the stained slides that there
was rapid loss of mononuclear cells frcm suspension during
incubation with yeast and therefore only incomplete recovery of
monocytes for assessment of phagocytosis (vide infra). This was
clearly a potential source of error in assessing rates of
phagocytosis and percentages of phagocytic cells.
For these reasons alternative methods of assessing rates of
phagocytosis were investigated. Additionally, since the loss of
cells from suspension was a potential source of error in future
experiments, this was investigated to see whether the problem could
be minimised.
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Fig III.2 Microscopic appearance of yeast and monocytes after 60
minutes of incubation in 20% AB serum.
Large clumps of monocytes and yeasts form during incubation making




2.0 RESULTS OF STUDY OF CELL LOSSES FROM SUSPENSION DURING
INCUBATION.
After incubation of mononuclear cells without the addition of
yeast, there was rapid loss of cells fran suspension and by 30
minutes over 60% of cells had been lost (Fig III.3). After further
incubation with EDTA, the cells were completely recovered,
confirming that they had adhered to the walls of the container. An
identical result was obtained with plastic tubes (NUNC, 3ml),
siliconised glass tubes (5ml) and sintered Teflon tubes.
Using the Coulter channeliser, it was shown that these cell
losses were due to selective depletion of monocytes (Fig III.4).
However, mononuclear cells incubated in wells machined from
Teflon block remained in suspension for up to 60 minutes (Fig
III.5), without selective depletion of monocytes. In all subsequent
experiments mononuclear cells were incubated in the wells of a
Teflon block.
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Fig III.3 Cell losses due to adherence to incubation tube.
After incubation in a variety of plastic or siliconised containers,
mononuclear cells were rapidly lost frm suspension, but could be
recovered by further incubation with EDTA (2mM final). The diagram
shows a representative experiment.
CELL LOSSES DUE TO ADHERENCE DURING
INCUBATION OF CELL SUSPENSION IN VARIOUS
TUBES ( PLASTIC, SILIC. GLASS . P.T.F.E.)
0 30 60 90 120
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Fig III.4 Coulter "Channeliser" 'size distribution plot of
mononuclear cells in suspension before ( ) and after 30 minutes
( ) incubation in plastic or glass tubes.
Cell losses were almost entirely attributable to loss of the large
cell population (i.e. monocytes).
("Channel number" represents arbitrary units of cell size)
DISTRIBUTION OF A "MONOCYTE-RICH" POPULATION - SELECTIVE
DEPLETION OF MONOCYTES AFTER INCUBATION AT 37°C
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Fig III.5 Coulter size histogram of mononuclear cells before ( )
and after 60 minutes ( ) incubation in machined, round-bottared
Teflon wells (n=2).
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3.0 MEASUREMENT OF RATES OF PHAGOCYTOSIS USING AN "INDIRECT"
MICROSCOPIC METHOD - INITIAL CONTROL STUDIES.
INTRODUCTION.
In view of the difficulties experienced in assessing rates of
phagocytosis by direct microscopic evaluation of ingested yeast, an
alternative "indirect" method described by Leijh et al (1977) was
investigated. In this method, the uptake of yeast is followed by
counting numbers of extracellular yeast in haemacytometers using
diluted aliquots of yeast-monocyte suspension which have been
incubated for timed intervals. No attempt is made to count ingested
yeast particles. The method is described on pl93.
TIME COURSE IN ONE INDIVIDUAL.
Using this "indirect" method the time course of phagocytosis
was measured using mononuclear cells from one individual on 12
separate occasions.
The time course of phagocytosis is shown in Fig III.6.
Disappearance of yeast from suspension is rapid and is expressed as
the %age (+/-s.d.) of yeast remaining extracellular at each time
point. The mean (+/- s.d.) monocyte concentration was
5.39(+/-0.92)xl06/ml.
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Fig III.6 Time coarse of phagocytosis by monocytes from one
individual (n=12).
STUDY OF ONE INDIVIDUAL
CONTROL











TIME COURSE IN NORMAL CONTROL SUBJECTS AND EFFECT OF N-ETHYL
MALEIMIDE AND TEMPERATURE ON PHAGOCYTOSIS.
The time coarse of yeast uptake was next measured in monocytes
frcm 20 normal controls using the "indirect" method and, to confirm
that disappearance of yeast reflected phagocytosis rather than
adherence, the effect of temperature and N-ethyl maleimide on yeast
uptake were studied.
Using monocytes frcm the normal controls, yeast uptake was
rapid and reproducible (Fig III.7). The mean (+/- s.d.) monocyte
concentration was 5.4 (+/-0.72)xlO'/ml and mean yeast concentration
5.3(+/-0.86)xl06/ml.
Ten minutes preincubation of mononuclear cells in lmM N-ethyl
maleimide resulted in 89% inhibition of yeast uptake at 15 and 30
minutes of incubation (Fig III.7), confirming that disappearance of
yeast depended on anaerobic glycolysis. EDTA also caused marked
inhibition of phagocytosis demonstrating a requirement for divalent
cations.
©
Similarly when the experiment was conducted at 4C, 90%
inhibition of yeast phagocytosis occurred (Fig III.7), confirming
the requirement for metabolic processes.
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Fig III.7 Time course of phagocytosis by monocytes from 20 normal
controls and effect of temperature, N-ethyl maleimide and EDTA.
PILOT STUDY - NORMALS + METABOLIC CONTROLS
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RESULTS OF ELECTRON MICROSCOPY ON PHAGOCYTOSING MONOCYTES.
To obtain qualitative confirmation that yeast phagocytosis was
occurring, electron microscopic studies were carried out on
monocytes after short incubations with yeast.
Electron microscopy of monocytes after 5 and 10 minutes
incubation with yeast showed that ingestion was rapid and numerous
monocytes containing yeast were seen. Typical electron micrographs
showing phagocytic vacuoles are shown in Fig III.8a and 8b. At 5
minutes (Fig III.8a) , numerous ingested yeast were seen, while
after ten minutes, the phagocytic vacuoles had became swollen and
yeast disintegration was apparent (Fig III.8b).
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Fig III.8a Electron microscopy of monocytes phagocytosing yeast.
5 minutes after addition of yeast to monocytes numerous
phagocytosed yeast are seen and other yeast are bound by
pseudopodia. A lymphocyte and erythrocyte are also present.
(Mag X 8,000)
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Fig III.8b Electron microscopy of monocytes phagocytosing yeast.
10 minutes after addition of yeast to monocytes, the phagocytic
vacuoles are swollen and digestion of yeast is apparent.
(Mag X 12,000)
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4.0 KINETICS OF YEAST PHAGOCYTOSIS.
INTRODUCTION.
In the following experiments the tine coarse of phagocytosis
by monocytes fran a group of patients with rheumatoid arthritis was
compared with that obtained frcm normal controls, and the kinetics
of the "indirect" assay system evaluated with respect to yeast and
monocyte concentration.
TIME COURSE OF PHAGOCYTOSIS BY MONOCYTES FROM NORMAL CONTROL
SUBJECTS AND PATIENTS WITH RHEUMATOID ARTHRITIS.
The time course of yeast phagocytosis was similar in the 20
normal controls described above and 12 randomly selected patients
with uncomplicated RA (Fig III.9). The mean (+/- S.D.) monocyte




RA patients 5.98(+/-0.64)xl06 5.24(+/~0.63)xlc£
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Fig III.9 Time coarse of phagocytosis of C. albicans by monocytes
from normal controls (n=20) and RA patients (n=12) in the presence
of 10% AB serum:
The time course is identical in controls and RA patients.
KINETICS OF PHAGOCYTOSIS BY Mfl FROM
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KINETICS OF PHAGOCYTOSIS WITH RESPECT TO YEAST CONCENTRATION.
The disappearance of yeast from suspension appeared to be
exponential, suggesting that yeast uptake followed first order
kinetics:
Rate of yeast uptake = dY/dt = k x Y,
i.e. ln(Y) = k x t,
where Y = yeast concentration, t = time & k = a constant.
To test this hypothesis the time course data from the normal
controls was plotted as ln(Y) versus time (Fig III.10). A straight
line relationship was obtained over the first 30 minutes of
incubation confirming that over this time period the kinetics are
first order with respect to yeast concentration.
Thus, the rate of phagocytosis for a given monocyte
concentration is given by:
Rate of phagocytosis = dY/dT = ln(Yo/Yt)/t
where Yo and Yt are the yeast concentrations at time = 0 and t
minutes respectively.
239
Fig III. 10. Kinetics of phagocytosis by monocytes with respect to
yeast concentration. (Each point represents the mean +/- 1 S.D. of
20 experiments)
Disappearance of yeast from suspension is exponential i.e. yeast






KINETICS OF PHAGOCYTOSIS WITH RESPECT TO MONOCYTE CONCENTRATION.
To determine whether the rate of phagocytosis was proportional
to the monocyte concentration, the mean rate was measured over 30
minutes at three different monocyte concentrations: l.OxlO^/ml
& 6
(n=9), 2.5x10 /ml (n=5) and 5.0x10 /ml (n=5). The monocytes were
obtained fran a single donor (NPH).
Measurement of the rate of phagocytosis in the presence of
these three different monocyte concentrations confirmed that the
rate of phagocytosis is proportional to the monocyte concentration
(Fig III.11):
i.e.Rate of phagocytosis = (ln(Yo/Yt) )/t = K x Mo,
where Mo = monocyte concentration and K is a constant.
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Fig III. 11. Kinetics of phagocytosis with respect to monocyte
concentration:
The initial rate of phagocytosis of yeast is proportional to the
monocyte concentration. Each point represents the mean +/- SD.
Monocytes/ml
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5.0 PHAGOCYTIC RATE CONSTANT.
Since yeast uptake follows first order kinetics and the rate
of phagocytosis is proportional to the monocyte concentration, a
value for a phagocytic rate constant "K" can be obtained from the
expression:
K = (ln(Yo/Yt))/(t x Mo) mls/min/monocyte
K provides a measure of the efficiency of phagocytosis and is
analogous to the rate constant for a chemical reaction with two
first order reactants.
The results of the above studies indicated that measurement of
yeast uptake over a single 20 minute time interval would provide a
value for the phagocytic rate constant "K". This would provide a
measure of the efficiency of phagocytosis and obviate the need for
a lengthy time course. However to make the method suitable for
clinical use a number of modifications were made to the basic
methodology.
6.0 MODIFICATIONS TO EXPERIMENTAL METHOD FOR MEASUREMENT OF
PHAGOCYTIC RATE CONSTANT USING "INDIRECT" METHOD.
In order to reduce the volume of blood required for clinical
studies the mean final concentration of cells used in the
phagocytic assay was reduced from 5.0 to 1.5x10*monocytes/ml. To
attain this final concentration only lQnls of venous blood were
required.
To reduce possible interexperimental variation in degree of
opsonisation of phagocytic particles and to avoid exposure of
monocytes to complement activation products, all yeast were
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preopsonised in a single batch and stored in aliquots in liquid
nitrogen until ready for use. Experiments were also performed to
investigate the type of opsonins present on the preopsonised yeast
particles (vide infra).
To minimise errors due to pipetting, aliquots of cells and
yeast were placed in all six wells of the Teflon block in each
experiment, rather than only one well.
The method for monitoring the fall in extra-cellular yeast
concentration involves the use of haemacytometers and it was noted
that there was frequently wide variation in counts between
individual haemacytometers. Since this was a potential source of
error further experiments were performed to determine the minimum
number of haemacytcmeter counts which should be performed to obtain
a reproducible estimate of yeast concentration at each time point
and thereby minimise this problem.
The full details of the method used to investigate this
problem are described above (pl94). Repeated haemacytcmeter counts
showed that to achieve less than 5% difference in the mean count
between opposite sides of the haemacytometers, a minimum of 11 or
12 haemacytometer counts should be performed (Figure III.12).
In all subsequent experiments therefore, 12 haemacytcmeters
were used to monitor the change in yeast concentration. The
complete method incorporating these modifications for measuring the
phagocytic rate constant is described above (ppl96-199).
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Fig III.12 Haemacytometer errors:
The %age difference between the mean count of yeast in opposite
sides of haemacytometers diminishes with the use of increasing
numbers of haemacytcrreters. Approximately 12 haemacytcmeter counts
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7.0 CONTROL STUDIES ON OPSONISED PARTICLES -
OPSONINS.
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THE NATURE OF THE
OPSONINS PRESENT ON C. ALBICANS OPSONISED WITH SERUM
In same studies C. albicans preopsonised with human AB serum
was used. Direct inmunofluorescence showed that this particle was
coated both with immunoglobulins (IgA, G & M) and complement C3/C3c
($lc/|3la). The rate constant measured with this yeast is designated
Ks.
OPSONISATION DOSE RESPONSE STUDIES AND OPSONINS PRESENT ON CL
ALBICANS OPSONISED WITH POOLED HUMAN IgG
In later studies C, albicans preopsonised with pooled human
IgG was used to measure Fc receptor mediated uptake. Opsonisation
dose response curves were preformed to establish the optimum ratio
of yeast to IgG (Fig III.13). The standard opsonisation ratio
chosen for all subsequent experiments was 5Cmg IgG/lCT yeast in 2mls
of PBS.
Treatment of these yeast with goat F£l$2 anti-Fc resulted in
95% inhibition of phagocytosis, confirming that uptaife is Fc
receptor dependent. Treatment of yeast with nonimmune goat Hah£ had
no effect.
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FIG III. 13. Opsonisation close response curve for C. albicans
opsonised with pooled human IgG.




OPSONISATION DOSE RESPONSE STUDIES AND OPSONINS PRESENT ON _S_.
CEREVISIAE OPSONISED WITH SERUM
To obtain a measure of rates of "complement (C3) receptor"
mediated ingestion (Kc), S. cerevisiae preopsonised in fresh human
serum was used (Rivero et al 1979), and dose response curves
performed to establish the optimum ratio of yeast to serum (Fig
III. 14). A ratio of 0.4mls.serum/107yeast was used in subsequent
experiments.
Preliminary immunofluorescence studies showed that the
particles were heavily coated with C3/C3c (^lc/^la) and no
immunoglobulin was detected. Furthermore, after heat inactivation
of the serum, opsonisation of the yeast was abolished (Fig III. 14).
To determine more precisely which complement components were
mediating ingestion, and to exclude the presence of small amounts
of IgG, the serum-opsonised yeast particles were incubated with
fragments of goat IgG directed against various complement
components before offering the yeast for phagocytosis in the assay.
E^j2 anti-Clq caused 15% inhibition and anti-C3 caused
85% inhibition at the highest dilutions tested. fragments of
IgG anti-C4, anti-plH, anti-Fc and nonixtmune IgG had no effect.
Furthermore, simultaneous treatment with anti-Clq and anti-C3
caused 10O% inhibition (Table 6.2). Nonimmune goat Pa6E had no
effect.
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Fig III.14. Opsonisation dose response curve for S. cerevisiae
opsonised with human serum.
Ratio of yeast to opsonin is plotted against rate of phagocytosis
(Kc 10 mls/min/monocyte). Yeast opsonised with heat inactivated
serum are not significantly phagocytosed.
Opsonisation -dose response
2L*
Table 6.2 Effect on phagocytosis of treating "complement" coated S.
cerevisiae with R^2 anti-Clq, C3, C4, ^1H or anti-IgG/Fc. Result
expressed as %age inhibition of phagocytosis:
Dilution Clq C3 C4 01H Fc Clq-KS
1/1 15 87 0 0 0 100
1/5 15 80 0 0 0 ND
1/10 15 72 0 0 0 ND
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CONFIRMATION THAT RATE OF PHAGOCYTOSIS IS PROPORTIONAL TO MONOCYTE
CONCENTRATION
To ensure that the kinetics of phagocytosis were unchanged
using yeast preopsonised with serum or IgG or complement alone, the
rate of phagocytosis was measured over 20 minutes in the presence
of concentrations of monocytes ranging from 1.0 to 2.QxloVml
obtained from healthy control subjects. The experiments were
repeated for C. albicans opsonised in serum, S. cerevisiae
opsonised in serum and C. albicans opsonised in IgG.
In each case the rate of phagocytosis was proportional to the
monocyte concentration (Figs 111.15,16,17).
251
Fig III. 15 Rate of phagocytosis of C. albicans preopsonised with
serum is proportional to monocyte concentration.
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Fig III.16 Kate of phagocytosis of C. albicans preopsonised with



















Fig III. 17 Rate of phagocytosis of S. cerevisiae preopsonised with





















6.0 RESULTS OF METABOLIC CONTROL STUDIES.
INTRODUCTION.
To confirm that apparent uptake of complement coated £L
cerevisae and IgG coated C. albicans was dependent on phagocytosis
rather than adherence the effect of various metabolic inhibitors on
the rate constants Kc and Kfc was investigated.
- N-ETHYL MALEIMIDE.
Ten minute preincubation of mononuclear cells with 0.01, 0.1
and l.CmM N-ethyl maleimide, caused dose dependent reduction of
both Kc and Kfc suggesting that uptake of both types of yeast
particle was dependent on anaerobic glycolysis and that adherence
made only a small contribution to disappearance of yeast (Fig
III.18).
SODIUM CYANIDE
Preincubation of cells for 60 minutes with up to lirM cyanide
had no effect on either Kc or Kfc confirming that aerobic
mitochondrial metabolism does not normally provide significant
amounts of energy for phagocytosis (Fig III.18).
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Fig III. 18 Effect of N-ethyl maleimide and sodium cyanide on rates
of phagocytosis of either IgG (Kfc) or "complement" (Kc) coated
yeast.
(a) N-ethyl maleimide causes dose dependent inhibition of




Preincubation of cells with lOrcM 2-deoxy glucose for either 20
or 60 minutes produced inhibition of both Kc and Kfc confirming
dependence of yeast phagocytosis on glycolysis (Fig III.19).
However, at most only 50% inhibition of phagocytosis occurred.
Rephosphorylation of ADP to ATP by stores of creatine phosphate
provides the cell with a major source of ATP during phagocytosis;
in the resting cell ATP is utilised for phosphorylation of creatine
to creatine phosphate which provides a high energy phosphate store.
Thus in order to deplete the cell of all sources of ATP which could
be utilised for phagocytosis, preincubation was performed in the
presence of 2-deoxy glucose and cyanide simultaneously.
2-DEOXY-GLUCOSE + SODIUM CYANIDE
Preincubation of cells for 60 minutes with lCtmM 2-deoxy
glucose and IimM sodium cyanide produced 98% inhibition of both Kc
and Kfc (Fig III.19), confirming that uptake of yeast is dependent
on active metabolic processes.
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Fig III.19 Effect of 2-deoxy glucose (2DG), or 2DG + cyanide on
phagocytosis of A) "corrplenent" coated yeast and B) IgG coated yeast.
Preincubation with lQmM 2DG produced approximately 50% inhibition
of phagocytosis of either IgG or "complement" coated yeast, cyanide
had no effect, but preincubation with lOrrM 2DG + luM cyanide caused
virtually complete inhibition of phagocytosis.
a) = Control cells preincubated with medium (20 or 60 min)
b) = 20 minute preincubation with lQmM 2DG
c) = 60 minute " " " "
d) = 60 minute " " ImM cyanide
fl) = 60 minute " " lOrrM 2DG + ImM cyanide













REQUIREMENT FOR DIVALENT CATIONS AND EFFECT OF EDTA.
Phagocytosis of IgG coated yeast was completely inhibited in
the absence of Ca++ and Mg++. Uptake of "complement" coated yeast
was only partially inhibited by omission of divalent cations and
was inhibited to a similar degree by preincubation of monocytes in
HBSS with lOrrM EDTA for 10 minutes (Fig III.20).
Fig III.20. Effect of Ca++ and Mg-H- free medium on phagocytosis of
A) "complement" coated yeast and B)IgG coated yeast, and effect of
EDTA on phagocytosis of "complement" coated yeast.
a) - Control cells preincubated 10 minutes with medium
b) = Cells preincubated 10 minutes with Ca++/Mg++ free medium













SECTION IV: RESULTS OF STUDIES ON PATIENTS WITH RHEUMATOID
ARTHRITIS.
1.0 RATES OF PHAGOCYTOSIS OF C. ALBICANS PREOPSONISED WITH AB
SERUM, BY MONOCYTES FROM NORMAL CONTROLS AND PATIENTS WITH
RHEUMATOID ARTHRITIS.
In the initial clinical study, the rate constant Ks for
combined IgG and "complement" mediated monocyte phagocytosis was
measured using C. albicans preopsonised with serum.
SUBJECTS
Controls: Fourteen healthy hospital employees (10 female, 4
male), mean age 35 years (range 20-63).
Patients: Fourteen patients with classical or definite
rheumatoid arthritis (RA) (Ropes et al 1959) (9 female, 5 male),
mean age 54 years (range 30-76). Five of the patients had cutaneous
rheumatoid vasculitis (RV) (1 male, 4 female), mean age 59 years.
One patient with vasculitis was restudied after resolution of the
vasculitic episode.
Drug therapy: Twelve RA patients were receiving nonsteroidal
anti-inflanmatory drugs (NSAID) alone and three were also receiving
corticosteroids. Of these three, one with vasculitis was receiving
prednisolone 6mg/day, and two patients without vasculitis were
receiving prednisolone 5mg/day and ACTH 20 units/day respectively.
The appearance of typical cutaneous vasculitic lesions is
shown in Figs IV.1 and 2.
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VALIDATION OF COULTER SIZING METHOD FOR PERFORMING MONOCYTE
DIFFERENTIAL COUNTS ON CELLS FROM RA PATIENTS.
To confirm that the Coulter sizing technique for performing
monocyte differential counts was valid for mononuclear cells
obtained from RA patients, the rrethod was compared with NSE
staining using cells from 24 RA patients.
As in the normal controls, a good correlation was found
between the percentage of monocytes in mixed mononuclear cell
populations estimated by NSE staining and the percentage estimated
by Coulter sizing (n=24, r=0.71, p<0.001),(Fig IV.3).
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Fig IV.3 %ages of monocytes in mixed mononuclear populations from
RA patients.
Differential counts obtained by NSE staining correlate well with
the Coulter "sizing" method in which monocytes are defined as cells



















RATE CONSTANT FOR MONOCYTE PHAGOCYTOSIS OF C. ALBICANS PREOPSONISED
WITH AB SERUM - STUDIES'OF NORMAL SUBJECTS AND RA PATIENTS WITH AND
WITHOUT VASCULITIS.
Mononuclear cells were separated from venous blood obtained
from the above subjects and the concentration of monocytes
determined using the Coulter counter. The monocyte phagocytic rate
constant "Ks" for uptake of C. albicans opsonised with AB serum was
then measured for each subject as described above (pl96).
There was no difference in the rate constant Ks between normal
controls and patients with unccmplicated RA, but Ks was
significantly reduced in patients with active vasculitis (p<0.01,
rank sum test) (Fig IV.4). In one patient who was restudied after
resolution of the vasculitic episode Ks was found to have returned
to normal.
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Fig IV.4 Rate constant Ks for phagocytosis of serum opsonised C.
albicans by monocytes from normal controls and RA patients with or
without cutaneous vasculitis:
Rates of phagocytosis by monocytes from patients with vasculitis
























The results of serological studies are shown in Table 6.3.
Although there is considerable overlap in the results the mean (+/-
S.D.) serum haemolytic complement level is lower in the vasculitic
subjects (42+/-32 %) than in the uncomplicated RA patients
(75.4+/-29 %) (Not significant; Students t-test) suggesting the
presence of circulating, complement activating immune corplexes.
All but one patient was seropositive for rheumatoid factor in
either the SHCT or latex agglutination test.
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Table 6.3 Results of serological studies in RA patients:
Patient ESR TITRE CH50
mm/lst hr. SHCT LATEX ANF %
RVl 42 512 +++ ++ 50
RV2 42 -ve -ve -ve 85
RV3 56 1024 +++ ++ 18
RV4 40 128 +++ +++ 15
RV5 90 128 N.D. + N.D
RAl 11 256 +++ +++ 83
RA2 4 256 ++ -ve 108
RA3 30 128 ++ + 108
RA4 97 1024 N.D. N.D. 21
RA5 80 N.D. +++ ++ 54
RA6 71 128 +++ ++ 70
RA7 35 -ve +++ ++ 51
RA8 54 128 +++ + 86
RA9 6 128 +++ -ve 98
RV = rheumatoid vasculitis
RA = rheumatoid arthritis without vasculitis
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IMMUNOFLUORESCEfsCE STUDIES
In three experiments where reduced rates of phagocytosis had
been found, indirect iirmunofluorescence was performed on the
mononuclear cells using goat anti-human gamma globulin and
anti-human complement (jBlc/fila) in an attempt to identify monocyte
associated immune complexes.
No evidence of cytoplasmic or membrane bound inrnune complexes
was found.
DISCUSSION
Since the yeast used in this study were coated with both
immunoglobulin and complement, it was not clear whether Fc
receptors or complement receptors or both were responsible for the
reduction in rates of phagocytosis of preopsonised yeast by
monocytes from vasculitis patients. To examine these possibilities,
further studies were performed using C. albicans preopsonised with
IgG to measure Fc receptor mediated phagocytosis and S. cerevisiae
preopsonised with serum to measure "complement" receptor mediated
phagocytosis.
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2.0 RATES OF PHAGOCYTOSIS OF YEAST PREOPSONISED WITH EITHER
"COMPLEMENT" OR IMMUNOGLOBULIN (IgG) BY MONOCYTES FROM NORMAL
CONTROLS AND PATIENTS WITH RHEUMATOID ARTHRITIS.
In the next group of subjects studied, the rate constants for
"complement" and Fc receptor mediated phagocytosis, Kc and Kfc
respectively, were measured separately. Kc was measured using S.
cerevisiae preopsonised with serum and Kfc using C. albicans
preopsonised with IgG as described above (pl96).
SUBJECTS.
Controls: Twenty three healthy hospital employees (10 male, 13
female), mean age 32.2 years (range 21-64).
Patients: Twenty six patients with definite or classical RA
(14 female, 12 male), mean age 59.4 years (range 35-73) were
divided into four groups: Group A - active vasculitis (n=9); Group
B - 3 patients frcm Group A whose vasculitis was inactive plus 2
patients with a history of vasculitis (n=5); Group C - multiple
nodules (n=9); Group D - patients with miscellaneous conditions
associated with RA (includes 1 patient from Group A who developed
pyoderma gangrenosum); pyoderma gangrenosum (n=2), pericarditis
(n=l), primary biliary cirrhosis (n=l), paravertebral abscess
(n=l), Feltys syndroms (n=l), pyarthrosis, sacral ulceration and
secondary Sjogrens syndrome (n=l). Five patients were studied
serially to examine the relationship between abnormalities of
phagocytosis, clinical status and serological parameters. Details
of drug therapy are shown in Table 6.4.
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Table 6.4 RA patients - Drug therapy:
Patient Groups *
DRUGS A B c D
NSAID alone 3 1 7 6
Prednisolone (<lCmg/day) 3 2 0 0
Penicillamine (500mg/day) 1 1 0 0
Prednisolone (<7.5mg/day)
+ penicillamine (<500mg/day) 2 1 0 0
Prednisolone (5mg/day)
+ chloroquine (25Cmg/day) 0 0 1 0
Sodium aurothicmalate
total dose 60Gng 0 0 1 0
* Patient group A = active vasculitis
B = Inactive vasculitis
C = Multiple nodules
D = Miscellaneous carpiications
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RATE CONSTANT (Kfc) FOR PHAGOCYTOSIS OF IgG COATED C. ALBICANS BY
MONOCYTES FROM NORMAL CONTROLS AND RA PATIENTS.
No significant differences in the rate of Fc receptor mediated
phagocytosis were found between the normal controls and any of the
patients studied (Fig IV.5). Thus the functional defect of
phagocytosis found when serum opsonised C. albicans was used could
not be attributed to a defect of Fc receptor mediated phagocytosis.
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Fig IV.5 Rate constant Kfc for phagocytosis of IgG co&feed C_.
albicans by monocytes form normal controls and RA patients.
Group A = RA patients with vasculitis;
Group B = RA patients with inactive vasculitis;
Group C & D = RA patients with multiple nodules or miscellaneous
carpiications and diseases associated with RA.
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2.2 RATE CONSTANT (Kc) FOR PHAGOCYTOSIS OF COMPLEMENT (C3b) COATED
S. CEREVTSIAE BY MONOCYTES FROM NORMAL CONTROLS AND RA PATIENTS.
All the patients with active cutaneous vasculitis had reduced
Kc compared with normal controls (p<0.001; Fishers one tailed exact
test) while five patients with inactive vasculitis had normal Kc
(Fig IV.6 - Groups A & B).
The nine patients with multiple nodules had normal Kc (Fig
IV.6 - Group C), but a significant proportion (4/7) of patients
with extra-articular manifestations other than vasculitis were
found to have reduced Kc (p<0.01; Fishers one tailed exact
best) (Fig IV.6 - Group D). Of these four, two had pyoderma
gangrenosum, one had pericarditis, and the fourth multiple nodules
and primary biliary cirrhosis. Of the three remaining patients with
normal Kc, one had Feltys' syndrome and two had serious pyogenic
infections.
Thus depressed rates of inmune phagocytosis by monocytes
appeared to be due to an abnormality of "ccmpDenent" rather than Fc
receptor mediated ingestion. Additionally, although the abnormality
was consistently present in patients with vasculitis, it was also
present in patients with other serious extra-articular
manifestations of RA. To confirm the preliminary observation that
the abnormality of phagocytosis was transient, serial studies were
carried out on five patients.
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Fig IV.6 Rate constant Kc for phagocytosis of "carplement"
opsonised S. cerevisiae by monocytes from normal controls and RA
patients.
Group A = RA patients with active vasculitis
Group B = RA patients with inactive vasculitis
Group C = RA patients with multiple nodules











































p = 4.10"8 N.S. NS. p = -007
Fishers exact test
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RESULT OF SERIAL S'lUDIES OF MONOCYTE PHAGOCYTOSIS IN PATIENTS WITH
DEPRESSED RATES OF "COMPLEMENT" RECEPTOR MEDIATED PHAGOCYTOSIS
The results of serial studies are shown in Fig IV.7. Two
patients (S.C. & J.H.) were studied initially when vasculitis was
active and again later after cessation of vasculitis. In both of
these patients Kc returned to the normal range during remission of
the vasculitis. Patient J.H. later developed pyoderma gangrenosum
during which Kc again fell below normal levels. A third patient
(L.D.) was studied fortuitously before development of vasculitis
and later during vasculitis - again depression of Kc was seen only
during the episode of vasculitis. Two patients with vasculitis
(J.D. & M.B.) each had further episodes of vasculitis seme weeks
later and were restudied. On both occasions Kc was found to be
reduced. It was therefore concluded that the reduction in Kc was
transient and temporally related to the inflairmatory episode.
Since vasculitis may be associated with the appearance of
complement activating immune complexes, the phagocytic data was
examined for correlations with serum complement (C3 & C4)
concentrations and levels of Clq binding activity. Also to examine
the possibility that receptor blockade by iimrune complexes might be
occurring, cytocentrifuge smears and washed cell suspensions of
mononuclear cells from four patients with reduced Kc were examined
by direct immunofluorescence for the presence of intracytoplasmic
immune complexes and membrane associated immune complexes
respectively.
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Fig TV.7 Serial studies of serum complement levels (C3 & C4), Clq
binding activity (Clqba), anti-complementary activity (ACA) and
phagocytosis by monocytes from RA patients with depressed rates of






























































CORRELATION OF RATES OF "COMPLEMENT" RECEPTOR MEDIATED PHAGOCYTOSIS
WITH SERUM COMPLEMENT (C3, C4), ANTICOMPLEMENTARY ACTIVITY & Clq
BINDING ACTIVITY.
Patients with vasculitis and low Kc had significantly lower
mean serum C3 levels (p<0.02; Students t-test) and C4 levels
(p<0.01) and higher titres of anticomplementary activity (ACA)
(p<0.001; Fishers one tailed exact test) than patients with normal
Kc (Fig TV.8), although many of the latter also had subnormal
complement levels and elevated ACA titres. It is also clear that
mean C3 levels in patients with vasculitis are biased by a single
low value and the numbers are snail. Furthermore, serum ACA titres
and mean serum C3 and C4 concentrations in the four RA patients
with reduced Kc who did not have vasculitis were no different from
RA patients with normal Kc (Fig IV.8). Thus, reduction of Kc was
not invariably accompanied by evidence of complement activation and
low serum complement levels.
Results of Clq binding activity were available from 29 studies
(22 patients). Although overall, depression of Kc correlated with
high levels of Clq binding activity, it is clear that seme patients
with gross elevation of Clq binding had normal Kc (Fig IV.9).
Values were also available for the five patients who were
studied serially, and this data was also examined individually for
correlations between Kc, serum complement and tests for immune
complexes (Fig IV.7). In patient S.C. remission of vasculitis was
accompanied by a rise in Kc and a concomitant fall in both Clq
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binding activity and serum anti-ccmplementary activity. Serum C3
and C4 did not change significantly. Patient J.H. was first studied
during active vasculitis and her subsequent clinical improvement
was marked by a rise in Kc, serum C3 and C4. However, Clq binding
activity and anti-ccmplementary activity remained high and 16 weeks
later this patient developed pyoderma gangrenosum. The appearance
of pyoderma gangrenosum was accompanied by a further fall in Kc and
a rise in anti-carrplementary activity. In view of this the further
rise in serum C3 levels was unexpected but may reflect an acute
phase response of C3. In patient L.D. the appearance of vasculitis
was accompanied by a marked fall in Kc, serum C3 and serum C4 and
rise in Clq binding activity. However titres of anti-complementary
activity surprisingly fell to zero. In patients M.B. and J.D. with
recurrent vasculitis Kc and serum C3 levels remained depressed and
titres of anti-ccnplementary activity and Clq binding activity
remained elevated. Serum C4 levels remained unchanged.
In general therefore, vasculitis was accompanied by evidence
of increased ccmplsnent consumption and increased levels of




Direct inmunofluorescence on mononuclear cells from four
patients with reduced Kc failed to reveal either cytoplasmic or
membrane bound ccnplement or immunoglobulin.
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Fig IV.8 Results of serum C3, C4 levels and anti complenentary
activity (ACA) in RA patients.
( indicates mean value)
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Fig IV.9 Correlation of Clq binding activity (Clqba) with rate of
phagocytosis of "carplement" coated S. cerevisiae (Kc).
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3.0 EFFECT OF RA SERUM ON RATES OF PHAGOCYTOSIS BY NORMAL
MONOCYTES.
Serum drawn at the time of each phagocytic assay was stored in
liquid nitrogen for studies of the effect of patients sera on
normal monocytes. Normal control sera were stored similarly.
To examine the possibility that immune ccmplexes or other
serum factors were responsible for reduction of "complement"
receptor mediated monocyte phagocytosis, normal monocytes (one
O
donor) were premcubated for 60 minutes at 37C with either 15%
normal control serum (n=8) or 15% serum from RA patients (n=6) with
reduced Kc. The phagocytic rate constant Kc was then determined as
before.
Serum from RA patients with low Kc did not inhibit
"complement" receptor mediated phagocytosis by normal monocytes
(Fig IV.10).
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Fig IV. 10 Effect of serum from RA patients with vasculitis on
"complement" receptor mediated phagocytosis by normal nonocytes.
Preincubation of normal monocytes for 60 minutes with RA serum did




























J = Mean is.e.m.
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4.0 RELATION BETWEEN -RATES OF C3b RECEPTOR MEDIATED PHAGOCYTOSIS
AND THE CYTOCHEMISTRY OF LARGE MONONUCLEAR CELLS.
After separation of mononuclear cells in each experiment
monocytes were enumerated routinely using the Coulter counter
except in 15 experiments where a differential count was also
performed using NSE staining. Also, to exclude the possibility of
significant contamination by neutrophil granulocytes, AS-D
chloroacetate esterase staining was carried out on 8 normal control
subjects and 14 RA patients.
Since no direct evidence of monocyte receptor blockade by
irtmune complexes was found which could account for impaired
"complement" receptor phagocytic function an alternative hypothesis
was considered; viz. that changes in the composition of blood
subpopulations of monocytes were occurring and that increased
numbers of inmature monocytes with poorly expressed CR1 or CR3
receptors, but normal Fc receptors, were appearing in the
circulation. To examine this possibility the cytochanical
characteristics of the mononuclear cells f rem these patients were
reviewed, and the assumption that all large mononuclear cells (>250
cubic microns) were non specific esterase positive monocytes was
re-examined.
AS-D chloroacetate esterase staining of mononuclear cells
showed few neutrophil granulocytes (Table 6.5"), and there was no
significant difference between controls, RA patients with normal Kc
and those with reduced Kc. Thus there was no evidence of
significant contamination by neutrophil polymorphs.
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Large (>250 cub.microns) mononuclear cells were more frequent
in RA patients than in normal controls (p<0.001; students t-test),
but there was no significant difference between RA patients with
normal Kc and those with low Kc (p<0.5) (Table 6.6). Thus using
size as the criterion for counting monocytes there was a
significant increase in the relative number of monocytes in RA
patients, but no difference between those with low or normal Kc.
Although in RA patients with normal Kc the proportion of
mononuclear cells staining with NSE correlated closely with the
proportion of large cells (>250 cub microns) (Fig IV.3), in RA
patients with low Kc this was not the case. In these patients the
percentage of monocytes determined by NSE staining (19.0 +/- 5.3)
was significantly less than that obtained by Coulter sizing (33.9
+/- 7.0) (p<0.001; students t-test). Furthermore the rate constant
Kc for "complement" receptor mediated phagocytosis declined in
direct proportion to the discrepancy between the Coulter and NSE
differential counts (Fig IV.11) while Kfc remained unchanged.
These observations suggested that the reduction in Kc was due
to the presence of increased numbers of "NSE-negative" mnocytes
with reduced "complement" receptor but normal Fc receptor
phagocytic function. To test this possibility the composition of
the mononuclear cell population was examined prospectively in a
group of normal controls, a group of RA patients and a group of RA
patients with vasculitis or other extra-articular disease. In each
group the %age of large (>250 cub microns) cells, %age of NSE +ve
cells, %age of cells phagocytosing IgG coated yeast and %age of
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cells pliagocytosing complement coated yeast were estimated
microscopically.
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Table 6.5 Percentage of neutrophil polymorphs (PMN) contaminating






Normal subjects 8 0.5
RA - normal Kc 9 0.4
RA - reduced Kc 5 1.0
Table 6.6 Percentage of monocytes (mononuclear cells > 250 cubic
microns) in mixed mononuclear cell preparations estimated by
Coulter "sizing"
n %monocyte (+/- S.D.) Range
Normal subjects 13 24.2 +/-3.9 16.7-31.7
RA - normal Kc 17 34.8 +/-S.0 27.4-59.0
RA - reduced Kc 15 33.9 +/-7.0 21.4-44.2
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Fig IV.11 Correlation between reduction in Kc and percentage of
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5.0 COMPOSITION OF THE MONONUCLEAR CELL POPULATION IN NORMAL
CONTROLS & RA PATIENTS
Controls:
Eleven healthy hospital employees (8 female, 3 male) nean age
38years (range 21-54).
RA patients:
Rheumatoid arthritis "RA" group - 12 patients with classical
or definite RA (7 female, 5 male) mean age 60 (range 42-79).
Rheumatoid vasculitis "RV" group - 11 patients with classical
or definite RA with extra-articular manifestations including active
or recently active vasculitis (n=9); pyoderma gangrenosum (n=l);
multiple nodules and primary biliary cirrhosis (n=l).
Drug therapy: Patients drug therapy is shown in Table 6.7.
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INVESTIGATION OF THE COMPOSITION OF THE MONONUCLEAR CELL POPULATION
IN CONTROLS AND RA PATIENTS
Mononuclear cells were separated from venous blood obtained
from the above subjects and the concentration of monocytes
determined using both NSE staining and Coulter sizing.
The %age of monocytes capable of phagocytosing either IgG or
"complement" coated yeast were estimated by incubating the
mononuclear cells with yeast in suspension for 40 minutes, after
which cytocentrifuge slides were prepared and stained with NSE. The
number of phagocytic cells was then estimated microscopically frcm
a count of at least 200 cells as described above (p200). The
typical microscopic appearance of phagocytic cells is shown in Fig
IV.12.
There was no significant difference (Students t-test) between
the three groups in the percentage of monocytes in the mononuclear
cell population as estimated by NSE staining or Coulter sizing,
although the latter consistently but systematically overestimated
the percentage of monocytes by 3-4% (Table.6.8). Thus there was no
evidence in this study of a greater proportion of large NSE
negative cells in the "extra-articular manifestations" (RV) group
than in the unccmplicated RA patients or controls. However, in the
R.V group there was a significant reduction in the number of
monocytes phagocytosing "complement" coated yeast compared to the
%age phagocytosing IgG coated yeast, while in the controls and
unconplicated RA patients there was no difference (Table 6.9).
These results demonstrate that the reduction in Kc seen in
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patients with rheumatoid vasculitis is due to the presence of NSE
positive monocytes with phagocytic Fc receptors but functionally
inactive or absent "complement" receptors. Thus although the results
suggest a change in the composition of the peripheral mononuclear
cell population in vasculitis they do not support the hypothesis
that there are NSE-negative, Fc-bearing, mononuclear phagocytes
with functionally inactive complement receptors.
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Fig IV. 12 Microscopic appearance of monocyte containing
phagocytosed yeast. Cells are stained with NSE and counterstained
with methyl green.
Top - Strongly staining NSE-positive monocyte containing a single
yeast.
Bottom - Weakly staining NSE-positive monocyte containing two
ingested yeast, with three adherent yeasts on its surface. Two
yeast are lying free at bottom.
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Table 6.8 Percentage (+/- S.D.) of monocytes in mixed mononuclear
cell populations estimated by NSE staining or Coulter "sizing".
Mononuclear cells
n % NSE +ve % >250 cub microns
Normal controls 11 27.0 +/-6.2 32.2 +/-7.8
"RA" patients 12 31.3 +/-9.1 35.1 +/-9.3
"Rv" patients 11 27.8 +/-7.9 32.6 +/-8.6
Table 6.9 Percentage (+/- S.D.) of cells in mixed mononuclear cell
populations phagocytosinq IqG coated yeast (%Fc positive) or
"complement" coated yeast (%CR positive).
A significant reduction in %age of mononuclear cells phagocytosing
"complement" coated yeast is seen in the "RV" group of patients:
Mononuclear cells
n % FcR +ve % CR +ve FcR vs CR*
Normal controls 11 21.1 +/-3.7 21.1 +/-4.0 N.S.
"RA" patients 12 22.2 +/-5.0 22.0 +/-6.3 N.S.
"RV" patients 11 20.9 +/-5.6 13.9 +/-4.0 p<0.001
Students t-test.
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INVESTIGATION OF THE COMPOSITION OF THE ADHERENT CELL POPULATION IN
CONTROLS AND RA PATIENTS
Having established that there is a reduction in numbers of
monocytes capable of phagocytosing "complement" coated yeast in the
mixed mononuclear cell population obtained from patients with
extra-articular manifestations ("RV" patients), limited preliminary
studies have been performed in four "RV" subjects and five of the
above "RA" patients to determine whether these cells can be
isolated in the adherent cell population.
Mononuclear cells were plated onto glass coverslips and
cultured as described above (p201). After removal of nonadherent
cells, the adherent population was incubated with either IgG or
complement coated yeast with rocking for 40 minutes and the %age of
phagocytic cells estimated after staining with NSE. Seme coverslips
were not incubated with yeast but stained with NSE to determine the
%age of NSE positive cells.
The percentage of NSE positive mononuclear cells and the
percentage of cells phagocytosing either IgG coated (FcR +ve) or
"complement" coated yeast (CR +ve) in both the mixed mononuclear
cell population and the adherent cell population are shown in Table
6.10. Although there is a marked reduction in the percentage of
CR-positive cells compared to the number of FcR-positive cells in
the mixed mononuclear cell population from four "RV" patients,
there is no such difference in the adherent cell population.
Mononuclear cells from 5 control "RA" patients shewed no reduction
in numbers of CR-positive cells in either the mixed mononuclear
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cells in suspension or in the adherent cell population. Thus it
appears from these preliminary results that the FcR-positive,
CR-negative cells are not glass adherent and are therefore lost
during the adherence procedure. Studies of cells frcm further
patients will be required to establish this point.
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Table 6.10 Comparison of mean (+/- S.D.) percentages of NSE
positive, FcR positive and CR positive cells in the mixed
mononuclear cell population and the adherent cell population.
Mixed mononuclear cells in suspension
n %NSE +ve %FcR +ve %CR +ve
"RA" patients 5 36.7 +/-10 27.2 +/-3 27.1 +/-6
"RV" patients 4 26.5 +/-5 24.3 +/-8 15.5 +/-3
Adherent mononuclear cell population
n %NSE +ve %FcR +ve %CR +ve
"RA" patients 5 83.8 +/~5 77.8 +/-10 84.0 +/-7
"RV" patients 4 73.3 +/-17 75.9 +/-11 85.1 +/-9
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SECTION V: RESULTS OF STUDIES ON PATIENTS WITH SYSTEMIC LUPUS
ERYTHEMATOSUS (S.L.E.).
1.0 RATES OF PHAGOCYTOSIS OF YEAST PREOPSONISED WITH EITHER
"COMPLEMENT" OR IMMUNOGLOBULIN (IgG) BY MONOCYTES FROM NORMAL
SUBJECTS AND PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS.
In the group of SLE patients studied, the rate constants for
"complement" and Fc receptor mediated phagocytosis, Kc and Kfc
respectively, were measured separately.
SUBJECTS.
Controls: Twenty three healthy hospital erployees (13 female,
10 male), mean age 32.2 years (range 21-64).
Patients: Eighteen patients with SLE (17 female, 1 male), mean
age 34.8 years (range 23-65). Seventeen patients fulfilled the ARA
criteria (Cohen & Canoso 1972) for definite SLE. Details of
clinical features are shown in Table 6.11. Disease activity is
indicated by a "clinical disease activity score" in which each
active disease manifestation is given a score of +1 (Cairns et al
1980).
SEROLOGY
Serum stored at 4C was used to measure ANF titres and to
detect antibodies to soluble cellular antigens as described above
(p202-212). Results are shown in Table 6.11.
DRUG THERAPY
Drug therapy is shown in Table 6.12.
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VALIDATION OF COULTER SIZING METHOD FOR PERFORMING MONOCYTE
DIFFERENTIAL COUNTS ON CELLS FROM SLE PATIENTS.
To confirm that the Coulter sizing method for performing
monocyte differential counts was valid for mononuclear cells from
SLE patients the method was compared with NSE staining on
mononuclear cells from 17 of the 18 patients studied.
A good correlation was found between the percentage of
monocytes in mixed mononuclear cell populations estimated by NSE
staining and the percentage estimated by Coulter sizing (n=19,
r=0.94, p<0.001) (FigV.l).
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Fig V.l %ages of monocytes in mixed mononuclear cell populatins
fran SLE patients.
Differential counts obtained by NSE staining correlate well wth the
Coulter "sizing" method in which monocytes are defined as cells of
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RATE CONSTANT (Kc) FOR MONOCYTE PHAGOCYTOSIS OF COMPLEMENT COATED
S. CEREVISIAE BY MONOCYTES FROM PATIENTS WITH SLE.
Using complement coated S. cerevisiae rate constants for
"complement" receptor mediated monocyte phagocytosis were measured
as described above (pl96).
Rate constants for "complement" receptor mediated phagocytosis
(Kc) were reduced in 9/18 SLE patients compared to the normal
controls (p=0.0001; Fishers one tailed exact test) (Fig V.2).
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Fig V.2 Rate constant Kc for phagocytosis of "complement" coated S.
cerevisiae by monocytes from normal controls and SLE patients.
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RATE CONSTANT (Kfc) FOR MONOCYTE PHAGOCYTOSIS OF IgG COATED C.
ALBICANS BY MONOCYTES FROM PATIENTS WITH SLE.
Using IgG coated C. albicans the rate constants for Fc
receptor mediated monocyte phagocytosis were measured as described
above (pl96).
Rate constants for Fc receptor mediated phagocytosis were
reduced in only 3/18 SLE patients compared to the normal controls,
a proportion which is not statistically significant (Fig V.3).
However the magnitude of the reduction suggested that this might
reflect a biological abnormality, so to determine whether it was
reproducible and correlated with serological and clinical
parameters, two of these three subjects were studied at intervals
over an eleven month period.
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Fig V.3 Rate constant Kfc for phagocytosis of IgG coated C.
albicans by monocytes frem normal controls and SLE patients.
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RESULT OF SERIAL STUDIES OF PHAGOCYTOSIS BY MONOCYTES FROM PATIENTS
WITH DEFECTS OF Fc OR "COMPLEMENT" RECEPTOR MEDIATED PHAGOCYTOSIS.
To further examine the relationship between abnormalities of
monocyte phagocytosis and clinical and serological parameters,
serial studies of Fc and "complement" receptor mediated monocyte
phagocytosis were undertaken in two subjects A and B over a twelve
month period. The results of these studies are shown in Fig V.4.
PATIENT A:
Kfc and Kc were reduced on 2 out of 5 occasions. Reduction in
rates of phagocytosis correlated with disease activity but not with
serological parameters. During an episode of neurological
involvement, thrombocytopenia and leucopenia, both Kfc and Kc were
reduced. Clinical ramission and improvement in phagocytic function
occurred following an increase in dosage of prednisolone to 2Cmg
daily. Serum complement levels were persistently lew, but DNA
binding was normal and Clq binding activity was only slightly
elevated (30%) throughout the period of study.
PATIENT B:
Kfc was reduced on 4 out of 5 occasions and showed a close
correlation with serum complement levels and disease activity. On
the one occasion Kfc fell within the normal range, there were no
active clinical manifestations. On all other occasions, reduction
of Kfc was associated with either active cutaneous rash, arthritis
or leucopenia. Kc was also reduced on 4 out of 5 occasions but
showed no correlation with either serological parameters or disease
307
activity. Clq binding activity and DNA antibody levels were normal
throughout the period of study.
There was no relationship between phagocytic function and drug
therapy and changes in the former always reflected alterations in
clinical status before changes in drug, therapy ware instituted.
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Fig V.4 Serial study of Kfc, Kc, serological and clinical
parameters in patients A & B.
e\
Key: Clinical features; lp = leucopenia < 4X10 wbc/1.
tp = platelets < 100X10** platelet/1.
nps = neuropsychiatry syndrome
arth = arthritis
Normal values; serum C4 > 2Cmg/dl
serum C3 > 120mg/dl
Kfc > 8. 9X10*1ml/min/monocyte
Kc > 7.SXIO1ml/min/monocyte
Drug therapy; (1) = prednisolone mg/day (* alt. day)
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CORRELATION OF RATES OF PHAGOCYTOSIS WITH SEROLOGICAL PARAMETERS
Serum drawn at the time of the phagocytic assay was stored in
liquid nitrogen for subsequent measurement of serum C3 and C4
concentrations, Clq binding activity (Clqba), and DNA binding
activity as described above (p202-212).
Kfc correlated with serum C3 (Fig V.5) «TMd.57; p<0.01; rank
correlation) but not with serum C4 (Fig V.6) (/£=0.33; p>0.05; rank
correlation). Kc did not correlate with either serum C3 or C4 (Fig
V.7 and 8) (rank correlation). Similarly no significant correlation
was found between DNA or Clq binding activity and either Kfc or Kc
(Table 6.11), and there was no significant correlation between Kfc
and Kc (rank correlation).
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Fig V.5 Correlation of.Kfc with serum C3.
Reduction in Kfc correlates with reduced serum C3 levels
(#=€>.57;p<0.01;rank correlation):












Fig V.6 Correlation of Kfc with serum C4.
Reduction in Kfc does not correlate significantly with serum C4
(rank correlation).
















Fig V.7 Correlation of Kc with serum C3.
Reduction in Kc does not correlate significantly with serum C3
(rank correlation).













Fig V.8 Correlation of Kc with serum C4.
Reduction in Kc does not correlate significantly with serum C4
(rank correlation).















CORRELATION OF RATES OF PHAGOCYTOSIS WITH CLINICAL MANIFESTATIONS.
To avoid bias, the clinical data obtained frem the serial
study of patients is excluded from the analysis and only the
initial observations made in each patient are included. Disease
activity in each patient is indicated by a "clinical disease
activity" score in which each active disease manifestation is given
a score of +1 (Cairns et al 1980).
Clinical disease activity correlated closely with Kc (T^=0.6;
p<0.003; rank correlation) but not with Kfc (1^=0.11; pX).01; rank
correlation) (FigV.9).
Only five patients had active CNS disease and of these four
had low Kc. Two had a previous history of CNS involvement of whem
one had normal Kc.
Seven had a history of previous renal involvement and although
three had persistent proteinuria (>3gms/24 hours), none had
deteriorating renal function or active urinary sediment. Three of
these had low Kc.
IMMUNOFLUORESCENCE.
Direct immunofluorescence on monocytes frcm two patients with
low Kfc and low Kc were performed on two separate occasions but no
evidence for membrane bound or cytoplasmic associated immune
complexes was found.
EFFECT OF DRUGS ON Kc AND Kfc.
No significant association (Fishers two tailed exact test) was
found between reduction of Kc or Kfc and treatment with
prednisolone, hydroxychloroquine or both in combination.
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Fig V.9 Correlation of rates of "complement" receptor (Kc) and Fc
receptor (Kfc) mediated phagocytosis with clinical disease activity
score.
Clinical disease activity score correlates closely with Kc






















2.0 EFFECT OF SLE SERUM ON PHAGOCYTOSIS BY NORMAL MONOCYTES.
To determine whether serum factors might be responsible for
defects of Fc or "complement" receptor mediated phagocytosis,
normal monocytes were preincubated with serum frcm S.L.E. patients
with defective phagocytosis. The serum was obtained in each case at
the time of drawing blood for each phagocytic assay and was stored
in liquid nitrogen until ready for use. Normal control serum was
treated in the same way.
Normal monocytes (one donor) were preincubated for 60 minutes
at 3"^: with either 15% normal control serum, 15% serum frcm five SLE
patients with low Kc or 15% serum frcm three SLE patients (5
separate serum samples) with low Kfc. Kc and Kfc respectively were
then measured in these normal monocytes to determine whether any
inhibitory material was present.
No significant inhibition of phagocytosis was detected (Fig
V.10) suggesting that immune complexes or other inhibitory factors
were not responsible for reduced rates of phagocytosis.
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Fig V.10 Effect of SEE serum on phagocytosis by normal monocytes.
Preicubation of normal monocytes with 15% serum frem SLE patients
with defective monocyte phagocytosis had no significant inhibitory
effect, compared with normal serum, on rates of either "complement"





































3.0 RELATION BETWEEN'RATES OF "COMPLEMENT'" RECEPTOR MEDIATED
PHAGOCYTOSIS AND THE CYTOCHEMISTRY OF LARGE MONONUCLEAR CELLS.
Reduced rates of "complement" receptor mediated phagocytosis
were not associated with changes in the ratio of NSE positive to
large mononuclear cells (>250 cub microns) and even in patients
with marked phagocytic defects there was a good correlation between
the Coulter "sizing" estimate of numbers of monocytes and the NSE
differential.
In only one patient, with a profound reduction in Kc, a
discrepancy between the NSE and Coulter "sizing" method of
enumerating monocytes was observed. This patient is discussed in
further detail below.
4.0 FURTHER STUDIES OF AN SLE PATIENT WITH PROFOUND DEPRESSION OF
"COMPLEMENT" RECEPTOR BUT NORMAL Fc RECEPTOR MEDIATED MONOCYTE
PHAGOCYTOSIS.
Monocytes from one patient with active SLE (patient C) which
exhibited low rates of "complement" receptor mediated phagocytosis
were studied in further detail to try and determine more fully the
nature of the defect. The aim of these studies was to determine:
i) the effect of therapy on Kc and on the relative numbers of
NSE positive and "large" mononuclear cells (>250 cu microns)?
ii) whether a similar defect of "complement" receptor mediated
phagocytosis was present in monocytes from other family members
which might therefore suggest an intrinsic or genetic defect of
"carplement" receptor expression?
iii) if it was possible to enhance "carpiement" receptor
expression in this patients cells using an activating agent such as
casein?
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EFFECT OF CORTICOSTEROID THERAPY ON RATES OF PHAGOCYTOSIS OF
"COMPLEMENT" COATED S. CEREVISIAE BY MONOCYTES FROM PATIENT C.
Venous blood was drawn inmediately prior to and at 4 and 72
hours after intravenous administration of one gramme of methyl
prednisolone. Mononuclear cells were separated in the usual way and
numbers of monocytes and lymphocytes determined both by Coulter
sizing and by NSE staining. The rate constant Kc was measured as
before.
The total yield of mononuclear cells per 20mls of blood rose
slightly following steroid administration. However although the
percentage of large mononuclear cells (>250cu microns) remained
almost constant, the number of NSE positive mononuclear cells
doubled during the period of study (Fig V.ll). Although Kc remained
belcw normal it rose slightly during the period of study;
furthermore the value obtained for Kc was lew regardless of whether
the monocyte concentration was based on the Coulter or the NSE
estimate of monocyte concentrations.
Thus while acute administration of high doses of
corticosteroids had a marked effect on relative numbers of NSE
positive and negative mononuclear cells and caused a doubling in
the absolute number of NSE positive mononuclear cells it did not
reverse the defect of "complement" receptor mediated phagocytosis.
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Fig V.ll Effect of acute administration of corticosteroids on
relative numbers of NSE positive and large (>250 cub micron)
mononuclear cells, and on rates of phagocytosis of "complement"
coated S. cerevisiae.
72 hours after lgranme of methyl prednisolone (I.V.) the number of
NSE positive mononuclear cells has doubled while the number of
large (>250 cub microns) cells is almost unchanged.
A rise in Kc is seen, regardless of whether the monocyte
concentration is calculated from the %age of NSE positive cells
( ), or the %age of large cells ( ). However the highest
value of Kc is still well below the normal range
(normal >7.9X10 mls/min/ironocyte).
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FAMILY STUDY OF "COMPLEMENT" RECEPTOR MEDIATED MONOCYTE
PHAGOCYTOSIS.
The relatives of patient C (father, mother, sister and
brother) were studied to seek evidence for a genetically determined
defect of monocyte "complement" receptor phagocytic function. The
relatives were in good health apart from the mother who had long
standing discoid lupus erythematosus. Mononuclear cells were
obtained frem each relative on three separate occasions for
determination of Kc which was measured using "complement" coated S.
cerevisiae as before.
Monocytes from the mother, brother and sister gave values for
Kc which were no different frem the normal controls whereas Kc for
monocytes from the father lay below the normal control range (Fig
V.12).
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Fig V.12 Mean (+/-S.E.M.) of three determinations of Kc in
monocytes frem patient C and her relatives.
Monocytes frem the patient (P) and her father (F) have low mean Kc,
while monocytes from the mother (M), sister (S) and brother (B)
appear to be normal.
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ENHANCEMENT OF "COMPLEMENT" RECEPTOR MEDIATED PHAGOCYTOSIS
To test the possibility that defective "complement" receptor
mediated phagocytosis by SLE monocytes was due to excessive
"masking" of complement receptors or failure of monocyte activation
attempts were made to enhance phagocytosis of "complement" coated
yeast using casein as an in vitro activating agent.
In each experiment 150ul of cell suspension were incubated
either with 20ul of casein solution (3.0mg/ml final) in HBSS or
with 20ul of HBSS alone. Preincubation was performed for either 20
or 70 minutes. Control experiments were carried out on normal
mononuclear cells for comparison.
The results are shown in Fig V.13. Preincubation of either
normal or patients' cells with HBSS alone for 70 minutes resulted
in lcwer values of Kc than preincubation for 20 minutes. However in
the presence of casein both control and patients cells showed an
increase in phagocytosis of "ccrrplorient" coated yeast (Kc). The
mean Kc for the patients' cells rose by 55% and 46% after 20 and 70
minutes preincubation and for the normal control cells by 20% and
34% respectively.
Thus casein enhanced "carpiement" receptor activity both in
monocytes from patient C and in normal monocytes in the expected
fashion confirming the presence of cryptic receptors. However
the increase in SLE monocytes paralleled that seen in normal
monocytes and it therefore seems unlikely that there is an excess
of cryptic receptors which are not fully expressed on monocytes
from SLE patients.
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Fig V.13 Effect of casein on rates of monocyte phagocytosis of
"carpiement" coated yeast (Kc).
20 or 70 minutes preincubation with casein stimulates the mean rate
of phagocytosis of "complement" coated yeast by both SLE (n=3)

























5.0 PHAGOCYTOSIS OF IgG AND "COMPLEMENT" COATED YEAST BY MONOCYTES
FROM NORMAL SUBJECTS WITH THE HLA-B8 HAPLOTYPE
A recent study has demonstrated impaired in vivo "Fc-mediated"
clearance of IgG coated erythrocytes in apparently healthy
individuals with the HLA-B8/DRW3 haplotype (Lawley et al 1981) and
the authors suggest that this may reflect an intrinsic defect of
MPS function which could predispose to immune complex disease.
However others have not found any impairment of Fc receptor
expression in blood monocytes frcm such individuals (Fries et al
1982).
To determine whether any functional impairment of Fc or
"complement" receptor mediated phagcoytosis could be detected in
HLA-B8 positive subjects, which might provide a genetic basis for
the abnormalities found in the SLE patients described above, rates
of phagocytosis by monocytes from a group of HLA-B8 normal subjects
were measured.
Eleven healthy HLA-B8 positive medical staff (6 male; 5
female) mean age 24 years (range 21-26) were studied. These
individuals were kindly provided frcm a register of tissue-typed
individuals by Dr M. Steele (MRC Unit; Western General Hopsital,
Edinburgh). Their full HLA-A & B haplotype is shown in Table 6.13.
326














Fc AND "COMPLEMENT" RCEPTOR MEDIATED PHAGOCYTOSIS BY MONOCYTES FROM
HLA-B8 POSITIVE NORMAL SUBJECTS
There was no significant difference (Fishers exact test) in
the rate constants for "ccnplement" receptor or Fc receptor
mediated monocyte phagocytosis (Kc and Kfc) between the normal
control group and HLA-B8 positive individuals (Fig V.14).
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Fig V.14 Rate constants for "complement" receptor (Kc) and Fc
receptor (Kfc) mediated monocyte phagocytosis in normal controls
and HLA-B8 subjects.
There is no significant difference between the normal controls and
































6.0 COMPOSITION OF THE MONONUCLEAR CELL POPULATION IN NORMAL
CONTROLS AND SLE PATIENTS
A limited number of preliminary experiments have been
performed on mononuclear cells frem SLE patients to determine
whether reduced rates of "complement" receptor mediated
phagocytosis reflect a reduction in the number of CR bearing
monocytes as demonstrated above in RA patients. Only 6 SLE patients
have so far been studied, five of whom were in complete remission
and one had active disease. The method of assessing percentages of
NSE positive and percentages of phagocytic cells is exactly as
described above (p290) for RA patients. The sane group of 11 normal
control subjects has been used (p288).
SLE PATIENTS:
The serological features of these eight SLE patients (7
female, 1 male) (ARA criteria) are shown in Table 6.14 and drug
therapy in Table 6.15.
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Table 6.14 Clinical and serological features of SLE patients
Patient Age Hb WBC ESR Clinic;
number yrs gm/dl 10/1 mm/lst hr. score
1 16 10.5 2.7 101 6 *
2 27 13.3 3.6 7 1
3 34 13.1 10.5 - 0
4 50 14.5 6.5 4 0
5 22 13.8 3.2 1 1
6 26 11.3 4.1 62 1
7 17 12.2 3.3 25 1
8 31 12.1 4.4 30 1
Patient ANF DNA C3 C4 ENA
number u/dl mg/dl mg/dl
1 + 115 40 10 Sm/RNP
2 + <25 60 13 Ro/La
3 - <25 67 24 Sm
4 + <25 63 16 -
5 + <25 63 29 -
6 + 64 28 Sm/RNP
7 + 60 17 Sm/RNP
8 + 64 8 Sm
(* arthritis; leucopenia; PUO; glomerulonephritis; malar rash;
vasculitis; splencmegaly/lynphadenopathy)
Table 6.15 Drug therapy of SLE patients
Patient Therapy
number A B D
mg/day mg/day
1 - - +
2 - 200 -





6 12 400 +
7 15 400 +






The preliminary results, which are shown in Tbble 6.16,
suggest that a much smaller percentage of monocytes frcm the
patient with active SLE (clinical score = 6) are capable of
phagocytosing "ccnplement" coated yeast than IgG coated yeast, but
no difference is seen in mononuclear cells frcm the seven patients
with clinically inactive SLE (clinical score = 0 or 1).
There also appears to be a reduction in the number of NSE
positive cells capable of phagocytosing either type of particle in
the SLE group compared with the normal controls. Whereas 80% of
NSE-positive cells frcm normal controls are phagocytic, only 60% of
NSE positive mononuclear cells from SLE patients are phagocytic for
either particle. However it must be emphasised that the numbers are
too small to draw firm conclusions.
Table 6.16 Percentage (+/-S.D.) of cells in mixed mononuclear cell
population phagocytosing IgG coated yeast (%FcR positive) or
complement" coated yeast (%CR positive) and percentage (+/-S.D.)
NSE positive cells.
Mononuclear cells
n % NSE +ve % FcR +ve % CR +ve
Normal controls 11 27.0 +/-6.2 21.1 +/-3.7
"Inactive" SLE 7 31.9 +/-2.4 18.2 +/-6.8









To avoid selection or loss of subpopulations of monocytes with
abnormal properties, mixed mononuclear cell preparations were used
during phagocytic studies and no attempt was made to separate
monocytes from lymphocytes on the basis of functional properties
(e.g. adherence) or physical properties (e.g. density). Although
there is the possibility that the presence of lymphocytes might
influence phagocytic function, it was felt that this was unlikely
to be critical during short term studies lasting 15) to an hour.
However, distinction of monocytes frem lynphocytes was of
considerable importance in quantitative studies where the monocyte
concentration formed an integral ccmponent of rate calculations.
Two methods were used to estimate monocyte concentrations - a
Coulter sizing method and NSE staining. The Coulter sizing
technique, which identifies monocytes by their larger volume,
counts large numbers of cells rapidly and reproducibly. However it
has the disadvantage that there is overlap in the size distribution
curves of monocytes and lymphocytes and changes in numbers of the
large lymphocyte population or an increase in numbers of smaller
monocytes will give misleading results. Diffuse NSE staining is
widely accepted as a marker of mononuclear phagocytes and was used
as an additional criterion of relative numbers of lymphocytes and
monocytes. The principal disadvantages are that it is more time
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consuming and, while tissue macrophages stain strongly and
uniformly, blood monocytes vary considerably in the intensity of
staining and may give rise to uncertainties in identification. The
use of two markers - the first using large numbers of cells and a
physical characteristic and the second using smaller numbers of
cells but a more specific cytochenical marker, was thus a suitable
compromise.
Phagocytic assay system
Two methods for measuring phagocytosis by blood monocytes were
used in these studies. The first required direct microscopic
identification of phagocytic cells and the second measured rates of
phagocytosis indirectly by monitoring the fall in extracellular
yeast concentration in a mixture of monocytes and yeast.
An initial pilot study of a direct microscopic method of
assessing phagocytosis described by Territo and Cline (1977) gave
disappointing results but was later used successfully in a modified
form to identify phagocytic subpopulations. In the original method
yeast were used as substrate and phagocytosis allowed to proceed in
the presence of 10% AB serum; phagocytosis was assessed by counting
numbers of phagocytic cells and ingested yeast in cytocentrifuge
slides of cells stained with Jenner-Gionsa. During the assay large
clumps of yeasts and monocytes formed making subsequent microscopic
counting of cells and yeast difficult. Furthermore, monocytes were
also rapidly lost from suspension as a result of adherence to the
wall of the incubation vessel. The latter problem was overcome by
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incubating cells in wells machined frcm Teflon block. Clumping of
\
cells and yeast did not occur providing preopsonised yeast were
used. The "direct" method employing yeast preopsonised with
different opsonins was later successfully applied to the
identification of subpopulations of phagocytic cells. Also, since
Jenner-Giemsa was found to be an unsatisfactory stain for these
studies, NSE stains were used which enabled clearer distinction of
phagocytic and nonphagocytic monocytes from lymphocytes.
For studies of the kinetics of phagocytosis and subsequent
clinical studies, an "indirect" assay described by Leijh et al
(1977) was arployed. The method monitors the rate of phagocytosis
by following the fall in extracellular yeast concentration in a
mixture of yeasts and monocytes and no attempt is made to count
numbers of ingested yeast.
The method was validated by metabolic controls studies.
N-ethyl maleimide which irreversibly inhibits thiol dependent
enzyme systems including anaerobic glycolysis caused dose dependent
inhibition of phagocytosis while cyanide, an inhibitor of
mitochondrial respiration had no effect. Since N-ethyl maleimide is
relatively nonspecific and may for exanple inhibit Fc receptor
binding, the effect of 2-deoxyglucose (2DG) which is a more
specific inhibitor of anaerobic glycolysis was also studied.
However, in agreement with Michl (1976), 2DG caused only partial
inhibition of phagocytosis. The failure of 2DG to produce complete
inhibition has been attributed to the presence of stores of
creatine phosphate which is used by macrophages to rephosphorylate
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ADP to ATP and provide energy for phagocytosis even when anaerobic
glycolysis is inhibited. Creatine phosphate stores are created by
phosphorylation of creatine by ATP in resting cells, thus to
produce ccrrplete metabolic inhibition of phagocytosis, simultaneous
inhibition of anaerobic glycolysis by 2DG and depletion of ATP
dependent synthesis of creatine phosphate in resting cells is
required. This was achieved by preincubating cells with 2DG and
cyanide simultaneously and under these conditions 100% inhibition
of phagocytosis was obtained. Qualitative evidence that the
"indirect" method was a measure of phagocytosis was obtained by
electron microscopy.
Nature of opsonins present on yeast
As the studies progressed, the nature of the opsonins present
on the phagocytic particle assumed greater importance and control
studies were performed to identify the type of opsonins present.
In initial studies, C. albicans opsonised with human serum was
used which was found on direct immunofluorescence to be coated with
IgA, IgM, IgG and C3/C3c (|3lc/^la). Thus Fc receptors, CR1 and CR3
receptors and possibly others were potentially involved in
mediating binding and ingestion of this particle. The involvement
of lectin-like receptors was also considered, and although
unopsonised particles were ingested very slowly, saccharide ligands
may none the less act synergistically with opsonins such as
complement in mediating ingestion. Using serum opsonised C.
albicans, reduced rates of phagocytosis were found in monocytes
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frcm certain RA patients and as a first step towards resolving
which type of receptor was involved in the abnormality, two
different types of preopsonised yeast were developed. To study Fc
receptor mediated uptake, C. albicans opsonised with pooled human
IgG was used and for "carplement" receptor mediated uptake, S.
cerevisiae preopsonised with serum from a single donor was used.
To examine which ligands were responsible for mediating
phagocytosis these two types of particle were treated with P^2
fragments of IgG antibody to potential ligands including Fc, Clq,
C4, jilH, C3/C3c (^lc/^la). Anti C3/C3c does not enable a
distinction to be made between C3b and C3bi. Treatment of the IgG
coated C. albicans with Fa.1^2 anti-Fc produced complete inhibition
of phagocytosis confirming that uptake was mediated by Fc
receptors. However it is not known whether IgGl or IgG3 is the more
inportant ligand. Phagocytosis of "complement" coated S. cerevisiae
was not inhibited fcy Faloj2 anti-C4 or |3lH but was strongly inhibited
by anti-C3/C3c and, unexpectedly, to a small extent by anti-Clq.
Simultaneous treatment of these yeast with anti-C3 and anti-Clq
produced complete inhibition of ingestion. Although it has been
reported that monocytes carry a receptor for Clq there have been no
reports to suggest that these receptors are involved in
phagocytosis. However the contribution of Clq appeared to be small
and binding and ingestion was mainly dependent on C3/C3c and
therefore probably involves either the CR1 or CR3 receptors.
Further studies using anti-CRl or anti-CR3 antibody as inhibitors
are required to clarify this issue.
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Kinetics of phagocytosis
Using the "indirect" method the kinetics of monocyte
phagocytosis of yeast opsonised in various ways were studied. The
results of pilot studies of monocytes frcm normal controls and RA
patients danonstrated that phagocytosis followed simple second
order collision kinetics and enabled a "rate constant" to be
obtained from a rapid 20 minute study. The "rate constant" is a
measure of the efficiency of binding and phagocytosis and, as
demonstrated, is dependent on the degree of opsonisation of the
yeast particles. A major advantage of calculating a "rate constant"
is that it incorporates the monocyte concentration and avoids the
need for accurate adjustment of the cells to a specific
concentration in each experiment.
In later studies where the aim was to determine the maximum
number of monocytes capable of phagocytosing either IgG or
"carplement" coated yeast, cells were incubated with yeast for 40
minutes and allowed to reach the plateau phase of the phagocytic
rate curve.
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Results of studies on monocytes from RA patients
In general, identification of monocytes by Coulter sizing
correlated well with NSE staining of mononuclear cells frctn RA
patients and the Coulter sizing result was used for calculation of
the phagocytic rate constant. However as will be discussed below,
the Coulter sizing methoddid not always correlate with NSE
staining, giving rise to problems in the interpretation of kinetic
data.
Initial studies of monocytes from RA patients using C.
albicans opsonised with serum demonstrated a significant reduction
in rates of phagocytosis (Ks) in patients with rheumatoid cutaneous
vasculitis (RV) but not in patients with uncomplicated RA.
Monocytes from one of the RV patients were restudied after
cessation of the vasculitic episode and found to have normal rates
of phagocytosis, suggesting that the abnormality was transient and
secondary to the disease process.
Cutaneous vasculitis in RA is associated with
hypoccrrplementaemia (Mongan et al 1969) and large circulating 19S
IgM containing irtmune ccrtplexes (Weisman & Zvaifler 1975) and as
expected there was a tendency for the RV patients to have reduced
levels of serum haemolytic complement. This suggested that
complement fixing circulating immune complexes might be responsible
for the phagocytic abnormality, perhaps by causing blockade of
monocyte receptors. However inmunofluorescence studies on monocytes
from three of the RV patients revealed no intracytoplasmic
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inclusions of gamma-globulin or complement thus providing some
evidence against this hypothesis.
It was also not clear from this preliminary study which types
of monocyte receptor were involved in the functional abnormality of
phagocytosis and to examine this question further the studies were
repeated using IgG coated C. albicans to measure rates of Fc
receptor mediated phagocytosis, and serum opsonised S. cerevisiae
to measure "complement" receptor mediated uptake. "£he results were
correlated with tests for immune complexes and serum complement
levels.
The results of this second study demonstrated that reduced
rates of phagocytosis by monocytes from patients with cutaneous
vasculitis were confined to uptake of "complement" coated yeast and
that phagocytosis of IgG coated yeast was normal. In addition, four
patients who did not have vasculitis also had a similar phagocytic
defect. Two of these four had pyoderma gangrenosum, a known
association of both RA and seronegative arthritis (Holt et al
1980), one had nodular RA in association with primary biliary
cirrhosis (James et al 1981) and the fourth had nodular RA
complicated by pericarditis. None of the remaining patients, who
included two with pyogenic infection and one with Feltys syndrome,
had a phagocytic defect.
The phagocytic data was examined for correlations with
circulating inmune complexes and serum complement.
Hypoconplementaenia, elevated anti-ccmplementary activity (ACA) and
Clq binding activity (Clqba) were features of many of the patients
340
with reduced "complement" receptor mediated phagocytosis (Kc).
t
However, reduced Kc did not always correlate with these serological
changes and of four patients with reduced Kc without vasculitis,
two had normal C3 and C4 levels and three had no increase in ACA.
Conversely, normal Kc was seen in scrre patients with very high
levels of Clqba, lowered serum C3 and C4 levels and elevated ACA
titres. Thus the association between serological evidence of
complement fixing circulating immune carpiexes and reduced Kc was
not invariable. Although this evidence suggests that abnormalities
of "complement" receptor mediated phagocytosis may not be due to
receptor blockade by immune carpiexes, it is by no means
conclusive. For exanple the finding of normal levels of
irrmunoreactive C3 does not preclude complement consumption since
increased canplement synthesis may be occurring simultaneously.
Conversely, the failure to demonstrate abnormalities of
phagocytosis in all patients with evidence of circulating immune
complexes may sirrply reflect a lack of sensitivity in the
phagocytic assay system. None the less, direct immunofluorescence
on mononuclear cells from patients with reduced Kc again failed to
reveal the presence of monocyte associated immunoglobulin or
carpiement, suggesting that receptor blockade by immune complexes
was not responsible for the functional alteration of phagocytosis.
Furthermore, incubation of normal monocytes with serum from RA
patients with reduced Kc did not inhibit their ability to
phagocytose "complement" coated yeast.
An alternative hypothesis, namely that reduced Kc was due to
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an alteration in the composition of the circulating pool of blood
monocytes with a concomitant reduction in function was therefore
considered. This could arise either by dilution of the peripheral
blood pool of monocytes with immature monocytes prematurely
released frcm the marrow or alternatively by increased removal of
the most functionally active cells from the blood stream or by a
combination of both these mechanisms. The net effect of either
mechanism might be to reduce the mean functional "complement"
receptor activity of circulating monocytes accessible to sampling.
Furthermore if increased removal and margination of monocytes were
secondary to phagocytosis of immune complexes within the
circlation, this would explain the failure to demonstrate monocyte
associated immune complexes as the relevant cells would no longer
be accessible for study.
In support of an "altered population" hypothesis was the
finding that in same patients there was a discrepancy between the
Coulter and NSE estimates of monocyte concentrations and that
reduced Kc correlated with the magnitude of this discrepancy. Thus
the data appeared to show that reduced Kc correlated with the
appearance of increasing numbers of NSE-negative, large (>250 cub
microns) mononuclear cells. Since Kfc remained normal, the data
implied that there were large NSE-negative cells with phagocytic Fc
receptors but functionally inactive or absent "complement"
receptors appearing in the circulation. However because
cytochemical data was not available on every patient there was the
possibility of bias, and further studies of patients with defective
"ccnplement" receptor mediated phagocytosis were undertaken. These
studies sought to confirm or refute the hypothesis that changes in
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phagocytic function reflected an alteration in monocyte
subpopulations and the appearance of NSE-negative, FcR-positive,
CR-negative mononuclear phagocytes. In these experiments the
percentages of mononuclear cells showing either Fc or "carpiement"
receptor dependent phagocytosis (FcR and CR positive cells) were
enumerated and carpared with the percentage of NSE positive
mononuclear cells and the percentage of large (>250 cub microns)
mononuclear cells. Mononuclear cells were obtained frem normal
controls, patients with uncomplicated RA, and RA patients with
vasculitis or a history of vasculitis. The results confirmed that
there is a reduction in the percentage of monocytes capable of
phagocytosing " complement" coated yeast and no reduction in the
percentage of FcR positive cells. The results did not confirm that
there was an increase in numbers of NSE-negative large mononuclear
cells bearing phagocytic Fc receptors. The data therefore gives
only partial support to the previous findings and demonstrates the
presence of NSE-positive, FcR positive, CR negative cells. Although
the presence of NSE-negative phagocytic cells was not confirmed,
the possibility remains that the CR deficient cells are immature
monocytes prematurely released from the marrow.
Horwitz and Steagall (1972) reported increased numbers of
non-phagocytic, NSE negative monocyte precursors in the peripheral
blood of patients with RA. They used latex particles to measure
phagocytic function and Fc and "complement" receptor function was
not measured directly. Thus a direct comparison with the data
343
reported in this thesis is not possible. More recent studies of the
functional and cytochemical characteristics of monocyte precursors
have produced conflicting data. Lohmann-Mattes et al (1979) have
identified a murine bone marrow derived monocyte precursor which is
non-adherent, nonphagocytic and NSE negative and has natural killer
cell (NK) activity. They have shown that this NSE negative cell
matures into a typical NSE positive mononuclear phagocyte on
culture in vitro. These observations have been extended to human
peripheral blood where similar nonadherent, NSE-negative
mononuclear cells with NK activity have been identified which
mature into NSE-positive macrophages (Lohmann-Mattes et al 1981).
The phagocytic function of this cell has not been reported. On the
other hand, studies of human bone marrow cells (van Furth et al
1980), identified the human promonocyte as a large NSE positive
cell with a phagocytic Fc receptor. These cells carry C3b receptors
which have little if any phagocytic activity. The cytochenical and
functional properties of human monoblasts have not been fully
characterised. Studies of murine marrow precursors (van Furth et al
1980) show that only 30% of promonocytes are NSE positive and are
less phagocytic than their human counterparts.
Although the "CR-negative" cells identified in these
experiments appear to have the characteristics of promonocytes i.e.
they are NSE-positive and have a phagocytic Fc receptor (van Furth
et al 1980), the results do not preclude the possibility that the
inability to phagocytose "caiplement" coated yeast might be due to
the effect of serum factors such as iirmune complexes.
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A prequisite for further characterisation of these cells is
their isolation frcm other mononuclear cells. Preliminary
experiments, described in this thesis, have been performed on
monocytes frcm a limited number of subjects in which the phagocytic
function of the glass adherent population has been compared with
that of the whole mononuclear cell population in suspension. These
experiments suggest that the CR-negative monocytes are not
glass-adherent and in this respect resemble the monocyte precursors
described by Lohmann-Mattes et al (1981). If further experiments
confirm that these cells are non-adherent, this property could
provide a basis for their isolation and further study.
Conclusions
The aim of these studies was to determine whether defects of
phagocytosis by mononuclear phagocytes are present in RA patients
which might contribute to the persistence of immune complexes.
The experimental results show that functional defects of
"complement" receptor mediated phagocytosis are found in blood
monocytes from RA patients with vasculitis and certain other
"extra-articular" complications. However, the abnormalities when
present are transient and appear to be secondary to the disease
process. The evidence suggests that alterations in phagocytic
function reflect alterations in the composition of the monocyte
population which may be secondary to release of monocyte precursors
from the bone marrow. However, the possibility that immune
complexes are responsible for alterations in phagocytic function
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either directly by "receptor blockade" or indirectly by causing
increased emigration of monocytes from the blood cannot be
completely excluded on the available evidence.
The inportance of using more than one criterion for
identifying monocytes is emphasised by the findings in these
studies as well as the results of studies of monocyte precursors
reported by others (Lohmann-Mattes et al 1979, 1981).
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Results of studies on monocytes frcxn SLE patients
The initial studies of a group of 18 SLE patients demonstrated
a reduction in rates of phagocytosis of both IgG and complement
coated yeast by blood monocytes frcm some patients with SLE.
Reduced uptake of IgG coated yeast was an infrequent finding, but
was correlated with reduced serum C3 levels and, in two patients
studied serially, with disease activity. In the group as a whole
however, there was no correlation between Kfc and the "disease
activity" score. Reduced phagocytosis of "complement" coated yeast
on the other hand was found in monocytes fran 50% of SLE patients,
correlated well with "disease activity" but not with any of the
serological parameters measured. It should be noted however that in
one patient studied longitudinally, phagocytosis of "complement"
coated yeast tended to be depressed regardless of disease activity
suggesting that the functional abnormality might not be a secondary
phenomenon.
The data suggests that different factors may be responsible
for altering Fc and "complement" mediated phagocytosis. Several
mechanisms might be responsible and include blockade of phagocytic
receptors by circulating immune complexes; the presence of monocyte
subpopulations with altered phagocytic receptor function;
modulation of phagocytosis by drugs; and intrinsic abnormalities of
monocyte receptor expression.
Although no correlation was found between reduced Kc and
reduced serum complement levels or tests for immune complexes, a
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positive correlation -was noted between KFc and serum C3 levels
which could be the result of immune complex blockade by Fc bearing,
complement fixing immune complexes. However, direct examination
with immunofluorescence failed to reveal the presence of membrane
bound or cytoplasmic immune complexes. Furthermore, serum from SLE
patients with marked defects of phagocytosis had no inhibitory
effect on phagocytosis by normal monocytes, a finding which is
agreement with Svensson et al (1980).
Dilution of the peripheral blood monocyte pool with immature
cells could provide an alternative explanation for a reduction in
"complement" receptor mediated monocyte phagocytosis. It should be
noted that with the exception of one patient (patient C) discussed
below, there was a good correlation between the Coulter sizing and
NSE staining methods for estimating monocyte concentrations. Thus
the discrepency between these two methods of assessing monocyte
concentrations noted during studies of RA patients did not occur in
studies of SLE patients. As discussed in relation to RA patients
the premature release of immature cells from the marrow in response
to an inflammatory stimulus could dilute the blood monocyte
population and result in reduction of numbers of monocytes
expressing functional "complement" receptors. The correlation
between reduction in Kc and increasing disease activity in SLE
patients supports this possibility. This hypothesis was tested
further by measuring the relative percentages of mononuclear cells
which were capable of phagocytosing either IgG or "complement"
coated yeast particles. The results of these preliminary studies
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identified one patient with active SLE with a marked reduction in
the percentage of monocytes phagocytosing "complement" coated yeast
while the remaining patients with mild or inactive disease had
normal percentages of phagocytic cells. This preliminary data
suggests that there may be a reduction in the proportion of
monocytes capable of phagocytosing "complement" coated yeast in
active SLE, and although studies of more patients are clearly
required, the results are very similar to those obtained in RA
patients with vasculitis.
No inhibitory effect of drug therapy on monocyte function was
found in the patients considered as a group or in two patients
(A&B) studied serially. In one patient (C) with depressed
phagocytosis of "complement" coated yeast an increase in rates of
phagocytosis was seen up to 72 hours after a single intravenous
dose of lgm of methylprednisolone. An enhancing effect of steroid
therapy on phagocytosis of serum opsonised cryptococci by monocytes
has been reported previously (Rinehart et al 1975). The fact that
* the number of NSE positive cells in the mononuclear cell population
obtained from this patient doubled during the period of study while
the the number of large (>250 cub microns) cells remained constant
strongly suggests that steroids are influencing monocyte traffic
and that increased numbers of smaller NSE positive monocytes were
present in the circulation. The associated increase in "complement"
receptor dependent phagocytosis suggests that these may be
relatively mature cells derived from the marginated pool of
monocytes which are about to leave the circulation for tissue
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sites.
The possibility of intrinsic abnormalities of mononuclear
phagocyte receptors analogous to the genetic defect of low density
lipoprotein receptors found in familial hypercholesterolaeriia
(Goldstein et al 1975) should also be considered. Although one
study (Lawley et al 1981) has demonstrated abnormal in vivo Fc
mediated RES clearance in 50% of healthy B8/DRW3 positive subjects,
a more recent study (Fries et al 1982) of the number and affinity
of blood monocyte Fc receptors in B8 positive individuals showed no
abnormality. Similarly no Fc or "complement" receptor dependent
phagocytic defect was found in monocytes from a group of eleven B8
healthy subjects described in this thesis. The significance of
studies suggesting that there may be genetic variation in
erythrocyte C3b receptor (CRl) density and that low densities of
CRl are found more frequently in patients with SLE and sane of
their healthy relatives (Miyakawa et al 1982; Wilson et al 1982)
has already been discussed in Chapter 3. To test the hypothesis
that defective "complement" receptor dependent phagocytosis by
monocytes might be inherited, monocyte phagocytic function was
studied in the relatives of one SLE patient (patient C) with
reduced Kc. Monocytes from the father of this patient showed
reduced rates of phagocytosis, while monocytes from 2 siblings and
the mother were normal. Although the result is consistent with the
presence of an inherited defect of "complement" receptor phagocytic
function, the possibility remains that "complement" receptor
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deficiency has nothing to do with the occurrence of SLE in this
patient. Studies of healthy control families as well as of "SLE
families" will be required to answer this question. In contrast,
other studies suggest that reduced erythrocyte CR1 expression in
SLE patients (Iida et al 1982) and absent glomerular CR1 in SLE
patients with diffuse proliferative nephritis (Kazatchkine et al
1982) is likely to be secondary to the disease process and the
presence of intrinsic complement receptor defects is by no means
certain.
To test the possibility that "masking" of receptors was
responsible for defective "complement" receptor mediated
phagocytosis, the effect of casein was examined on monocytes from
an SLE patient (patient C). Although casein enhanced phagocytosis
of "complement" coated yeast by monocyte frcm this patient,
confirming the presence of latent receptor activity, the increase
was no greater than that seen in normal controls suggesting that




The aim of these studies wah to determine whether defects of
phagocytosis by mononuclear phagocytes are present in SLE patients
which might contribute to the persistence of immune complexes. The
studies have identified functional defects of both Fc and
"complement" receptor mediated monocyte phagocytosis and the
possible significance of these findings has been discussed.
Same of the evidence suggests that defective "complement"
receptor mediated phagocytosis may be secondary to disease activity
while data frcm a family study suggests that it may be inherited.
Abnormalities of Fc receptor mediated phagocytosis appeared to be
infrequent and when present were related to changes in disease
activity. The exact nature of the defect of "complement" receptor
mediated phagocytosis remains to be established and may involve
CR1, CR3 or possibly Clq receptors.
Whatever their cause these functional abnormalities of
monocyte phagocytosis have important implications. Initial contact
with antigen involves opsonisation by antibody and complement and
is followed by phagocytosis. The development of an effective immune
response is dependent on this phagocytic step as well as on
subsequent presentation of antigen to lymphoid cells. Inefficient
phagocytosis of antigen could therefore impair the subsequent
immune response, allow persistence of antigen and favour the
development of immune complex disease. The same phagocytic defect
could also contribute to the persistence of immune complexes and
thus exacerbate the immune defect.
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Suggestions for further experiments
The significance of diminished "complement" receptor function
in blood monocytes and its relation to the pathogenesis of RA and
SLE must remain uncertain until the irechanism of the alteration is
understood. Additional experiments which might help to further
elucidate the abnormality include the following.
1) "Ccmplement" receptors on monocytes frcm patients with RA
and SLE should be studied with anti-CRl and anti-CR3 antibodies to
determine whether functional defects are due to diminished numbers
of CRl or CR3 receptors.
2) More sensitive methods should be applied to study whether
or not blood monocytes with phagocytic defects contain iimrune
complexes. Radiolabelled antibody to carplement carponents,
complement degradation products and immunoglobulin would be a more
sensitive probe than immunofluorescence for studying this question.
3) This thesis has not examined whether defective mononuclear
phagocytes are found in the tissues and this is clearly relevant
both to possible alterations in monocyte traffic as well as to the
"clearance" function of macrophages in the joints, liver and
spleen. Synovial fluid and skin exudate cells would be accessible
for studies of macrophage receptor number and function.
Immunochemical studies of monocytes migrating into skin exudates
would also help to address the question of whether marginated
monocytes contain immune complexes or not.
4) In vitro studies of the modulation of "complement"
receptors by immune ccnplexes would also be valuable and in
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particular should address whether defects of phagocytosis are more
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Evidence for defect of
complement-mediated phag¬
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Abstract
In-vitro measurements of the rate of monocyte phago¬
cytosis of heat-killed yeast preopsonised in human AB
serum fMMoa 14 patients with rheumatoid arthritis and 14
normal controls showed a significant reduction in five
patients with active vasculitis but no change in nine with
active arthritis alone. Further studies of complement-
and Fc-mediated monocyte phagocytosis in which the
rate constants (Kc and KFc respectively) were determined
using complement-coated Saccharomyces cerevisiae and
Candida albicans opsonised with IgG in monocytes from
nine patients with rheumatoid vasculitis and 12 controls
showed a significant reduction in Kc (p <0 01) but normal
Kfc. Kc was normal in three patients with inactive vas¬
culitis. Low Kc was correlated with low serum C3 con¬
centrations but not with Clq binding or anticomple¬
mentary activity, and no evidence of intracytoplasmic or
membrane-bound immune complexes was detected in
monocytes from patients with active vasculitis.
These results show that cutaneous vasculitis in rheuma¬
toid arthritis is associated with selective impairment of
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complement-mediated monocyte phagocytosis, which
does not appear to result from receptor blockade by
immune complexes.
Introduction
Cutaneous vasculitis in rheumatoid arthritis is associated with
hypocomplementaemia,1 increased complement consumption,2
large 19S IgM-containing circulating immune complexes,3
and deposition of complement-containing immune complexes in
small arterioles." The episodic nature of clinical manifestations
of vasculitis in rheumatoid arthritis suggests the possibility of
intermittent saturation of immune clearance mechanisms. The
cells thought to be responsible for clearance of circulating
immune complexes are the mononuclear phagocytes of the
spleen and liver.5 As part of an investigation of mononuclear
phagocyte function in rheumatoid arthritis we performed in-
vitro measurements of monocyte phagocytosis in patients with
uncomplicated rheumatoid arthritis, patients with rheumatoid
cutaneous vasculitis, and normal controls.
Subjects and methods
Mononuclear cells were separated from 10 ml of venous blood
using a density gradient," washed, and resuspended in Hanks's
balanced salt solution plus 01% gelatin. The concentration of mono¬
cytes present was determined using a rapid Coulter sizing technique7
validated by comparison with differential cell counts performed with
non-specific esterase stains.8
Heat-killed yeast were preopsonised in bulk, resuspended to
lO'/ml, and stored in aliquots in liquid nitrogen. Direct immuno¬
fluorescence verified that Candida albicans opsonised in fresh human
serum was coated with complement (C3) and immunoglobulins
(IgG, IgA, and IgM) while Saccharomyces cerevisiae in human serum
was coated only with complement (C3). To provide yeast coated
with IgG alone C albicans was opsonised in pooled human IgG.
Phagocytosis was measured by a modification of the method of
Leijh et alEqual volumes (150 (d) of mononuclear cells and yeast
particles were dispensed into six wells (400 (d), machined in a Teflon
block, and incubated at 37°C under rotation. Aliquots of cell sus¬
pension were removed immediately after mixing and at timed intervals
and diluted in counting fluid (2% acetic acid and gentian violet), and
numbers of extracellular yeast remaining were counted in haemacyto-
meters. The rate of phagocytosis was determined by the fall in yeast
concentration. The method was validated using metabolic controls and
electron microscopy. Pilot studies showed the kinetics of phago¬
cytosis to be second order and that a rate constant K, which is a
3
measure of the efficiency of phagocytosis, could be obtained from the
expression
1 No
K = x In ml/min/monocyte
t x [M<p] Nt
by measuring changes in the numbers of yeast (N) over a 20-minute
interval (t) in the presence of a known monocyte concentration [M9].
The rate constant was measured initially using C albicans opsonised
in human serum (Ks) 14 normal controls and 14 patients with
classical rheumatoid arthritis,10 five of whom had active cutaneous
vasculitis. Subsequently the rate constant was measured for Fc-
mediated uptake (Kfc) using C albicans opsonised in pooled human
IgG and for C3-mpdiated uptake (Kc) using S cerevisiae opsonised in
human serum group of 12 normal controls and nine patients
with cutaneous vasculitis. Serum and EDTA plasma drawn at the
time of the phagocytic assay were stored in liquid nitrogen for
subsequent measurement of serum C3 and C4 concentrations (radial
immunodiffusion; Seward Laboratories Immunostics), Clq binding
activity,11 and anticomplementary activity.12
Cytocentrifuge smears and washed cell suspensions of mononuclear
cells were examined for the presence of intracytoplasmic immune
complexes and membrane-associated immune complexes respectively
by direct immunofluorescenceusingfluoresceinconjugatedantigamma-
globulins and anti-fllC/plA (Nordic Diagnostics).
Results
In the initial study using C albicans opsonised with both C3 and
immunoglobulins there was no difference in the rate constant Ks
between normal controls and patients with uncomplicated rheumatoid
arthritis, but Ks was significandy reduced (p < 0 01, rank sum test) in the
patients with active vasculitis (fig 1). In subsequent studies, in which
the rate constants for C3-mediated uptake (Kc) and Fc-mediated
uptake (Kfc) were measured separately, no change was found in Kfc
in the patients with vasculitis compared with the normal controls
(fig 2) but Kc was significantly reduced (p<001, rank sum test)
(fig 3). In three subjects whose vasculitis was judged to be clinically
inactive Kc was in the normal range. All patients in whom Kt- was low
had low serum C3 concentrations, while the three subjects with
inactive vasculitis and normal Kr had normal serum C3 concentrations
(table). There was no clear correlation between a reduction in Kc and
results of immune complex assays. All patients had high Clq binding
activity both during and after vasculitic episodes and all had raised
anticomplementary activity during vasculitis (table). Two of the three























fig 1—Monocyte phagocytic rate
constant (Ks) in normal subjects and
patients with rheumatoid arthritis and
vasculitis.
fig 2—Rate constant (Kfc) for Fc-
mediated phagocytosis in normal
subjects and patients with active and
inactive vasculitis.
fig 3—Rate constant (Kc) for com-
plement-mediated phagocytosis in
Rheumatoid normal subjects and patients with
vasculitis active and inactive vasculitis.
(n=K) (n=9) (n=3)
J*
Complement-mediated phagocytosis (Kc), serum complement (C3 and C4)
concentrations, and results of immune complex assays in patients with rheuma¬
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No intracytoplasmic or membrane-associated immune complexes
were found in monocytes from four patients with active vasculitis and
low Kc.
Discussion
These studies appear to show for the first time selective
functional depression of complement-mediated monocyte
phagocytosis in patients with rheumatoid vasculitis. The
synchronous depression of Kc and serum C3 concentration in
the presence of high Clq binding activity and anticomple¬
mentary activity might suggest that saturation of complement-
mediated clearance mechanisms is associated with the
appearance of clinical vasculitis in rheumatoid arthritis. A
similar defect limited to complement-mediated clearance of
coated red cells has recently been shown in vivo in patients with
primary biliary cirrhosis,13 a disease that is associated with
circulating complexes containing IgM and IgG and with
increased complement catabolism.14 Large complexes containing
19S complement-fixing IgM are also found in rheumatoid
vasculitis, but the relation is not constant and the appearance of
vasculitis unpredictable.3 The finding that complement-
receptor-mediated phagocytosis is depressed in these patients
while Fc-receptor function is unchanged might suggest that these
complexes are binding preferentially to complement receptors
and that binding of IgG Fc ligands is sterically inhibited by the
presence of IgM rheumatoid factor. However, attempts to show
the presence of surface-attached or intracytoplasmic immune
complexes in monocytes from these patients by direct immuno¬
fluorescence have been unsuccessful.
An alternative explanation for these findings may be that
rheumatoid vasculitis is associated with a change in the com¬
position of the peripheral monocyte population and that the
defect in complement-mediated phagocytosis is unrelated to the
binding of immune complexes to these cells. Previous work15
has shown the presence of circulating functionally immature
monocyte precursors in patients with rheumatoid arthritis and
systemic lupus erythematosus. We are currently exploring the
relative maturation of complement and Fc-receptor function in
monocytes from patients with these diseases.
Whatever the basis for the underlying defect of complement-
mediated phagocytosis it could have direct relevance to the
pathogenesis of rheumatoid vasculitis.
Assays of Clq binding activity and anticomplementary activity
were kindly performed by Dr T B Wallington, of the South-west
Regional Transfusion Centre, Bristol, and complement assays by
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